‹ÆÑ@ƒŠ@ƒX@ƒg
(1999`2003)
‰p•¶Œ´’˜˜_•¶
•a‘ԉ𖾕”–åi¶—•”–åj
1.
Satoh Y, Williams MR, Habara Y: Effects of AlF4-
and ATP on Intracellular calcium dynamics of crypt epithelial cells in mouse
small intestine. Cell Tissue Res 298: 295-305, 1999
2.
Tachikawa E, Itoh K, Kudo K, Harada K, Kashimoto
T, Hirota Y: Effects of interferons on cortisol production in bovine adrenal
fasciculata cells stimulated by adrenocorticotropin. J
Pharm Pharmacol 51: 465-473, 1999
3.
Tachikawa E, Kudo K, Harada K, Kashimoto T,
Miyate Y, Kakizaki A, Takahashi E: Effects of ginseng saponins on responses
induced by various receptor stimuli. Eur
J Pharmacol 369: 23-32, 1999
4.
Onodera S, Hicks TP: Evolution of the motor
system: Why the elephantfs trunk works like a humanfs hand. Nueroscientist
5: 217-222, 2000
5.
Tachikawa E, Takahashi M, Kashimoto T: Effects
of extract and ingredients isolated from Magnolia obovata Thungberg on
catecholamine secretion from bovine adrenal chromaffin cells. Biochem
Pharmacol 60: 433-440, 2000
6.
Cui Z-J, Habara Y, Satoh Y: Photodynamic
modulation of adrenergic receptors in the isolated rat hepatocytes. Biochem
Bioph Res Co 277: 705-710, 2000
7.
Mori S, Saino T, Satoh Y: Effect of low temperatures
on compound 48/80-induced intracellular Ca2+ changes and exocytosis
of rat peritoneal mast cells. Arch Histol Cytol 63: 261-270, 2000
8.
Shinohe Y, Saino T: Effects of ATP on
intracellular calcium dynamics of the perineurium of peripheral nerve bundles. Histochem
Cell Biol 114: 497-504, 2000
9.
Kumagai M, Saino T: Effects of ATP on
intracellular calcium dynamics of neurons and satellite cells in rat superior
cervical ganglia. Histochem Cell Biol 115: 285-292, 2001
10.
Fujita R, Kimura S, Kawasaki S, Takashima K,
Matsumoto M, Hirano H, Sasaki K: ATP suppresses the K+ current
responses to FSH and adenosine in the folliculer cells of Xenopus oocyte. Jpn J Physiol 51: 491-500, 2001
11.
Kimura S, Kawasaki S, Takashima K, Sasaki K:
Physiological and pharmacological characteristics of quisqualic acid-induced K+-current
response in the ganglion cells of Aplysia.
Jpn
J Physiol 51: 511-521, 2001
12.
Yokota Y, Nara K, Miura H, Kimura S, Kawasaki S,
Somei K: Dual roles of protein kinase C in regulation of synaptic transmission on
the bullfrog sympathetic ganglia. J Iwate med Assoc 53: 31-41, 2001
13.
Gesase AP, Satoh Y: Sexual differences effects
of castration on secretory mode and intracellular calcium ion dynamics of
golden hamster harderian gland. Cell Tissue Res 304: 81-90, 2001
14.
Warashina A, Satoh Y: Modes of
secretagogue-induced [Ca2+]i responses in individual
chromaffin cells of the perfused rat adrenal medulla. Cell
Calcium 30: 395-401, 2001
15.
Masumiya H, Kase J, Kawanishi T, Hayakawa T,
Miyata S, Sato Y, Nakamura R, Tanaka H, Shigenobu K: Effect of T-type and
L-type Ca2+ channel blockade on early phase Ca2+
transients in rat atrial and ventricular cardiomyocytes. Bioimages
9: 87-93, 2001
16.
Hashikura S, Satoh Y, Cui ZJ, Habara Y:
Photodynamic action inhibits compound 48/80-induced exocytosis in rat
peritoneal mast cells. Jpn J Vet Res 49: 239-247, 2001
17.
Tanaka H, Masumiya H, Sekine T, Kase J,
Kawanishi T, Hayakawa T, Miyata S, Sato Y, Nakamura R, Shigenobu K: Involvement
of Ca2+ waves in excitation-contraction coupling of rat atrial
cardiomyocytes. Life Sci 70: 715-726, 2001
18.
Tachikawa E, Kudo K, Nunokawa, M, Kashimoto T,
Takahashi E, Kitagawa S: Characterization of ginseng saponin ginsenoside-Rg3
inhibition of catecholamine secretion in bovine adrenal chromaffin cells. Biochem
Pharmacol 62: 943-951, 2001
19.
Tachikawa E, Mizuma K, Kudo K, Kashimoto T,
Yamato S, Ohta S: Characterization of the functional subunit combination of
nicotinic acetylcholine receptors in bovine adrenal chromaffin cells. Neurosci
Lett 312: 161-164, 2001
20.
Ogawa T, Hagihara K, Suzuki M, Yamaguchi Y:
Brevican in the developing hippocampal fimbria: differential expression in
myelinating oligodendrocytes and adult astrocytes suggests a dual role for
brevican in central nervous system fiber tract development. J
Comp Neurol 432: 285-295, 2001
21.
Takahashi S, Hitomi J, Satoh Y, Takahashi T,
Asakura H, Ushiki T: Fine structure of the mouse portal vein in relation to its
peristaltic movement. Arch Histol Cytol 65: 71-82, 2002
22.
Saino T, Matsuura M, Satoh Y: Application of real-time
confocal microscopy to intracellular calcium ion dynamics in rat arterioles. Histochem
Cell Biol 117: 295-305, 2002
23.
Takashima K, Kawasaki S, Kimura S, Fujita R,
Sasaki K: Blockade of ionotropic receptor responses by progesterone in the
ganglion cells of Aplysia. Neurosci
Res 43: 119-125, 2002
24.
Kudo K, Tachikawa E, Kashimoto T: Inhibition by
pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin
cells. Eur J Pharmacol 456: 19-27, 2002
25.
Kitagawa S, Tachikawa E, Kashimoto T: Transbilayer
transport of a propyltrimethylammonium derivative of diphenylhexatriene
(TMAP-DPH) in bovine blood platelets and adrenal chromaffin cells. J Pharm Pharmacol 54: 1631-1636, 2002
26.
Saino T, Matsuura M, Satoh Y: Comparison of the
effect of ATP on intracellular calcium ion dynamics between rat testicular and
cerebral arteriole smooth muscle cells.
Cell Calcium 32: 153-16, 2002
27.
Kubo-Watanabe S, Satoh Y, Saino T: Adenosine-5'-triphosphate-induced
intracellular calcium changes through gap-junctional communication in the
corneal epithelium. Jpn J Ophthalmol 46: 479-487, 2002
28.
Kubo-Watanabe S, Goto S, Saino T, Tazawa Y,
Satoh Y: ATP-induced [Ca2+]i changes in the human corneal
epithelium. Arch Histol Cytol 66: 63-72, 2003
29.
Gesase A, Satoh Y: Apocrine secretory mechanism:
recent findings and unresolved problems. Histol Histopathol 18: 597-608, 2003
30.
Suzuki M, Obara K, Sasaki Y, Sasaki K, Matoh H,
Nunosawa F: Comparison of perivascular astrocytic structure between white
matter and gray matter of rats.@Brain Res (in press)
31.
Kawasaki S, Kimura S, Fujita R, Sasaki K: The
small GTP-binding protein RhoA regulates serotonin-induced Na+
current response in the neurons of Aplysia.
Neurosci
Res (in press)
32.
Tanaka H, Sato K, Saito Y, Yamashita T, Agoh M,
Okunishi J, Tachikawa E, Suzuki K: Insect Diapause-specific peptide from the
leaf beetle has consensus with a putative iridovirus peptide. Peptides
(in press)
33.
Tachikawa E, Kudo K, Hasegawa H, Kashimoto T,
Sasaki K, Miyazaki M, Taira H, Lidstrom JM: In
vitro inhibition of adrenal catecholamine secretion by steroidal
metabolites of ginseng saponins. Biochem
Pharmacol (in press)
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
34.
Fukudo S, Abe K, Itoyama Y, Mochizuki S, Sawai T,
Hongo M: Psychophysiological stress induces heat shock cognate protein 70
messenger RNA in the hippocampus of rats. Neuroscience
91: 1205-1208, 1999
35.
Kawamura T, Inada K, Nara N, Wakusawa R, Endo S:
Influence of methylprednisolone on cytokine balance during cardiac surgery.@Crit
Care Med
27: 545-548, 1999
36.
Yamada Y, Endo S, Nakae H, Kamei Y, Taniguchi S,
Ishikura H, Tanaka T, Taki K, Inada K: Nuclear matrix protein levels in burn
patients with multiple organ dysfunction syndrome. Burns
25: 705-708, 1999
37.
Nossik D, Kaplina E, Nossik N, Kalinina L,
Tsutsumi R, Miura Y, Sera K, Itoh C, Sato S, Lvov D: A Fe3+/DNA
complex induces an anti-human immunodeficiency virus factor(s) in CD4+ lymphocyte
cell lines. Acta Virologica 43: 25-30, 1999
38.
Kato S, Tsutsumi R, Sato S: Nucleotide sequence
of the 5' nontranslated and virion polypeptides regions of coxsackievirus B6. Microbiol
Immunol 43: 871-883, 1999
39.
Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M,
Ukitsu M, Genda Y: The methylation status of cytosines in a tau gene promoter
region alters with age to downregulate transcriptional activity in human
cerebral cortex. Neurosci Lett 275: 89-92, 1999
40.
Utsugisawa K, Nagane Y, Tohgi H, Yoshimura M,
Ohba H, Genda Y: Changes with aging and ischemia in nicotinic acetylcholine
receptor subunit alpha7 mRNA expression in postmortem human frontal cortex and
putamen. Neurosci Lett 270: 145-148, 1999
41.
Tohgi H, Utsugisawa K, Yoshimura M, Nagane Y,
Ukitsu M: Local variation in expression of pro- and antithrombotic factors in
vascular endothelium of human autopsy brain. Acta
Neuropathol 98: 111-118, 1999
42.
Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M,
Genda Y, Ukitsu M: Reduction with age in methylcytosine in the promoter
region-224 approximately-101 of the amyloid precursor protein gene in autopsy
human cortex.@Brain Res Mol Brain Res 70: 288-292,
1999
43.
Utsugisawa K, Tohgi H, Yoshimura M, Nagane Y,
Ukitsu M: Quantitation of nicotinic acetylcholine receptor subunits alpha 4 and
beta 2 messenger RNA in postmortem human brain using a non-radioactive RT-PCR
and CCD imaging system. Brain Res Protoc 4: 92-96, 1999
44.
Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M,
Ukitsu M, Genda Y: Decrease with age in methylcytosines in the promoter region
of receptor for advanced glycated end products (RAGE) gene in autopsy human
cortex. Brain Res Mol Brain Res 65: 124-128, 1999
45.
Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki
E, Isobe C: Increase in oxidized NO products and reduction in oxidized
glutathione in cerebrospinal fluid from patients with sporadic form of
amyotrophic lateral sclerosis. Neurosci Lett 260: 204-206, 1999
46.
Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki
E, Isobe C: Alteration of 3-nitrotyrosine concentration in the cerebrospinal
fluid during aging and patients with Alzheimer's disease. Neurosci Lett 269: 52-54,
1999
47.
Tohgi H, Abe T, Yamazaki K, Murata T, Ishizaki
E, Isobe C: Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in
patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 46:129-131, 1999
48.
Matsuno H, Sawai T, Nezuka T, Uzuki M, Tsuji H,
Nishimoto N and Yoshizaki K: Treatment of rheumatoid synovitis with
anti-reshaping human interleukin-6 receptor monoclonal antibody: use of
rheumatoid arthritis tissue implants in the SCID mouse model. Arthritis
Rheum 41: 2014-2021, 1999
49.
Takahashi Y, Kasahara T, Sawai T, Rikimaru A,
Mukaida N, Matsushima K, Sasaki T: The participation of IL-8 in the synovial
lesions at an early stage of rheumatoid arthritis. Tohoku
J Exp Med 188: 75-87, 1999
50.
Uzuki M, Watanabe T, Katsura Y, Sawai T:
Quantitative histochemical study of hyaluronic acid binding protein and the
activity of uridine diphosphoglucose dehydrogenase in the synovium of patients
with rheumatoid arthritis. Anal Quant Cytol Histol 21: 75-80, 1999
51.
Hishinuma T, Nakamura H, Sawai T, Uzuki M,
Itabashi Y, Mizugaki M: Microdetermination of prostaglandin E2 in joint
fluid in rheumatoid arthritis patients using gas-chromatography /selected ion
monitoring. Prostag Oth Lipid M 58: 179-186, 1999
52.
Watanabe M, Sawai T: Alteration of cross-linking
amino acids of elastin in human aorta in association with dissecting aneurysm:
Analysis using high performance liquid chromatography. Tohoku
J Exp Med 187: 291-303, 1999
53.
Watanabe M, Takahashi M, Sawai T: Unusual renal
involvement of polymyositis complicated with malignant hypertension. Jap
J Rheumatol 9: 381-390, 1999
54.
Kaneko C, Mizunashi K, Tanaka M, Uzuki M,
Kikuchi M, Sawai T, Goto M: Relationship between Ca-dependent change of serum
PTH and extracellular Ca2+-sensing receptor expression in
parathyroid adenoma. Calcif Tissue Int 64: 271-272, 1999
55.
Sawai T, Goto K, Watanabe M, Endoh W, Ogata K,
Nagura H: Constructing a local district telepathology network in
56.
Osaki T, Omotezako M, Nagayama R, Hirata M,
Iwanaga S, Kasahara J, Hattori J, Ito I, Sugiyama H, Kawabata S: Horseshoe crab
hemocyte-derived antimicrobial polypeptides, tachystatins, with sequence
similarity to spider neurotoxins. J Biol Chem 274: 26172-26178, 1999
57.
Kitada M, Mizoguchi A, Tohyama K, Ohtsubo A,
Fujimoto E, Chakrabortty S, Ide C: Comparison of the axonal and glial reactions
between the caudal and rostral border in the cryoinjured dorsal funiculus of
the rat spinal cord. Restract Neurol Neurosci 14: 251-263, 1999
58.
Maruyama Y, Abe T, Tohgi H, Naoi M: An
endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the
cerebrospinal fluid decreases with progression of Pakinson's disease. Neurosci Lett 262: 13-16, 1999
59.
Yoshida M, Igarashi A, Suwendra P, Inada K,
Masri SM, Komang K, Suda H, Maria TA, Puta ABN, Takikawa Y, Maesawa S, Yoshida
H, Chiba M: The first report on human cases serologically diagnosed as japanese
enchephalitis in
60.
Suzuki M, Asahara H, Endo S, Inada K, Doi M,
Kuroda K, Ogawa A: Increased levels of nitrite/nitrate in the cerebrospinal
fluid of patients with subarachnoid hemorrhage. Neurosurg
Rev 22: 96-98, 1999
61.
Kasai T, Endo S, Inada K, Yamada Y, Wakabayashi
G, Niimi M, Ishikura H, Tanaka T: Nitrite/Nitrate and type II phospholipase A2 increase in
patients with multiple organ dysfunction syndrome. Crit
Care Shock 2: 82-86, 1999
62.
Shibata M, Ueshima K, Harada M, Nakamura M,
Hiramori K, EndoS, Mukaida H, Suzuki T, Suzuki T, Inada K: Effect of magnesium
sulfate pretreatment and significance of matrix metalloproteinase-1 and
interleukin-6 levels in coronary reperfusion therapy for patients with acute
myocardial infarction. Angiology 50: 573-58,
1999
63.
Yamada Y, Endo S, Shibata M, Kikuchi M, Nakae H,
Wakabayashi G, Tanaka T, Taki K, Inada K: Interleukin 1 receptor antagonist and
interleukin 10 levels clearly reflect hemodynamics during septic shock. Crit
Care Shock 2: 27-31, 1999
64.
Jia Q, Ohka S, Iwasaki K, Tohyama K, and Nomoto
A: Isolation and molecular characterization of a poliovirus type 1 mutant that
replicates in the spinal cords of mice. J
Virol 73: 6041-6047, 1999
65.
Kubo Y, Suzuki M, Kudo A, Yoshida K, Suzuki T,
Ogasawara K, Ogawa K, Kurose A, Sawai T: Thrombin inhibitor ameliorates
secondary damage in rat brain injury: Suppression of inflammatory cells and
vimentin-positive astrocytes. J Neurotrauma 17: 163-172, 2000
66.
Kurose A, Beppu T, Miura Y, Suzuki M, Ogawa A,
Arai H, Kubo Y, Sugawara A, Sawai T: Desmoplastic cerebral astrocytoma of
infancy intermingling with atypical glial cells. Pathol Int 50: 744-749,
2000
67.
Nakae H, Endo E, Yamada Y, Inada K: Bound and
soluble adhesion molecule and cytokine levels in patients with severe burns. Burns
26: 139-14, 2000
68.
Takakuwa T, Endo S, Shirakura Y, Yokoyama M,
Tamatani M, Tohyama M, Aozasa K, Inada K: Interleukin-10 gene transfer improves
the survival rate of mic inoculated with Escherichia
coli. Crit Care Med 28: 26859-2689, 2000
69.
Kawamura T, Nara N, Kadosaki M, Inada K, Endo S:
Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting
proinflammatory cytokines production during cardiac surgery. Crit
Care Med 28: 2201-2208, 2000
70.
Nishikawa Y, Suzuki M, Kuwata N, Ogawa A:
Microvascular decompression for treating glossopharyngeal neuralgia complicated
by sick sinus syndrome. Acta Neurochir 142: 351-352, 2000
71.
Miura M, Endo S, Inada K, Inoue Y, Yamada Y,
Fujino Y, Baba E, Wakabayashi G, Katsuya H, Sato N, Sato S: Tumor necrosis
factor-a and nitrite/nitrate (NOx) levels in patients with acute pancreatitis. Crit
Care Shock 4: 189-194, 2000
72.
Tohgi H, Utsugisawa K, Nagane Y: Hypoxia-induced
expression of C1q, a subcomponent of the complement system, in cultured rat
PC12 cells. Neurosci Lett 291: 151-154, 2000
73.
Utsugisawa K, Nagane Y, Obara D, Tohgi H:
Increased expression of alpha7 nAChR after transient hypoxia in PC12 cells. Neuroreport
11: 2209-2212, 2000
74.
Tohgi H, Utsugisawa K, Nagane Y: Protective
effect of nicotine through nicotinic acetylcholine receptor alpha 7 on
hypoxia-induced membrane disintegration and DNA fragmentation of cultured PC12
cells. Neurosci Lett 285: 91-94, 2000
75.
Nagane Y, Utsugisawa K, Tohgi H: PCR
amplification in bisulfite methylcytosine mapping in the GC-rich promoter
region of amyloid precursor protein gene in autopsy human brain. Brain
Res Protoc 5: 167-171, 2000
76.
Utsugisawa K, Nagane Y, Tohgi H: Marked increase
in CD44-highly positive cells in hyperplastic thymuses from patients with
myasthenia gravis. Muscle Nerve 23: 507-513, 2000
77.
Tohgi H, Abe T, Takahashi S, Yonezawa H,
Utsugisawa K: Pathogenesis of vascular dementia of Binswanger Type (VDBT). J
Stroke Cerebrovasc Dis 9: 45-46, 2000
78.
Kurose A, Oyama K, Murakami Y, Ohyama K, Segawa
I, Sawai T: Dilated cardiomyopathy in Noonan syndrome: A first autopsy case. Hum
Pathol 31: 764-767, 2000
79.
Pan LH, Yamauchi K, Sawai T, Nakadate T, Kojima
Y, Takahashi N, Adachi K, Kameyama A, Inoue H: Inhibition of binding between E-
and P-selectins, and SLeX molecule suppresses the inflammatory response in
hypersensitivity pneumonitis in mice.
Am J Respir Crit Care Med 161:
1689-1697, 2000
80.
Nagaoka I, Hirota S, Yomogida S, Ohwada A,
Hirata M: Synergistic actions of antibacterial neutrophil defensins and
cathelicidins. Inflamm Res 49: 73-79, 2000
81.
St Swierzko A, Kirikae T, Kirikae F, Hirata M,
Cedzynski M, Ziolkowski A, Hirai Y, Kusumoto S, Yokochi T, Nakano M: Biological
activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin
B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. J
Med Microbiol 49: 127-138, 2000
82.
Arakawa N, Endo S, Nakamura M, Saito S, Inada K,
Ogawa M, Hiramori K: Increased plasma group II phospholipase A2 concentrations
in patients with acute myocardial infarction: correlation with tumor necrosis
factor-alpha. Cardiology 94: 106-110, 2000
83.
Nakae H, Endo S, Kikuchi M, Yamada Y, Shibata M,
Ishikura H, Tanaka T, Wakabayashi G, Kawamura T, Inada K, Sato S:
Nitrite/Nitrate (Nox) levels and hemodynamics during septic shock. Surg Today 30: 683-688, 2000
84.
Endo S, Inada K, Yamada Y, Wakabayashi G,
Ishikura H, Tanaka T, Sato S: Interleukin 18 (IL-18) levels in patients with
sepsis. J Med 31: 15-20, 2000
85.
Ozaki M, Tohyama K, Kishida H, Buonanno A, Yano
R, Hashikawa T: Roles of neuregulin in synaptogenesis between mossy fibers and
cerebellar granule cells. J Neurosci Res 59: 612-623, 2000
86.
Kawamura T, Inada K, Nara N, Endo S: The authors
reply. Crit Care Med 28: 3374, 2000
87.
Endo S, Inoue Y, Fujino Y, Yamada Y, Sato N,
Wakabayashi G, Sakamoto T, Ishikura H, Tanaka T, Inada K, Sato S: Soluble fas
and soluble fas L levels in patients with acute pancreatitis. Res
Com Chem Path Phar 108: 179-186, 2000
88.
Kudo A, Suzuki M, Kubo Y, Watanabe M, Yoshida K,
Doi M, Kuroda K, Ogawa A: Intrathecal administration of thrombin inhibitor
ameliorates cerebral vasospasm. Use of a drug delivery system releasing
hirudin.@Cerebrovasc Dis 10: 424-430, 2000
89.
Sapp E, Kegel KB, Aronin N, Hashikawa T,
UchiyamaY, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M: Early and progressive
accumulation of reactive microglia in the Huntington's disease brain. J Neuropathol
Exp Neurol 60: 161-172, 2001
90.
Uzuki M, Sasano H, Muramatsu Y, Totsune K, Oki
Y, Takahashi K, Iino K, Sawai T: Urocortin in the synovial tissue of patients
with rheumatoid arthritis. Clin Sci 100: 577-589, 2001
91.
Pan LH, Yamauchi K, Uzuki M, Nakanishi T,
Takigawa M, Inoue H, Sawai T: Type II alveolar epithelial cells and
interstitial fibroblasts express connective tissue growth factor in idiopathic
pulmonary fibrosis. Eur Respir J 17: 1220-1227, 2001
92.
Zang Y, Tohyama K, Winterbottom JK, Haque NSK,
Schachner M, Lieberman AR, Anderson PN,: Correlation between putative
inhibitory molecules at the dorsal root entry zone and failure of dorsal root
axonal regeneration. Mol Cellular Neurosci 17: 444-459, 2001
93.
Hirano N, Haga S, Sada Y, Tohyama K: Susceptibility
of rats of different ages to inoculation with swine haemagglutinating
encephalomyelitis virus (Coronavirus) by various routes. J
Comp Pathol 125: 8-14, 2001
94.
Hirano N, Tohyama K, Ootani N, Hashikawa T:
Infection of hemagglutinating encephalomyelitis virus (HEV) at the visual
pathways of rats. Adv Exp Med Biol 494: 149-154, 2001
95.
Hirano N, Tohyama K, Taira H, Hashikawa T:
Spread of hemagglutinating encephalomyelitis virus (HEV) in the CNS of rats
inoculated by intranasal route. Adv
Exp Med Biol 494: 127-132, 2001
96.
Mihara M, Utsugisawa K, Konno S, Tohgi H:
Isolated lesions limited to the bilateral substantia nigra on MRI associated
with influenza A infection. Eur
Neurol 45: 290-291, 2001
97.
Nagane Y, Utsugisawa K, Obara D, Tohgi H:
NKT-associated markers and perforin in hyperplastic thymuses from patients with
myasthenia gravis. Muscle Nerve 24: 1359-1364, 2001
98.
Yamauchi K, Tanifuji Y, Pan LH, Yoshida T,
Sakurai S, Goto S, Kuroda S, Kobayashi H, Inoue H: Effects of pranlukast, a
leukotriene receptor antagonist, on airway inflammation in mild asthmatics. J
Asthma 38: 51-57, 2001
99.
Matsuno H, Yudoh K, Uzuki M, Kimura T: The
SCID-HuRAg mouse as a model for rheumatoid arthritis.@Modern
Rheumatol
11: 6-9, 2001
100.
Nakao K, Shibusawa M, Ishihara A, Yoshizawa H,
Tsunoda A, Kusano M, Kurose A, Makita T, Sasaki K: Genetic changes in
colorectal carcinoma tumors with liver metastases analyzed by comparative
genomic hybridization and DNA ploidy. Cancer
91: 721-726, 2001
101.
Kurose A, Yoshida W, Yoshida M, Sawai T: Effects
of paclitaxel on cultured synovial cells from patients with rheumatoid
arthritis. Cytometry 44: 349-354, 2001
102.
Niyonsaba F, Someya A,
Hirata M, Ogawa H, Nagaoka I: Evaluation of the effects of peptide
antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and
prostaglandin D2 production from mast cells. Eur J Immunol 31: 1066-1075, 2001
103.
Sapp E, Kegel KB, Aronin N, Hashikawa T,
Uchiyama Y, Tohyama K, Bhide PG, Vonsattel JP, DiFiglia M: Early and
progressive accumulation of reactive microglia in the Huntington disease brain.
J Neuropathol Exp Neurol 60: 161-172,
2001
104.
Ohka S, Ohno H, Tohyama K, Nomoto A: Basolateral
sorting of human poliovirus receptor alpha involves an interaction with the mu
1B subunit of the clathrin adaptor complex in polarized epithelial cells. Biochem
Biophy Res Com 287: 941-948, 2001
105.
Sawai T, Uzuki M: Dynamics of hyaluronate in patients
with rheumatoid arthritis. Connective Tissue 33: 253-259, 2001
106.
Hatori M, Ohtani H, Yamada N, Uzuki M, Kokubun
S: Synchronous multifocal osteosarcoma with lymphatic spread in the lung: an
autopsy case report. Jpn J Clin Oncol 31: 562-566, 2001
107.
Shibata C, Kobari M, Tsuchiya T, Arai K, Anzai
R, Takahashi M, Uzuki M, Sawai T, Yamazaki T: Pancreatectomy combined with
superior mesenteric-portal vein resection for adenocarcinoma in pancreas. World J Surg 25: 1002-1005, 2001
108.
Nakazawa F, Matsuno H, Yudoh K, Katayama R,
Sawai T, Uzuki M, Kimura T: Methotrexate inhibits rheumatoid synovitis by
inducing apoptosis.@J Rheumatol 28: 1800-1808, 2001
109.
Umeda H, Kawamorita K, Suyama K:
High-performance liquid chromatographic quantification of allysine as
bis-p-cresol derivative in elastin. Amino Acids 20: 187-199, 2001
110.
Umeda H, Nakamura F, Suyama K: Oxodesmosine and
isooxodesmosine, candidates of oxidative maetabolic intermediates of pyridinium
cross-linking in elastin. Arch Biochem Biophys 385: 209-219, 2001
111.
Umeda H, Takeuchi M, Suyama K: Two new elastin
cross-links having pyridine skeleton.
J Biol Chem 276: 12579-12587, 2001
112.
Nakae H, Endo S, Inoue Y, Fujino Y, Onodera M,
Sakamoto T, Tanaka T, Inada K, Sato S: Chronological changes in the serum
levels of endothelin-1 in patients with acute pancreatitis. Crit
Care Shock 4: 1441-1444, 2001
113.
Nakae H, Endo S, Sato N, Wakabayashi G, Inada K,
Sato S: Involvement of soluble adhesion molecules in acute pancreatitis. Eur Surg Res 33: 377-382, 2001
114.
Sano H, Kumagai J, Sawai T: Experimental fascial
patch autografting for the supraspinatus tendon defect-remodeling process of
the grafted fascia and the insertion into bone-. J Shoulder Elb Surg 11: 166-173, 2002
115.
Yoshida M, Ichinohe S, Uzuki M, Yoshida W, Sawai
T, Shimamura T: Development of large pseudocysts adjacent to the knee joint in
rheumatoid arthritis.-Assessment of radiological and histopathological
approaches. Modern Rheumatol 12: 128-133,
2002
116.
Matsuno H, Yudoh K, Katayama R, Nakazawa F,
Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pitzalis C, Kimura T: The
role of TNF-ƒ¿ in the pathogenesis of inflammation and joint destruction in RA:
A study using a human RA / SCID mice chimera. Rheumatology
41: 329-337, 2002
117.
Matsuno H, Yudoh K, Uzuki M, Nakazawa F, Sawai
T, Yamaguchi N, Olsen BR, Kimura T: Treatment with angiogenesis inhibitor endostatin
represents a novel therapeutic approach in patients with rheumatoid arthritis. J
Rheumatol 29: 890-895, 2002
118.
Matsuno H, Yudoh K, Nakazawa F, Sawai T, Uzuki
M, Nishioka K, Yonehara S, Nakayama J, Ohtsuki M, Kimura T: Anti-rheumatic effects
of humanized anti-Fas monoclonal antibody in human RA/SCID mice chimera. J Rheumatol 29: 1609-1614, 2002
119.
Pan LH, Beppu T, Kurose A, Yamauchi K, Sugawara
A, Suzuki M, Ogawa A, Sawai T: Neoplastic cells and proliferating endothelial
cells express connective tissue growth factor (CTGF) in glioblastoma. Neuro
Res 24: 677-683, 2002
120.
Utsugisawa K, Nagane Y, Obara D, Tohgi H:
Over-expression of ƒ¿7 nicotinic acetylcholine receptor prevents G1-arrest and
DNA fragmentation in PC12 cells after hypoxia. J
Neurochem 81: 497-505, 2002
121.
Munakata R, Utsugisawa K, Nagane Y, Yamagata M,
Oikawa M, Obara D, Tohgi H: The effect of combined therapy with immunoadsorption
and high-dose intravenous methylprednisolone on myasthenia gravis. Eur
Neurol 48: 115-117, 2002
122.
Utsugisawa K, Nagane Y, Obara D, Tohgi H:
Over-expression of ƒ¿7 nicotinic acetylcholine receptor induces sustained ERK
phosphorylation and N-cadherin expression in PC12 cells. Mol
Brain Res 106: 88-93, 2002
123.
Obara D, Utsugisawa K, Nagane Y, Tohgi H:
Hypoxic condition interferes with phosphorylation of Akt at Thr308 in cultured
rat PC12 cells. Neurosci Lett 332: 167-170, 2002
124.
Nakae H, Endo S, Yamada Y, Sato K, Akasaka T,
Makabe H, Kaku L, Wakabayashi G, Inada K, Sato S: Interleukin 11 and stem cell
factor levels in patients with disseminated intravascular coagulation: a report
of four cases.@Crit
Care Shock
5: 126-129, 2002
125.
Nakae H, Endo S, Yamada Y, Aoki H, Inoue Y,
Kuroda K, Wakabayashi G, Tajimi K, Inada K, Sato S: Evaluation of chronological
changes in protein C activity and TNF-a and NOx levels in sepsis: a report of
four cases. Crit Care Shock 5: 33-36, 2002
126.
Konno D, Ko J-A, Usui S, Hori K, Maruoka H, Inui
M, Fujikado, Tano Y, Suzuki T, Tohyama K, et al.: The postsynaptic density and
dendritic raft localization of PSD-Zip70, which contains an N-myristoylation
sequence and leucine-zipper motifs. J Cell Sci 115: 4695-4706, 2002
127.
Hayashi S, Osawa T, Tohyama K: Comparative
observations on corneas, with special reference to Bowman's layer and
Descemet's membrane in mammals and amphibian. J
Morphol 254: 247-258, 2002
128.
Izumiyama T, Hama H, Miura M, Hatakeyama A,
Suzuki Y, Sawai T, Saito T: Frequency of broncho-bronchiolar disease in
rheumatoid arthritis: an examination by high-resolution computed tomography. Mod Rheumatol 12: 311-317, 2002
129.
Naganawa S, Sato S, Nossik D, Takahashi K, Hara
T, Tochikubo O, Kitamura K, Honda M, Nakasone T: First report of CRF03_AB
recombinant HIV type 1 in injecting drug users in
130.
Utsugisawa K, Nagane Y, Yonezawa H, Obara D,
Kondoh R, Tohgi H: Effects of FK506 on myasthenia gravis patients with high
interleukin-2 productivity in peripheral blood mononuclear cells. Muscle
Nerve 27: 245-248, 2003
131.
Utsugisawa K, Nagane Y, Obara D, Kondoh R,
Yonezawa H, Tohgi H: Interleukin-2 production by peripheral blood mononuclear
cells from patients with myasthenia gravis. Eur
Neurol 49: 160-163, 2003
132.
Nagane Y, Utsugisawa K, Obara D, Yamagata M,
Tohgi H: Dendritic cells in hyperplastic thymuses from patients with myasthenia
gravis. Muscle
Nerve 27: 582-589, 2003
133.
Yoshida W, Uzuki M, Kurose A, Yoshida M, Nishida
J, Shimamura T, Sawai T: Cell characterization of mononuclear and giant cells
constituting pigmented villonodular synovitis. Hum
Pathol 34: 65-73, 2003
134.
Miura Y, Kurose A, Kondo M, Maruyama A, Shibata
Y, Kanno H, Sawai T: Claer cell myoepithelial carcinoma of the breast. Tohoku J Exp Med 200: 103-109, 2003
135.
Pan L-H, Ito H, Kurose A, Yamauchi K, Inoue H,
Sawai T: Pulmonary lymphangioleiomyomatosis. Tohoku J Exp Med 199: 119-126, 2003
136.
Inada K, Tajkahashi K, Ichinohe S, Suda H,
Tsuchiya M, Takahashi J, Matsuura S, Kasai T, Yoshida M, Endo S, Sato S: A
silkworm larvae plasma test for detecting peptidoglycan in cerebrospinal fluid is
useful for the diagnosis of bacterial meningitis. Mircrobiol
Immunol 47: 701-707, 2003
137.
Hiranno N, Nomura R, Tawara T, Tohyama K: Neurotropism
of swine haemagglutinating encephalomyelitis virus (coronavirus) in mice
depending upon age and route of infection. J
Comp Pathol (in press)
138.
Koike Y, Uzuki M, Kokubun S, Sawai T:
Inflammatory cells infiltration improves the lumbar disc hernia. Spine
(in press)
139.
Yoshino O, Matsuno H, Nakamura H, Yudoh K, Abe
Y, Sawai T: The role of Fas-mediated apoptosis after traumatic spinal cord
injury. Spine (in press)
140.
Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y,
Nakayama J, Yonehara A, Kimua T, Matsuno H: Induction of apoptosis to activated
CD4+ T cells
suppresses osteoclastogenesis in rheumatoid arthritis. Arthritis Rheum (in press)
141.
Sawai T: Possible another important function of
VEGF related to polyneuropathy. Internal
Med (in press)
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
142.
Ogasawara K, Koshu K, Yoshimoto T, Ogawa A:
Transient hyperemia immediately after rapid decompression of chronic subdural
hematoma. Neurosurgery 45: 484-489, 1999
143.
Takahashi S, Tohgi H, Yonezawa H, Obara S, Yamazaki
E: The effect of trihexyphenidyl, an anticholinergic agent, on regional
cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.
J Neurol Sci 167: 56-61, 1999
144.
Beppu T, Yoshida Y, Arai H, Wada T, Suzuki M,
Ogawa A, Hakozaki S, Kubo N: A phase II study of nimustine hydrochloride, cisplatin,
and etoposide combination chemotherapy for supratentorial malignant gliomas. J
Neuro-Oncol 49: 213-218, 2000
145.
Ogasawara K, Ogawa A, Doi M, Konno H, Suzuki M,
Yoshimoto T: Prediction of acute embolic stroke outcome after local
intraarterial thrombolysis: Value of pretreatment and posttreatment 99mTc-Ethyl
cysteinate dimer single photon emission computed tomography. J
Cereb Blood Flow Metab 20: 1579-1586, 2000
146.
Kudo A, Suzuki M, Kubo Y, Watanabe M, Yoshida K,
Doi M, Kuroda K, Ogawa A: Intrathecal administration of thrombin inhibitor
ameliorates cerebral vasospasm.@Cerebrovascular Diseases 10: 424-430,
2000
147.
Ogasawara K, Ogawa A, Okuguchi T, Kobayashi M,
Suzuki M, Yoshimoto T: Postoperative hyperperfusion syndrome in elderly
patients with chronic subdural hematoma. Surg
Neurol 54: 155-159, 2000
148.
Ogawa A, Suzuki M, Ogasawara K: Aneurysms at
nonbranching sites in the supraclinoid portion of the internal carotid artery:
internal carotid artery trunk aneurysms. Neurosurgery
47: 578-586, 2000
149.
Suzuki M, Otawara Y, Doi M, Ogasawara K, Ogawa
A: Neurological grades of patients with poor-grade subarachnoid hemorrhage
improve after short-term pretreatment.
Neurosurgery 47: 1098-1105, 2000
150.
Abe M, Otawara Y, Suzuki M, Tomitsuka N, Ogawa
A, Hongo S, Abe M: Sonic detection system for cervical and intracranial
vascular disease. Neurosurg Rev 23: 90-93, 2000
151.
Sasaki M, Oikawa H, Tamakawa Y, Takahashi S,
Tohgi H: Disorganized unilateral cerebellar folia: a mild form of cerebellar
cortical dysplasia. Neuroradiology 43: 151-155, 2001
152.
Oikawa H, Sasaki M, Tamakawa Y, Kamei A: MR
findings of Papez circuit in mesial temporal sclerosis. Neuroradiology 43: 205-210, 2001
153.
Ogasawara K, Ogawa A, Ezura M, Yoshimoto T:
Dynamic and static 99mTc-ECD SPECT imaging of subacute cerebral infarction:
Comparison with 133Xe SPECT.
J Nucl Med 42: 543-547, 2001
154.
Ogasawara K, Ogawa A, Konno H, Shibanai K, Doi
M, Kuroda K, Yoshimoto T: Combination of early and delayed single-photon
emission tomography imaging using technetium-99m ethyl cysteinate dimer
immediately after local intraarterial thrombolysis. Eur
J Nucl Med 28: 498-505, 2001
155.
Ogasawara K, Yasuda S, Beppu T, Kobayashi M, Doi
M, Kuroda K, Ogawa A: Brain PET and technetium-99m-ECD SPECT imaging in
Lhermitte-Duclos disease. Neuroradiology 43: 993-996, 2001
156.
Inoue T, Shimizu H, Yoshimoto T, Kabasawa H:
Spatial functional distribution in the corticospinal tract at the corona
radiata: A three-dimensional anisotropy contrast study. Neurol
Med-Chir 41: 293-299, 2001
157.
Mikami C, Suzuki M, Tsuiki K, Ogawa A: Effect of nicardipine and magnesium on
cerebral infarction-Brain surface perfusion technique. Cerebrovasc Dis 11: 44-50, 2001
158.
Ogasawara K, Ogawa A, Ezura M, Konno H, Suzuki
M, Yoshimoto T: Brain single-photon emission CT studies using 99mTc-HMPAO and 99mTc-ECD early
after recanalization by local intraarterial thrombolysis in patients with acute
embolic middle cerebral artery occlusion.
Am J Neuroradiol 22: 48-53, 2001
159.
Inoue K, Kawashima R, Sugiura M, Ogawa A,
Schormann T, Zilles K, Fukuda H: Activation on the ipsilateral posterior parietal
cortex during tool use: A PET study. Neuro
Image 10: 1469-1475, 2001
160.
Ogasawara K, Beppu T, Yasuda S, Kobayashi M,
Yukawa H, Ogawa A: Blood fiow and oxygen metabolism in a case of
Lhermitte-Duclos Disease: results of positron emission tomography.@J
Neuro-Oncol 55: 59-61, 2001
161.
Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa
A: Intrathecal administration of nicardipine hydrochloride to prevent vasospasm
in patients with subarachnoid hemorrhage. Neurosurg Rev 24: 180-184, 2001
162.
Ogasawara K, Yoshida K, Otawara Y, Kobayashi M,
Yasuda S, Doi M, Ogawa A: Cerebral blood flow imaging in arteriovenous
malformation complicated by normal perfusion pressure breakthrough. Surg
Neurol 56: 380-384, 2001
163.
Suzuki M, Doi M, Otawara Y, Ogasawara K, Ogawa
A: Intrathecal administration of nicardipine hydrochloride to prevent vasospasm
in patients with subarachnoid hemorrhage.
Neurosurg Rev 24: 180-184, 2001
164.
Tohgi H, Takahashi S, Abe T, Utsugisawa K:
Symptomatic characteristics of parkinsonism and the width of substantia nigra
pars compacta on MRI according to ischemic changes in the putamen and cerebral
white matter: implications for the diagnosis. Eur Neurol 46: 1-10, 2001
165.
Sasaki M, Oikawa H, Yoshioka K, Tamakawa Y,
Konno H, Ogawa A: Combining time-resolved and single-phase 3D techniques in
contrast-enhanced carotid MR angiography.
Magn Reson Med Sci 1: 1-6,
2002
166.
Takahashi S, Yonezawa H, Takahashi J, Kudo M,
Inoue T, Tohgi H: Selective reduction of diffusion anisotropy in white matter
of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett 332: 45-48, 2002
167.
Ogasawara K, Konno K, Yasuda S, Yukawa H, Ogawa
A: Very early and standard Tc-99m ethyl cysteinate dimer SPECT imaging in a
patient with reperfusion hyperemia after acute cerebral embolism. Clinical
Nucl Med 27: 105-108, 2002
168.
Suzuki M, Kudo A, Sugawara A, Yoshida K, Kubo Y,
Suzuki T, Ogasawara K, Doi M, Ogawa A: Amino acid concentrarions in the blood
of the jugular vein and peripheral artery after traumatic brain Injury: Decreased
release of glutamate into the jugular vein in the early phase. J
Neurotrauma 19: 285-292, 2002
169.
Matsuura H, Inoue T, Konno H, Sasaki M,
Ogasawara K, Ogawa A: Quantification of susceptibility artifacts produced from
various biomaterials for neurosurgical implants in 3.0-tesla magnetic resonance
imaging. J Neurosurg 12: 1472-1475,
2002
170.
Oikawa H, Sasaki M, Tamakawa Y, Ehara S, Tohyama
K: The substantia nigra in Parkinson disease: proton density weighted spin-echo
and fast. Am J Neuroradiol 23: 1747-175, 2002
171.
Ogasawara K, Ogawa A, Terasaki K, Shimizu H,
Tominaga T, Yoshimoto T: Use of cerebrovascular reactivity in patients with
symptomatic major cerebral artery occlusion to predict 5-year outcome:
comparison of xenon-133 and iodine-123-IMP single-photon emission computed tomography.
J Cereb Blood Flow Metab 22: 1142-1148, 2002
172.
Iwata R, Pascali C, Bogni A, Flumoto S, Terasaki
K, Yanai K: [18F]Fluoromethyl triflate: a novel and reactive [18F]fluoromethylating
agent: preparation and application to the on-column preparation of [18F]fluorochpline.
Appl Radiat Isot 57: 347-352, 2002
173.
Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara
K, Ogawa A: Change of oxygen pressure in glioblastoma tissue under various
conditions. J Neuro-Oncol 58: 47-52,
2002
174.
Ogasawara K, Ogawa A, Yoshimoto T:
Cerebrovascular reactivity to acetazolamide and outcome in patients with
symptomatic internal carotid or middle cerebral artery occlusion a xenon-133
single-photon emission computed tomography study. Stroke 33: 1857-1862, 2002
175.
Ogasawara K, Yasuda S, Yukawa H, Yamagata M, Kin
M, Ogawa A: Atypical finding of brain Tc-99m-ECD SPECT imaging in herpes
simplex encephalitis. Ann
Nucl Med 16: 347-350, 2002
176.
Otawara Y, Ogasawara K, Ogawa A, Kogure T:
Dissecting aneurysms of the bilateral vertebral arteries with subarachnoid
hemorrhage: Report of three cases. Neurosurg
50: 1372-1375, 2002
177.
Otawara Y, Ogasawara K, Ogawa A, Sasaki M,
Takahashi K: Evaluation of vasospasm after subarachnoid hemorrhage by use of
multislice computed tomograhpic angiography. Neurosurg
51: 939-943, 2002
178.
Akabane A, Jokura H, Ogasawara K, Takahashi K,
Sugai K, Ogawa A, Yoshimoto T: Rapid development of interanidal aneurysm with
perifocal brain edema in an unruptured cerebral arteriovenous malfoemation. J
Neurosurg 97: 1436-1440, 2002
179.
Suzuki M, Kawamura S, Watanabe H,
180.
Yoshioka Y, Oikawa H, Ehara S, Inoue T, Ogawa A,
Kambara Y, Itazawa S, Kubokawa M: Noninvasive estimation of temperature and pH
in human lower leg muscles using 1H nuclear magnetic resonance spectroscopy. Spectroscopy 16: 183-190, 2002
181.
Inoue T, Ogasawara K, Konno H, Ogawa A, Kabasawa
H: Diffusion tensor imaging in patients with major cerebral artery occlusive
disease. Neurol Med Chir 43: 421-426,
2003
182.
Beppu T, Inoue T, Shibata Y, Kurose A, Arai H,
Ogasawara K, Ogawa A, Nakamura S, Kabasawa H: Measurement of fractional
anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neuro-Oncol 63: 109-116, 2003
183.
Kashimura H, Inoue T, Ogasawara K, Ogawa A:
Preoperative evaluation of neural tracts using three-dimensional anisotropy
contrast imaging. Neurosurgery 52: 1226-1229, 2003
184.
Yoshioka K, Niinuma H, Ohira A, Nasu K, Kawakami
T, Sasaki M, Kawazoe K: MR angiography and CT angiography of the artery of
Adamkiewicz: noninvasive preoperative assessment of thoracoabdominal aortic
aneurysm. Radiographics 23: 1215-122, 2003
185.
Sasoh M, Ogasawara K, Kuroda K, Okuguchi T,
Terasaki K, Yamadate K, Ogawa A: Effects of EC-IC bypass surgery on cognitive
impairment in patients with hemodynamic cerebral ischemia. Surg Neurol 59: 455-460, 2003
186.
Ogasawara K, Okuguchi T, Sasoh M, Kobayashi M,
Yukawa H, Terasaki K, Inoue T, Ogawa A: Qualitative versus quantitative assessment
of cerebrovascular reactivity to acetazolamide using
iodine-123-N-Isopropyl-p-Iodoamphetamine SPECT in patients with unilateral major
cerebral artery occlusi. Am
J Neuroradiol 24: 1090-1095, 2003
187.
Ogasawara K, Ito H, Sasoh M, Okuguchi T,
Kobayashi M, Yukawa H, Terasaki K, Ogawa A: Quantitative measurement of
regional cerebrovascular reactivity to acetazolamide using 123I-N-isopropyl-p-iodoamphetamine
autoradiography with SPECT: validation study using H215O with PET. J Nucl Med 44: 520-525, 2003
188.
Ogasawara K, Noda A, Yasuda S, Kobayashi M,
Yukawa H, Ogawa A: Effect of calcium antagonist on cerebral blood flow and
oxygen metabolism in patients with hypertension and chronic major cerebral
artery occlusion: a positron emission tomography study. Nucl Med Commun 24: 71-76, 2003
189.
Beppu T, Kamada K, Nakamura R, Oikawa H, Takeda
M, Fukuda T, Arai H, Ogasawara K, Ogawa A: A phase II study of radiotherapy
after hyperbaric oxygenation combined with interferon-beta and nimustine
hydrochloride to treat supratentorial malignant gliomas. J
Neuro-Oncol 61: 161-170, 2003
190.
Kuroda K, Kanbara Y, Inoue T, Ogawa A: Analysis
of NMR-CT images to detect the xylem dysfunction and lesiona in tree trunks. IAWA Jounal 23: 469-470, 2003
191.
Ogasawara K, Yukawa H, Kobayashi M, Mikami C,
Konno H, Terasaki K, Inoue T, Ogawa A: Prediction and Monitoring of cerebral
hyperfusion after carotid endarterectomy by using single-photon emission
computerized tomography scanning. J
Neurosurg 99: 504-510, 2003
192.
Shouzushima M, Tsutsumi R, Sato S, Terasaki K,
Izumisawa M, Sato H, Shoji S, Sakamaki K: Quantification of 11C-methionine uptake
during proliferation of cultured human cancer cells. Rdioisotopes 52: 10-16, 2003
193.
Sasaki M, Inoue T, Tohyama K, Ehara S, Ogawa A:
High field MRI: current concepts on clinical and microscopic imaging. Magn
Reson Med Sci, 2003 (in press)
194.
Sasaki M, Oikawa H, Ehara S: Clinical Impact of
16-row Multislice CT on the Central Nervous System Imaging. Diagnostic
Imaging, 2003 (in press)
195.
Oikawa H, Sasaki M, Ehara S, Abe H: Substantia
innominata: MR findings in Parkinson disease. Neuroradiology, 2003 (in press)
196.
Mikami C, Inoue T, Ogasawara K, Ogawa A:
Medullary streaks in a patient with atherosclerotic internal carotid artery
occlusion: Case report. Surg Neurol (in press)
197.
Inoue T, Ogasawara K, Beppu T, Ogawa A:
Three-Dimensional Anisotropy Contrast Imaging of Gliomatosis Cerebri: Two Case
Reports. Surg Neurol (in press)
198.
Sasaki T, Funaki Y, Shozushima M, Terasaki K:
Effect of anoxia on choline uptake and release of acetylcholine in brain slices
estimated with a bioradiographic technique using [11C] choline. Radioisotopes (in press)
199.
Shozushima M, Tsutsumi R, Terasaki K, Sato S,
Nakamura R, Sakamaki K: Augmentation effects of lymphocyte activation by
antigen-presenting. Ann
Nucl Med (in press)
200.
Ito N, Hanawa A, Suzuki K, Nabeshima N, Nagai Y,
Natsuhori M, Ishikawa T, Hatakeyama S, Futatsugawa S,Terasaki K, Sakamoto Y: External
dose estimation of the human related to Veterinary Nuclear Medicine of
companion animals. Radioisototes (in press)
201.
Terasaki K, Takahashi K, Sasaki M, Shozushima M,
Iwata R: Adaptation of an automated [11C]methylation system for the loop
method using [11C] methyl triflate. Radioisotopes
(in press)
‰p•¶‘àE•ª’S’˜‘
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
Kawasaki S, Kimura S, Fujita R, Takashima K,
Sasaki K, Sato M: Facilitatory effect of calmodulin-dependent protein kinase on
the K+-current responses to dopamine, acetylcholine, and
Phe-Met-Arg-Phe-NH2 in the ganglion cells of Aplysia, pp 97-100, Snow Synaptic Responses and Modulation, Kuba K,
Higashida H, Brown D, Yoshioka T ed, Springer, Amsterdam, 1999
2.
Onodera S: Evolution of the motor system: why
the elephant's trunk works like a human's hand. Neuroscientist 5: 217-226, 1999
3.
Saino T, Satoh Y: Application of real-time
confocal laser scanning microscopy to observe living cells in tissue specimens. Microscopy
(in press)
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
4.
Sawai T, Uzuki M: Serum hyaluronic acid level is
a good marker for evaluating the process of joint destruction in rheumatoid
arthritis, pp 273-277, Excerpta Medica International Congress Series (ICS), Endo
M ed,
5.
Uzuki M, Sawai T: A comparison of the affinity
of sodium hyaluronate of various molecular weights for degenerated cartilage: a
histochemical study using hyaluronic acid binding protein, pp 279-284, Excerpta
Medica International Congress Series (ICS), Endo M ed, Elsevier Science BV,
Amsterdam, 2001
6.
Hirano N, Tohyama K, Taira H, Hashikawa T: Swine
coronavirus (HEV) as a transneuronal tracer for analyzing polysynaptic pathways
in the CNS of laboratory animal, pp 41-42, Animal Research and Welfare, Association
for Laboratory Animal ed, Lab Anim Ltd., London, 2001
‘ÛƒVƒ“ƒ|ƒWƒEƒ€
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
Satoh Y, Miyata S, Saino T: Dynamic morphology
by real-time digital imaging analysis: with special reference to the
intracellular calcium ion dynamics, XV Congress of IFA, 1999, 9,
2.
Satoh Y: Real time confocal microscopy for
dynamic morphology of living tissue specimens, 15th International Morphological
Sciences, 2000, 9,
3.
Satoh Y: Real time confocal microscopy for
dynamic morphology of living tissue specimens. 15th International Morphological
Sciences, 15th International Morphological Sciences, 2000, 9,
4.
Satoh Y, Saino T: ATP-induced intracellular
calcium changes in the peripheral nervous system, The Joint JAAA-AAAA Symposium,
2001, 4,
5.
Nakagawa H, Tanigawa T, Tomita K, Tomihara Y,
Araki Y, Tachikawa E: Recent studies in sea urchin venomes, International
Symposium on Toxins and Natural Products in Honor of Professor Anthony T. Tu, 2002,
11, Naha
6.
Tachikawa E, Nagaoka Y, Iida Fujita T, Nakagaw H: Trichosporin- an
ƒ¿-aminoisobutyric acid-containing peptide isolated from Trichoderma polysporum,
forms Ca2+-permeable channels and results in Ca2+ influx
into cells, International Symposium on Toxins and Natural Products in Honor of
Professor Anthony T. Tu, 2002, 11, Naha
7.
Satoh Y, Saino T, Goto S: Confocal microscopy
for dynamic morphology of living tissue/cells: with special reference to [Ca2+]i
changes induced by ATP, 6th Joint Meeting of the JSHC and HCS, 2003,7, Sheattle
8.
Kudo K, Tu AT, Tachikawa E, Kashimoto T: Characterization
of hyaluronidase isolated from Agkistrodon
contortrix contortrix (Southern copperhead) venom, International Symposium
on Toxins and Natural Products in Honor of Professor Anthony T. Tu, 2003, 11,
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
9.
Inada K: The role of anti-inflammatory cytokines
in sepsis, The 5th National Congress of Indonesian Tropical and Infectious
Diseases Research Society, 1999, 11,
10.
Tohgi H, Abe T, Takahashi S, Yonezawa H,
Utsugizawa K: Pathogenesis of vascular dementia of Binswanger type, International
Stroke Society Regional Meeting, 1999, 4,
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
11.
Sasaki M:
12.
Sasaki M: CT in the assessment of perfusion in
stroke patients, Advanced Imaging Multidisciplinary Symposia: International
Neuroimaging Symposium, 2003, 6,
‰p•¶Proceedings
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
Watanabe M, Doi M, Tsuiki K, Suzuki M, Sasaki K,
Ogawa A: Involvement of protein tyrosine kinase activation in the mechanism of
cerebral vasospasm, Cerebral Vasospasm, 1999
2.
Doi M, Watanabe M, Tsuiki K, Suzuki M, Sasaki K,
Ogawa A: Mechanism of the mutual
augmenting effect of spasmogenic agents, Cerebral Vasospasm, 1999
3.
Tachikawa E, Hasegawa H, Kudo K, Kashimoto T,
Miyate Y, Kakizaki, A, Takahashi, K, Takahashi E: Inhibitory effects of ginseng
saponins metabolized in digestive tracts on adrenal secretion of catecholamines
in vitro, Advances in Ginseng Research 2002, 2002, 10, Seoul
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
4.
Uzuki M, Sasano H, Totsune K, Takahashi K, Sawai
T: Urocortin (UCN) and corticotropin-releasing factor (CRF) receptors in the
synovial tissue of patients with rheumatoid arthritis (RA), Arthritis Rheum, 1999
5.
Yoshida M, Uzuki M, Kurose A, Ichinohe S, Sawai
T, Shimamura T: Abundant localization of matrix metalloproteinase 9 and its
inhibitor in osteoclasts and osteoblasts at sites of the excessive bone
resorption in rheumatoid arthritis, Arthritis Rheum, 2000
6.
Yoshida W, Uzuki M, Yoshida M, Nishida J, Sato
T, Hosaka M, Shimamura T, Sawai T: Histological and cellular characterization
of pigmented villonodular synovitis, Arthritis Rheum, 2000
7.
Uzuki M, Matsuno H, Yudoh K, Nakazawa F, Katayama
R, Kimura T, Sawai T: Apoptotic chondrocyte death and matrix metalloproteinases
in rheumatoid arthritis, Arthritis Rheum, 2000
8.
Tsuchihashi Y, Okada Y, Ogushi Y, Mazaki T,
Tsutsumi Y, Sawai T: The current status of medicolegal issues surrounding telepathology
and telecytology in
9.
Nakae H, Endo S, Kikuchi M, Yamada Y, Shibata M,
Inada K, Inada H: Nitrite / Nitrate levels reflect hemodynamics during septic
shock, 5th World Congress on Trauma, Shock, Inflammation and Sepsis, 2000
10.
Yoshida M, Uzuki M, Yoshida W, Itoh T, Ichinohe
S, Sawa T, Shimamura T: Abundant expression of matrix metalloproteinase 9 and
osteoclast differentiation factor mRNA in osteoclasts and osteoblasts at sites
of punnus bone interface in rheumatoid arthritis, Arthritis Rheum, 2001
11.
Ouchi N, Uzuki M, Yoshida M, Shimamura T, Sawai
T: Cartilage destruction is partly induced by the internal proteolytic enzymes
and apoptotic phenomenon of chondrocytes in polychondritis, Arthritis Rheum, 2001
12.
Matsuno H, Yudoh K, Nakazawa F, Uzuki M, Sawai
T, Otsuki M, Ogawa Y, Nishioka, Kimura T: Treatment with novel humanaized
anti-Fas monoclonal antibody in rheumatoid arthritis, Arthritis Rheum, 2001
13.
Tanaka M, Fujii K, Tsuji M, Funaki K, Ueno Y,
Tanabe N, Hayashi H, Sawai T, Ito Y, Nishizawa T, Sawai T: Early immune
reaction to type II collagen and cartilage degeneration in MRL/Mp-lpr mouse, Arthritis
Rheum, 2001
14.
Uzuki M, Kaiyama J, Miyoshi T, Sawai T: Three
hyaluronan synthases, HAS1, HAS2, HAS3 and hyaluronan synthetic activity in the
synovial tissue of patients with rheumatoid arthritis, Arthritis Rheum, 2002
15.
Yoshida M, Uzuki M, Yoshida W, Ouchi N, Koyama
A, Ichinohe S, Sawai T, Shimamura T: Expression of matrix metalloproteinase 9
and osteoclast differentiation factor mRNA in osteoclasts and osteoblasts in
rheumatoid arthritis, Scandinavian Journal of Rheumatology, 2002
16.
Ouchi N, Uzuki M, Yoshida M, Yoshida M,
Shimamura T, Sawai T: Cartilage destruction is partly induced by the internal
proteolytic enzymes and apoptotic phenomenon of chondrocytes in polychondritis,
Scandinavian Journal of Rheumatology, 2002
17.
Yoshida W, Uzuki M, Ouchi N, Yoshida M,
Shimamura T, Sawai T: Examination of gelatinolytic activity in rheumatoid
arthritis synovium using in situ
zymography and image analyzer, Scandinavian Journal of Rheumatology, 2002
18.
Matsuno H, Yudoh K, Katayama R, Nakazawa F,
Uzuki M, Sawai T, Yonezawa T, Saeki Y, Panayi GS, Pizalis C: The role of TNF-ƒ¿
in the pathogenesis of inflammation and joint destruction in Human RA/SCID mice
chimera, Arthritis Rheum, 2002
19.
Munakata T, Uzuki M, Yoshida M, Shimamura T,
Sawai T: Interleukin (IL)-18 concentration in synovial fluid represents a
positive correlation between the number of inflammatory cells especially
lymphocytes and macrophages, in RA synovium, Arthritis Rheum, 2002
19.
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
20.
Inoue T, Shimizu H, Kumabe T, Yoshimoto T,
Kabasawa H: Imaging the corticospinal tract by diffusion weighted magnetic
resonance imaging in patients with brain tumors, Proc Intl Soc Mag Reson Med, 2000
21.
Inoue T, Shimizu H, Nakasato N, Kumabe T,
Yoshimoto T, Kabasawa H: Comparative study of MRI and MEG for objective
indentification of the central sulcus in patients with brain tumors, Proc Intl
Soc Mag Reson Med, 2000
22.
Inoue T, Ogawa A, Shimizu H, Ogasawara K: Spatial
functional distribution in the corticospinal tract at the corona radiata: a
3DAC study, Proc ISMRM, 2001
‘ÛŠw‰ï
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
Tachikawa E, Kudo K, Harada K, Kashimoto T,
Takahashi E: Inhibitory effects of ginsenosides, ginseng saponins on various
receptor stimulation-responses, Society for Neuroscience 29th Annual Meeting, 1999,
10, Miami (USA)
2.
Fukushima T, Shingai R, Marshall J, Sakata K,
Ichinose M, Ogurusu T, Tachikawa E: Ion permeability of willardine-induced
response in kainate receptor GLUR(G)/KA-2, Society for Neuroscience 30th Annual
Meeting, 2000, 11, New Orlens (USA)
3.
Shinohe Y, Kumagai M, Saino T, Satoh Y: Effects
of ATP and its analogues on [Ca2+]i dynamics of
perineurium in the rat sciatic nerve, 40th American Society for Cell Biology
Annual Meeting, 2000, 12, San Francisco (USA)
4.
Shinohe Y, Kumagai M, Saino T, Satoh Y: Effects
of ATP on intracellular calcium dynamics of perineurium in the rat sciatic
nerve, 15th International Morphological Sciences, 2000, 9,
5.
Kumagai M, Shinohe Y, Saino T, Joh S, Satoh Y: Effects
of ATP on intracellular calcium dynamics of neurons and satellite cells in rat
superior cervical ganglion, 15th International Morphological Sciences, 2000, 9,
Kyoto
6.
Watanabe S, Miyata S, Saino T, Tazawa Y, Satoh Y:
Communication through [Ca2+]i dynamics in rabbit corneal
epithelium, 15th International Morphological Sciences, 2000, 9, Kyoto
7.
Saino T, Matsuura M, Satoh Y: Effect of ATP on
intracellular calcium ion dynamics of smooth muscle cells in testicular and
cerebral arterioles of rats, 15th International Morphological Sciences, 2000, 9,
8.
Miyata S, Sato Y: The imaging of nitric oxide on
neonatal rat cardiomyocytes, 15th International Morphological Sciences, 2000, 9,
9.
Kumagai M, Shinohe Y, Saino T, Joh S, Satoh Y: Measurements
of intracellular calcium in superior cervical ganglion of rats, 40th American
Society for Cell Biology Annual Meeting, 2000, 12, San Francisco
10.
Kawasaki S, Kimura S, Fujita R, Takashima K,
Sasaki K: Regulatory role of monomeric G-protein RhoA on the serotonin-induced
Na+-current
response in the ganglion cells of Aplysia,
The 34th World Congress of the International Union of Physiological Sciences, 2001,
8, Christchurch (New Zealand)
11.
Kimura S, Kawasaki S, Fujita R, Takashima K,
Sasaki K: CaM-kinase II and protein phosphatase 2A reciprocally regulate
quisqualic acid-induced K+-current response in the identified neurons
of Aplysia, The 34th World Congress
of the International Union of Physiological Sciences, 2001, 8, Christchurch (New
Zealand)
12.
Fujita R, Hirano H, Kawasaki S, Kimura S,
Matsumoto M, Sasaki K, Takashima K: Stimulation of P2-receptor suppresses the K+-current
responses to FSH and adenosine in the follicular cells of Xenopus oocyte, The 34th World Congress of the International Union
of Physiological Sciences, 2001, 8, Christchurch (New Zealand)
13.
Nishikawa Y, Koji T, Kawasaki S, Kimura S, Doi
M, Ogawa A, Sasaki K: Role of Rho-kinase in the serotonin-induced contraction
in the middle cerebral artery of bovine, The 34th World Congress of the
International Union of Physiological Sciences, 2001, 8, Christchurch (New
Zealand)
14.
Koji T, Nishikawa Y, Doi M, Kawasaki S, Kimura
S, Ogawa A, Sasaki K: Prolonged contraction induced by stimulation of receptor
for cyclicthromboxane A2 in the middle cerebral artery of bovine, The
34th World Congress of the International Union of Physiological Sciences, 2001,
8,
15.
Matsuura M, Saino T, Satoh Y: Effect of ATP on
Intracellular Calcium Concentration Dynamics of Arterioles of Heart of Golden
Hamster, 41st American Society for Cell Biology Annual Meeting, 2001, 12,
16.
Satoh Y,
Watanabe S, Saino T, Tazawa Y, Tohyama K: ATP-induced intracellular
calcium increase of human corneal epithelium, 41st American Society for Cell
Biology Annual Meeting, 2001, 12,
17.
Kudo K, Tachikawa E, Kashimoto T, Harada K: Pregnenolone
sulfate, a neuropeptide, inhibits catecholamine secretion stimulated by
acetylcholine in cultured bovine adrenal chromaffin cells, Society for
Neuroscience 31st Annual Meeting, 2001, 11,
18.
Saino T, Matsuura M, Satoh Y: Dipyridamole
Inhibits ATP-induced smooth muscle contraction in testicular and cerebral
arterioles of rats, 41st American Society for Cell Biology Annual Meeting, 2001,
12,
19.
Matsuura M, Saino T, Satoh Y: Effect of ATP on
Intracellular Calcium Concentration Dynamics of Arterioles of Heart of Golden
Hamster, 41st American Society for Cell Biology Annual Meeting, 2001, 12,
20.
Sasaki K,
Kawasaki S, Kimura S, Takashima K: D1-receptor-induced current response
reverses from inward to outward after the injection of guanosine
thiotriphosphate in the ganglion cells of Aplysia,
The 3rd International Symposium on the Study of Brain Function, 2002, 5,
21.
Fujita R, Kimura S, Kawasaki S, Takashima K,
Matsumoto M, Hirano H, Sasaki: Suppressing action of P2Y-receptor stimulation
on the K+-current response to adenosine and FSH in the follicular
cells of Xenopus Laevis oocyte, The
3rd International Symposium on the Study of Brain Function, 2002, 5,
22.
Ogasawara M, Yamauchi K, Satoh Y, Maeyama K: Molecular mechanism of
intracellular translocation of histamine N-methyltransferase, 42nd American
Society for Cell Biology Annual Meeting, 2002, 12, San Francisco
23.
Suzuki M, Matoh K, Sasaki Y, Ikemoto K,
Nishimura A, Nishi K: Neuroanatomical basis of the white matter disease,@XII World Congress of Psychiatry,
2002, 8, Yokohama
24.
Matsuura M, Saino T, Satoh Y: ATP-induced
contraction of coronary arterioles in golden hamster is accompanied with Ca2+
influx via P2X ion channel type receptors, 42nd American Society for Cell
Biology Annual Meeting, 2002, 12,
25.
Satoh Y,
Saino T, Goto S, Tohyama K: Photodamage of Harderian gland cells
containing porphyrins is resulted from production of nitricoxide, 42nd American
Society for Cell Biology Annual Meeting, 2003, 12,
26.
Saino T, Matsuura M, Satoh Y: Dipyridamole
inhibits ATP-induced smooth muscle contractions in testicular and cerebral
arterioles of rats, 42nd American Society for Cell Biology Annual Meeting, 2003,
12,
27.
Matsuura M, Saino T, Satoh Y: ATP-induced
contraction of coronary arterioles in golden hamster is accompanied with Ca2+
influx via P2X ion channel type receptors, 42nd American Society for Cell
Biology Annual Meeting, 2003, 12,
28.
Fujita R, Kimura S, Kawasaki S, Hirano H,
Matsumoto M, Sasaki K: Inhibition of K+-current responses to FSH and
adenosine by stimulation of P2Y-receptor in the follicular cells of Xenopus
oocyte, 6th IBRO World Congress of Neuroscience, 2003, 7, Praque (Czech
Republic)
29.
Kawasaki S, Kimura S, Fujita R, Matsumoto M,
Sasaki K: Reversal of D1 receptor-induced current response from
inward to outward after the injection of GTP-analogue in the ganglion cells of Aplysia, 6th IBRO World Congress of
Neuroscience, 2003, 7, Praque (Czech Republic)
30.
Koji T, Kimura S, Nishikawa Y, Kawasaki S, Doi
M, Ogawa A, Sasaki K: Regulatory Role of Rho- and PI 3-kinase in the slowly
developing contraction induced by thromboxane A2 receptor in the
middle cerebral artery of bovine, 6th IBRO World Congress of Neuroscience, 2003,
7, Praque (Czech Republic)
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
31.
Kumagai J, Kawamata T, Sano H, Sato K, Sawai T:
Histopathology of the torn rotator cuffs, 3rd Academic Congress of the Asian
Shoulder Association, 1999, 10, Bali
32.
Pan LH, Yamauchi K, Yoshida K, Nakanishi T,
Takigawa M, Uzuki M, Mouri T, Ito H, Shikanai T, Inoue H, Sawai T: Expression
of connective tissue growth factor (CTGF) in pulmonary fibrosis, 1999
International Conference, 1999, 4, San Diego
33.
Uzuki M, Sasano H, Totsune K, Takahashi K, Sawai
T: Urocortin (UCN) and corticotropin-releasing factor (CRF) receptors in the
synovial tissue of patients with rheumatoid arthritis (RA), American College of
Rheumatology 63rd Annual Scientific Meeting, 1999, 11, Boston
34.
Hirano N, Tohyama K, Hashikawa T: Hemagglutinating
encephalomyelitis virus HEV (coronavirus) infects the CNS of laboratory animals
through transneuronal pathways, XIth International Congress of Virology, 1999, 8,
35.
Hirano N, Tohyama K, Hashikawa T: Swine
coronavirus (HEV) as a transneuronal tracer analysing polysynaptic pathways in
the CNS of laboratory anumals, ICLAS and 7th FELASA Joint Meeting, 1999, 5,
Plama de Malllorca
36.
Sapp E, Kegel KB, Aronin N, Tohyama K, Uchiyama
Y, Bhide P, VonSattel IP, Difiglia M: Microglia accumulate in the HD stratum
and cortex, 29th Annual Meeting, Society for Neuroscience, 1999, 10, USA
37.
Inada K, Endo S, Sato S: Activation of
granulocytes by shiga-like toxins and its possible role in pathogenesis of
hemolytic uramic syndrome, 3rd Asia Pacific Conference on Travel Health, 2000, 7,
Denpasar (Indonesia)
38.
Ichinohe N, Tsutsumi R, Sasaki M, Shimooki O,
Takahashi K, Inada K, Chida S, Sato S: Specific and nonspecific antibody
responses to lipopolysaccharide (LPS) in enterohemorrhagic E. Coli infection, 4th International symposium on Shiga Toxin
(Verocytotoxin)-Producing Escherichia
coli infections, 2000, 10, Kyoto
39.
Inada K, Sato S, Endo S: Activation of
granulocytes with vero toxins: A possible role of the activation for
pathogenesis of hemolytic uremic syndrome caused by enterohemorrhagic E. Coli, 4th International symposium on
Shiga Toxin (Verocytotoxin)-Producing Escherichia
coli infections, 2000, 10,
40.
Sawai T, Uzuki M: Increased levels of
circulating hyaluronate in the sera of patients with rheumatoid arthritis with
special reference to joint destruction, The 4th Meeting of Hirosaki
International Forum of Medical Science, 2000, 10, Hirosaki
41.
Uzuki M, Sawai T: Hyaluronic acid (HA) with high
molecular weight shows high affinity to degenerated cartilage in tissue
sections, The 4th Meeting of Hirosaki International Forum of Medical Science, 2000,
10, Hirosaki
42.
Yoshida M, Uzuki M, Kurose A, Ichinohe S, Sawai
T, Shimamura T: Abundant localization of matrix metalloproteinase 9 and its
inhibitor in osteoclasts and osteoblasts at sites of the excessive bone
resorption in rheumatoid arthritis,
43.
Yoshida W, Uzuki M, Yoshida M, Nishida J, Sato
T, Hosaka M, Shimamura T, Sawai T: Histological and cellular characterization
of pigmented villonodular synovitis, American College of Rheumatology 64th
Annual Scientific Meeting, 2000, 10, Philadelphia
44.
Uzuki M, Matsuno H, Yudoh K, Nakazawa F,
Katayama R, Kimura T, Sawai T: Apoptotic chondrocyte death and matrix
metalloproteinases in rheumatoid arthritis, American College of Rheumatology
64th Annual Scientific Meeting, 2000, 10, Philadelphia
45.
Sawai T,
Ashihara T, Itoh H, Itoh M, Tsuchihashi Y, Nakamura S, Mukai K, Watanabe
M: Telepathology in Japan; its history, present state and future, IAP NAGOYA
2000, 2000, 10, Nagoya
46.
Sawai T: Medicolegal and administrative issues
of telepathology in Japan, ’nˆæˆã—ÂƃeƒŒƒpƒ\ƒƒW[‚ÉŠÖ‚·‚é‹ž“s‘ÛƒtƒH[ƒ‰ƒ€, 2000, 10, ‹ž“s
47.
Ishii K, Tohyana K, Sasaki N, Hashikawa T: Distribution
of microglila and macrophages in developing rat brain using immunohistochemical
labeling methods, 30th Annual Meeting, Society for Neuroscience, 2000, 11, New
Orleans (USA)
48.
Tohyama K, Murate M, Yamazaki Y, Hirata M,
Hashikawa T: Cationic anti-microbial protein-like immunoactivity in astrocytes
of rat brain, 30th Annual Meeting, Society for Neuroscience, 2000, New Orleans
(USA)
49.
Hirano N, Tohyama K, Taira H, Hashikawa T: Spread
of hemagglutinating encephalomyelitis virus in the CNS of rats inoculated
intranasal route, VIIth International Symposium on Nidoviruses, 2000, 5, Lake
Harmony (USA)
50.
Hirano N, Ootani N, Tohyama K, Hashikawa T: Infection
of hemagglutinating encephalomyelitis virus (HEV) at the visual pathways of
rats, VIIth International Symposium on Nidoviruses, 2000, 5, Lake Harmony (USA)
51.
Hirano N, Tohyama K, Taira H, Hashikawa T: Trans-synaptic
infection of CNS neurons in rats after intranasal inoculation of swine
hemagglutinating encephalomyelitis virus, 19th Annual Meeting, American Society
for Virilogy, 2000, 7, Fort Collins (USA)
52.
Hirano N, Tohyama K, Taira H, Hashikawa T: Pathogenicity
of swine hemagglutinating encephalomyelitis virus (HEV) for rats, 11th
Federation of Asian Veterinary Association Congress, 2000, 11,
53.
Kumagai J, Sato K, Kawamata T, Komatsuda T,
Sawai T: Pathogenesis of rotator interval lesions in younger and older age
groups, 8th International Congress of Surgery of the Shoulder, 2001, 4, Cape
Town
54.
Suzuki M, Obara K, Kitabatake A, Kawamura S,
Mato K, Yasuda S, Ito K: Is perivascular glial structure related to the
pathogenesis of white matter disease? 10th Congress of the International Psychogeriatric
Association, 2001, 9, Nice
55.
Yoshida M, Uzuki M, Yoshida W, Itoh T, Ichinohe
S, Sawai T, Shimamura T: Abundant
expression of matrix metalloproteinase 9 and osteoclast differentiation factor
mRNA in osteoclasts and osteoblasts at sites of punnus bone interface in
rheumatoid arthritis, American College of Rheumatology 64rd Annual Scientific
Meeting, 2001, 11, San Francisco
56.
Ouchi N, Uzuki M, Yoshida M, Shimamura T, Sawai
T: Cartilage destruction is partly induced by the internal proteolytic enzymes
and apoptotic phenomenon of chondrocytes in polychondritis, American College of
Rheumatology 64rd Annual Scientific Meeting, 2001, 11, San Francisco
57.
Matsuno H, Yudoh K, Nakazawa F, Uzuki M, Sawai
T, Otsuki M, Ogawa Y, Nishioka K,
Kimura T: Treatment with novel humanaized anti-Fas monoclonal antibody in
rheumatoid arthritis, American College of Rheumatology 64rd Annual Scientific
Meeting, 2001, 11, San Francisco
58.
Sasaki N, Kurose A, Yamauchi K, Inoue H, Sawai T:
Endothelial cell apoptosis is a possible mechanism of pulmonary hypertension in
patients with mixed connective tissue disease, 98th International Conference of
American Thoraic Society, 2002, 5, Atlanta (USA)
59.
Yoshida M, Uzuki M, Yoshida W, Ouchi N, Koyama
A, Ichinohe S, Sawai T, Shimamura T:
Expression of matrix metalloproteinase 9 and osteoclast differentiation factor
mRNA in osteoclasts and osteoblasts in rheumatoid arthritis, 29th Scandinavian
Congress of Rheumatology, 2002, 8, Tromso (
60.
Ouchi N, Uzuki M, Yoshida M, Yoshida M,
Shimamura T, Sawai T: Cartilage destruction os partly induced by the internal
proteolytic enzymes and apoptotic phenomenon of chondrocytes in polychondritis,
29th Scandinavian Congress of Rheumatology, 2002, 8, Tromso (Norway)
61.
Yoshida W, Uzuki M, Ouchi N, Yoshida M,
Shimamura T, Sawai T: Examination of gelatinolytic activity in rheumatoid
arthritis synovium using in situ
zymography and image analyzer, 29th Scandinavian Congress of Rheumatology, 2002,
8, Tromso (Norway)
62.
Hirano N, Tohyama K, Taira H, Hashikawa T:
Susceptibility of mice of diffrent ages to inoculation with swine HEV by
various routes, XIIth International Congress of Virology, 2002, 7, Paris (
63.
Tohyama K, Nishiyama H, Hanasaki T, Nakamura M,
Itohara S, Hashikawa T: S100B may not be essential for regeneration of
peripheral nerve axons, 32th Annual Meeting, Society for Neuroscience, 2002, 11,
Orlando (USA)
64.
Anderson PN, Pavlides M, Rezajool K, Stallcup WB,
Tohyama K,
65.
Uzuki M, Kaiyama J, Miyoshi T, Sawai T: Three
hyaluronan synthases, HAS1, HAS2, HAS3 and hyaluronan synthetic activity in the
synovial tissue of patients with rheumatoid arthritis, American College of
Rheumatology 66th Annual Scientific Meeting, 2002, 10, New Orleans
66.
Matsuno H, Yudoh K, Katayama R, Nakazawa F,
Uzuki M, Sawai T, Yonezawa T, Saeki
Y, Panayi GS, Pizalis C: The role of TNF-ƒ¿ in the pathogenesis of inflammation
and joint destruction in Human RA/SCID mice chimera, American College of
Rheumatology 66th Annual Scientific Meeting, 2002, 10, New Orleans
67.
Munakata T, Uzuki M, Yoshida M, Shimamura T,
Sawai T: Interleukin (IL)-18 concentration in synovial fluid represents a
positive correlation between the number of inflammatory cells especially
lymphocytes and macrophages, in RA synovium, American College of Rheumatology
66th Annual Scientific Meeting, 2002, 10, New Orleans
68.
Kumagai J, Sawai T: Tendon insertion into bone-anatomy
and its surgical reconstruction-, 4th Academic Congress of the Asian Shoulder
Association, 2002, 10,
69.
Ouchi N, Uzuki M, Kanno H, Yoshida M, Shimamura
T, Sawai T: Cartilage destruction in polychondritis is induced by internal
factors as well as inflammatory reaction around cartilage, 5th Pan-Pacific
Connective Tissue Societies Symposium, 2003, 6, Ube
70.
Uzuki M, Itano N, Kimata K, Kaiyama J, Miyoshi
T, Yoshida M, Sawai T: Three hyaluronan synthases, HAS1, HAS2, HAS3 in the
synovial tissue of patients with rheumatoid arthritis, 5th Pan-Pacific
Connective Tissue Societies Symposium, 2003, 6, Ube
71.
Itoh Y, Uzuki M, Fujii K, Sawai T: Connective
Tissue Growth Factor (CTGF) mRNA expressed especially in RA synovium in early
Stage, 5th Pan-Pacific Connective Tissue Societies Symposium, 2003, 6, Ube
72.
Yoshida M, Ichinohe S, Uzuki M, Ouchi N, Yoshida
W, Sawai T, Shimamura T: Pathogenesis
of large bone cysts adjacent to the knee joint in rheumatoid arthritis, 4th
Annual European Congress of Rheumatology, 2003, 6,
73.
Yoshida W, Uzuki M, Ouchi N, Yoshida M,
Shimamura T, Sawai T: Examination of gelatinolytic activity in rheumatoid
arthritis synovial tissue using newly developed in situ zymography and image
analyzer, 4th Annual European Congress of Rheumatology, 2003, 6,
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
74.
Oikawa H, Tamakawa Y: The Evaluation of the
difference between Alzheimer type dementia and vascular dementia using proton
magnetic resonance spectroscopy, RSNA 85th Scientific Assembly and Annual
Meeting, 1999, 11, Chicago
75.
Sasaki M, Oikawa H, Ehara S, Tamakawa Y: Ventral
thalamus and subthalamic nucleus: MR findings using optimized fast short
inversion-time inversion-recovery technique, RSNA 86th Scientific Assembly and
Annual Meeting, 2000, 11, Chicago
76.
Sasaki M, Oikawa H, Ehara S, Tamakawa Y: Magnetization
transfer MR imaging of the hippocampus and entorhinal cortex in early Alzheimer
disease: evaluation with high-resolution fast spin-echo and fast STIR
techniques, RSNA 86th Scientific Assembly and Annual Meeting, 2000, 11, Chicago
77.
Sasaki M, Oikawa H, Ehara S, Tamakawa Y: Substantia
nigra at 3 Tesla MR imaging using dual-echo spin-echo and fast short
inversion-time inversion-recovery techniques, American Society of
Neuroradiology (ASNR) 39th Annual Meeting, 2001, 4, Boston
78.
Sasaki M, Oikawa H, Ehara S, Tamakawa Y: Internal
structures of cerebral gray matter at 3 Tesla: MR imaging using fast short
inversion-time inversion-recovery technique, Radiological Society of North
America (RSNA) 87th Scientific Assembry and Annual Meeting, 2001, 11, Chicago
˜a•¶Œ´’˜˜_•¶
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
“n•Ó”üŠì—YC“y”ìŽçC—é–Ø—Ï•ÛC²X–ؘa•FC¬ì²: PKC ‚ÌŠˆ«‰»‚É‚æ‚鎑±«‚Ì”]ŒŒŠÇŽûk‚É‚¨‚¯‚é protein
kinase cascade ‚ÌŠÖ—^D”]ŒŒŠÇ¹k14: 167-173, 1999
2.
“y”ìŽçC“n•Ó”üŠì—YC—§–ØŒõC®–ìLC—é–Ø—Ï•ÛC²X–ؘa•FC¬ì²: ”]ŒŒŠÇ¹k‚¨‚æ‚Ñ”]ŒŒŠÇ‚ÌŽûk‚É‚¨‚¯‚é protein
kinases ‚ÌŠÖ—^D”]ŒŒŠÇ¹k14: 40-49, 1999
3.
¼ì‘׳C“y”ìŽçC“n•Ó”üŠì—YC—é–Ø—Ï•ÛC¬ì²C–Ø‘ºáÁŒáC²X–ؘa•F: ƒXƒtƒBƒ“ƒSƒŠƒ“Ž‰Ž¿sphingosylphosphorylcholine‚É‚æ‚é”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚Ì”¶‹@˜D”]ŒŒŠÇ¹k15: 226-229, 2000
4.
“y”ìŽçC ¼ì‘׳C “n•Ó”üŠì—YC—é–Ø—Ï•ÛC¬ì²C–Ø‘ºáÁŒáC²X–ؘa•F: Rho kinase activator ‚É‚æ‚é Žûk‚ɑ΂·‚éŠeŽí”]ŒŒŠÇŠg’£–ò‚Ì—}§Œø‰ÊD”]ŒŒŠÇ¹k15: 242-246, 2000
5.
“n•Ó”üŠì—YC“y”ìŽçC¼ì‘׳C—é–Ø—Ï•ÛC¬ì²Cìè•qC²X–ؘa•F: ”]ŒŒŠÇ‚ÌŽ‘±«Žûk‚É‚¨‚¯‚éRho kinase inhibitor Y-27632‚Ì—}§Œø‰ÊD”]ŒŒŠÇ¹k15: 247-250, 2000
6.
Ö–ì’©KC¼‰Y½C²“¡—mˆê: ‚‘¬‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚ð—p‚¢‚½×“®–¬‚É‚¨‚¯‚é×–E“àƒJƒ‹ƒVƒEƒ€”Z“x•Ï“®‚̉摜‰ðÍDzŠÂ§Œä21: 10-16, 2000
7.
¼ì‘׳CKŽ¡F—TC“y”ìŽçCìè•q: ƒZƒƒgƒjƒ“‚É‚æ‚Á‚Ĉø‚«‹N‚±‚³‚ꂽƒEƒV”]ŒŒŠÇ•½ŠŠ‹ØŽûk‚É‚¨‚¯‚éRho-kinase ‚É‚æ‚é‘‹‹@\DŠâŽèˆãŽ53: 117-127, 2001
8.
¼ì‘׳C“y”ìŽçCKŽ¡F—TC“n•Ó”üŠì•vCìè•qC–Ø‘ºáÁŒáC¬ì²: ƒXƒtƒBƒ“ƒSƒŠƒ“Ž‰Ž¿Sphingosylphosphorylcholine‚É‚æ‚é”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚É‚¨‚¯‚éRho kinase‚ÌŠÖ—^D”]ŒŒŠÇ¹k16: 283-286, 2001
9.
“y”ìŽçC¼ì‘׳C“n•Ó”üŠì•vCKŽ¡F—TC¬ì²Cìè•qC–Ø‘ºáÁŒáC²X–ؘa•F: Myosin
light chain phosphataseŠˆ«‚Ì’²ß‚É‚æ‚é”]ŒŒŠÇ‚ÌŽûk§Œä‹@\D”]ŒŒŠÇ¹k16: 290-293, 2001
10.
KŽ¡F—TC¼ì‘׳C“y”ìŽçC–Ø‘ºáÁŒáCìè•qC²X–ؘa•FC¬ì²: ƒgƒƒ“ƒ{ƒLƒTƒ“‚`‚QŽó—e‘ÌŽhŒƒ‚Å”¶‚·‚鎑±«‚Ì”]ŒŒŠÇŽûk‚É‚¨‚¯‚éRho-kinase‚É‚æ‚éŽûk‘‹‹@\D”]‘²’†‚ÌŠO‰È29: 61-65, 2001
11.
KŽ¡F—TC¼ì‘׳Cìè•qC–Ø‘ºáÁŒá: ƒEƒV’†‘å”]“®–¬‚̃gƒƒ“ƒ{ƒLƒTƒ“‚`‚QŽó—e‘ÌŽhŒƒ‚Å”¶‚·‚éŠÉ™‚ÈŽûk‰ž“š‚Ì‘‹‹@\DŠâŽèˆãŽ54: 137-150, 2002
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
12.
ŒF’JƒCì–”•ü–›C²–씎‚C²“¡Ž–¤CàVˆä‚ŽuCΈäG’‰: äF”‘a•”‘¹‚Ì•a‘Ô\10‘ã`20‘ã‚ÌÇ—á‚ɂ‚¢‚Ä\DŒ¨ŠÖß23: 385-389, 1999
13.
‰““¡dŒúCŠ‹¼Œ’Cˆî“c·–ç: ‘Sg«‰ŠÇ”½‰žÇŒóŒQ‚É‚¨‚¯‚銴õÇ‚¨‚æ‚ÑdÇ“xf’f‚Æ‚µ‚ẴvƒƒJƒ‹ƒ`ƒgƒjƒ“’l‘ª’è‚̈Ӌ`DŠ´õÇŽ97: 197-204, 1999
14.
àVˆä‚ŽuC‰FŒŽ”ü˜a: –«ŠÖ߃ŠƒEƒ}ƒ`iRAj‚Ì•a—D ƒJƒŒƒ“ƒgƒeƒ‰ƒs[17: 41-48, 1999
15.
‰FŒŽ”ü˜a: Ú’…•ªŽq‚ÌV‚µ‚¢“WŠJD×–E31: 19-20, 1999
16.
¼–씎–¾C—V“¹˜a—YC’†‘ò•s“ñ—YC•ÐŽR—ŒbC‰FŒŽ”ü˜aC–Ø‘º—FŒú: V‚µ‚¢“®•¨ƒ‚ƒfƒ‹‚ÌŠJ”D×–E31: 24-29, 1999
17.
¬¼“c’C˜YC²“¡Ž–¤C¬“‡’‰ŽmCŒF’JƒCàVˆä‚Žu: Š£á«—¼Œ¨ŠÖ߉Š‚¨‚æ‚ÑŒ¨•ô‰ºŠŠ‰t•ï‰Š‚Ì‹¾Ž‹‘œDŠÖß‹¾ 24: 69-75, 1999
18.
•£Œ°C‹g“c“nC‹g“c¹–¾CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ”|—{×–E‚Ì×–EŒv—ÊŠw“I‰ðÍ \
pacritaxel‚É‚æ‚é×–E“®‘Ԃ̕ω» \D Cytometry
Res 9: 85-88, 1999
19.
–Ø‘º—FŒúC’†‘ò•s“ñ—YC¼–씎–¾CàVˆä‚ŽuC‰FŒŽ”ü˜a: ŠÖ߉Š‚É”º‚¤“j‰óDRAƒZƒ‰ƒs[ 5: 40-48, 1999
20.
ì–”•ü–›CŒF’JƒC²–씎‚C²“¡Ž–¤C¬¼“c’C˜YC¬d’CàVˆä‚Žu: ”½•œ«Œ¨ŠÖß‘O•û’E‰P‚Ì‘¹ŠÖßO‚Ì•a—‘gD‘œDŒ¨ŠÖß23: 236-266, 1999
21.
‹g“c¹–¾CˆêŒË’啶C@‘œF‰ÀC“ˆ‘º³C‰FŒŽ”ü˜aC•£Œ°C‹g“c“nCàVˆä‚Žu: RA‚Ì‹‘圔XŽî‚É‚¨‚¯‚éMMP‚Æ‚»‚Ì‘jŠQy‘f‚Ì”Œ»‚ɂ‚¢‚ÄDŠâŽèˆãŽ51: 661, 1999
22.
Šâè^‹|C‰FŒŽ”ü˜aC“n•Ó‚Ý‚©C”~“c‰pKC{ŽR‹ŽOCˆ¢•”ŒhŽqCàVˆä‚Žu: ƒqƒg”x“®–¬‚̃Gƒ‰ƒXƒ`ƒ“‰Ë‹´ƒAƒ~ƒmŽ_iƒfƒXƒ‚ƒVƒ“CƒCƒ\ƒfƒXƒ‚ƒVƒ“j‚Ì’è—ʉ»‚ÌŽŽ‚Ýi‘æ1•ñjDŠâŽèˆãŽ51: 441-452, 1999
23.
àN—§‰ØCŽR“àL•½: ”x×–E‘BDŒÄ‹z‚ÆzŠÂ47: 899-905, 1999
24.
ˆÉ“¡ŒOŽ÷C‘ºˆäˆê”ÍCΓc—zŽ¡C~Mˆê˜YC“cŒû‰ëŠCC•£Œ°: ‰¡–ä‹Ø“÷Žî‚Ì‚Ñ‚Ü‚ñ«œ‘ZDŠâŽèˆãŽ51: 573-576, 1999
25.
•£Œ°CàVˆä‚Žu: AIDS‚Ì•a—FƒƒVƒAAIDSƒZƒ“ƒ^[‚̃GƒCƒY–UŒŸ—á‚ɂ‚¢‚ÄDŠâŽèˆãŽ 51: 662, 1999
26.
‰Á“¡‚³‚‚çC’ç—æŽq: ƒRƒNƒTƒbƒL[ƒEƒCƒ‹ƒX‚a6i‚b‚u‚a‚Uj‚Ì5'”ñ–|–ó—̈æ‹y‚уLƒƒƒvƒVƒbƒh’`”’—̈æ‚Ì‚ƒ‚c‚m‚`‰–Šî”z—ñŒˆ’è‚ÉŠÖ‚·‚錤‹†DŠâŽèˆãŽ51: 89-104,
1999
27.
’†‰®•×CŽ›“‡‰ë“TCˆî“c·–ç: ˆÝŠàŠ³ŽÒŒŒ‰t‚Ìex vivo”|—{‚É‚¨‚¯‚éè÷—±‹…‚̃Cƒ“ƒ^[ƒƒCƒLƒ“-‚PƒŒƒZƒvƒ^[ƒAƒ“ƒ^ƒSƒjƒXƒgiIL-1rajŽY¶”\’ቺDŠâŽèˆãŽ 51: 537-554, 1999
28.
ˆî“c·–çC‰““¡dŒú: ƒŠƒ€ƒ‹ƒXŽŽ–ò‚ð—p‚¢‚½ŒŒ’†ƒGƒ“ƒhƒgƒLƒVƒ“‚¨‚æ‚уÀ-ƒOƒ‹ƒJƒ“’è—Ê‚É‚¨‚¯‚éƒJƒCƒlƒeƒBƒbƒN–@‚Å‚Ì“ÁˆÙ”½‰ž‚Æ”ñ“ÁˆÙ”½‰ž‚Ì”»•ÊDˆãŠw‚Æ–òŠw 42: 885-897,
1999
29.
àVˆä‚ŽuC‰FŒŽ”ü˜aC“n•Ó‚Ý‚©: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[jEƒeƒŒƒpƒ\ƒƒW[‚ÌŒ»ó‚Æ–â‘è“_DŠO‰È61: 613-618, 1999
30.
àVˆä‚ŽuC“n•Ó‚Ý‚©C‰FŒŽ”ü˜a: ƒeƒŒƒpƒ\ƒƒW[i‰“Šu•a—f’fjŽÀ—p‰»‚Æ–â‘è“_DŒŸ¸‚Æ‹Zp27: 85-88, 1999
31.
ŽO‰YNGC•£Œ°CŽÄ“c—S“ñC•Ê•{‚–¾CàVˆä‚Žu: ¶‘¤“ª—t‚É”¶‚µ‚½Dysembryoplastic
neuroepithlial tumor iDNTj ‚Ì1Ç—áDf’f•a—17: 120-122, 2000
32.
²–씎‚CŒF’JƒCàVˆä‚Žu: Ž©‰Æ‘å‘Ú‹Ø–Œpatch–@‚É‚¨‚¯‚éäF‘gD‚¨‚æ‚ÑäFœ•t’…•”‚ÌÄŒ`¬‰ß’öDŒ¨ŠÖß24: 253-258, 2000
33.
쑺—@, —é–Ø –ž, –k”©Œ°_, ¬Œ´ƒPƒCŽq: ƒtƒ‰ƒNƒgƒOƒ‰ƒtƒB•Ï–@‚É‚æ‚é‘å”]”’Ž¿‚̃OƒŠƒAŽ²õŠÔ‘ŠŒÝŠÖŒW‚Ì3ŽŸŒ³“IŠÏŽ@D”]‚̉Ȋw22: 329-338, 2000
34.
¬–ì’¼”V, —é–Ø–ž, ¬Œ´ƒPƒCŽq, –k”©Œ°_: ‘å”]”’Ž¿ŒŒŠÇŽüˆÍ‚̃OƒŠƒA\‘¢ \ ŠD”’Ž¿‚Ì‚»‚ê‚Æ‚Ì”äŠrD˜V”N¸_ˆãŠw11: 539-547, 2000
35.
ŽO‰YNGC•£Œ°CàVˆä‚ŽuC‹g“c_ŽqCˆäã—m¼: –Ɖu—}§—Ö@‚ª‘tŒ÷‚µ‚½‚à‚Ì‚Ì”x•¡‡Š´õ‚Ì•¹”‚É‚æ‚莀–S‚µ‚½Wegener“÷‰èŽîÇ‚Ì1Ç—áD—Õ°ƒŠƒEƒ}ƒ` 12: 143-149, 2000
36.
“n•Ó“O—YCàVˆä‚ŽuC²“¡¬C‰FŒŽ”ü˜aC—¢Œ©i: • •”‘å“®–¬áŽi“W‚É‚¨‚¯‚éMatrix
metalloproteinases ‚Ì–ðŠ„D –¬ŠÇŠw40: 505-510, 2000
37.
•£Œ°CàVˆä‚Žu: ”ñ’èŒ^“I‚ÈS‹ØÇ‚Ì2—áD•a‰@•a—17: 86, 2000
38.
ŒÃ‰Æ‘ô–çC—«¯¯CH“¡½Ž¡C‚‹´MDC—é–Ø—BŽiC•l“c˜aˆê˜YCŽO‰YNG: ‹ó’°‚Ö’¼ÚZ‚µ‚½”A–ŒŠÇŽîᇂÌ1—áD”å”AŠíŠO‰È13: 297-299, 2000
39.
¼–씎–¾C’†‘ò•s“ñ—YC—V“¹˜a—YC‰FŒŽ”ü˜aCàVˆä‚ŽuC–Ø‘º—FŒú: RA‚ÌŠÖߓj‰ó‚É‚¨‚¯‚éƒAƒ|ƒg[ƒVƒXDƒŠƒEƒ}ƒ`‰È 23: 275-281, 2000
40.
àN—§‰ØCàVˆä‚Žu: üˆÛ‰»”x‚Æconnective tissue growth
factoriCTGFjD•ªŽqŒÄ‹zŠí•a4: 89i433j-91i435j, 2000
41.
ˆÉ“¡Œ[CŒ‹é–L•FCΓcˆê•FC²“¡‹§C•Ð‘q–FŽ÷C•½àV‘åC–ì“c—TC“¡“c’¼FC“y‰®—_CŽR苧C‰FŒŽ”ü˜aCàVˆä‚Žu: Ž‰–b‘gD‚¨‚æ‚уuƒ‹ƒ“ƒlƒ‹‘B‚ðŽå‘Ì‚Æ‚·‚é\“ñŽw’°ƒuƒ‹ƒ“ƒlƒ‹‘B‰ßŒëŽî‚Ì1—áD“úÁ•a‰ïŽ97: 449-454, 2000
42.
àVˆä‚Žu: ŒŒŠÇ‰Š‚Ì•ª—Þ‚Æ‘gDŠw“I“Á’¥DÅVˆã55: 2663-267, 2000
43.
“n•Ó“O—YCàVˆä‚ŽuC²“¡¬C—¢Œ©i: • •”‘å“®–¬áŽ‚É‚¨‚¯‚éMatrix
metalloproteinasesiMMP-2‚ÆMMP-9j‚Ì”Œ»‚Æ’†–Œ’e«üˆÛ•ö‰ó‚Æ‚ÌŠÖ˜AD“úŒŒŠÇŠO‰ïŽ9: 539-54, 2000
44.
àVˆä‚ŽuC‰FŒŽ”ü˜a: •úŽËüƒvƒ[ƒuD•a—‚Æ—Õ°18i—ÕŽž‘Š§j: 258-262, 2000
45.
àVˆä‚Žu: ‰ä‚ª‘‚É‚¨‚¯‚éƒeƒŒƒpƒ\ƒƒW[‚ÌŒ»óDVˆã—Ã27i•Êûj 29-32, 2000
46.
‰FŒŽ”ü˜aCàVˆä‚Žu: d‘gD‚É‚¨‚¯‚é–Ɖu‘gD‰»ŠwD•a—‚Æ—Õ°18i—ÕŽž‘Š§j: 57-62, 2000
47.
’·‰ªŒ÷CœA“c‘ŽqCùì“ÖŽqC‘å˜a“c–¾•FC•½“c—¤³: D’†‹…‚ÌŽE‹Ûƒyƒvƒ`ƒhdefensin ‚Æcathelicidin‚Ì‹¤“¯ì—pD‰ŠÇ20: 131, 2000
48.
‰““¡dŒúC²“¡M”ŽCˆî“c·–ç: ƒEƒŠƒiƒXƒ^ƒ`ƒ“‚É‚æ‚éƒTƒCƒgƒJƒCƒ“ŽY¶‚ÌCüDTherapeutic
Res 21: 1921-1923, 2000
49.
àVˆä‚Žu: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚ÌŒ»ó‚Æ–â‘è“_Dˆã‚Ì‚ ‚ä‚Ý194: 120-126,
2000
50.
àVˆä‚ŽuC‰FŒŽ”ü˜aC“n•Ó‚Ý‚©: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚ÌŒ»ó‚Æ–â‘è“_D—Õ°•a—48: 458-462, 2000
51.
àVˆä‚ŽuC‰FŒŽ”ü˜a: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j¡Œã‚ÌŒ©’Ê‚µD—Õ°ŒŸ¸44: 965-969, 2000
52.
“Œ•ŸŽ›Šô•vC”ª–Ø—RŽqC“y‹´N¬CàVˆä‚Žu: •Ä‘‰“Šuˆã—Êw‰ïƒeƒŒƒpƒ\ƒƒW[@SIG‚É‚æ‚éƒeƒŒƒpƒ\ƒƒW[—Õ°‰^—pƒKƒCƒhƒ‰ƒCƒ“DVˆã—Ã1: 138-141, 2000
53.
›Œ´~C—é–Ø—Ï•ÛCàVˆä‚ŽuC¬ì²: Rƒgƒƒ“ƒrƒ“ÜiƒAƒ‹ƒKƒgƒƒoƒ“j‚̃‰ƒbƒg‚Ì‘¹”]‚É—^‚¦‚é‰e‹¿ \ ŒŒŠÇ‚É‚¨‚¯‚éÚ’…•ªŽqiintercellular adhesionmolecule(ICAM-1)‚Ì”Œ»‚ÆMac-1—z«×–E‚ÌZ \D‰ŠÇEĶ21: 63-69, 2001
54.
àVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`iRAj‚Ì•a‘Ô‚Ì•a—Šw“I‰ðÍ \ “Á‚É“îœEœ”j‰ó‚ɂ‚¢‚Ä \DŠâŽèˆãŽ53: 99-109, 2001
55.
@‘œF‰ÀC‰FŒŽ”ü˜aC“ˆ‘º³CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éInterleukiniILj-18‚Ì“®‘ÔDƒŠƒEƒ}ƒ`41: 625-634, 2001
56.
‘å‹v•Û‹±ŽqCŒ‹é–L•FC²“¡‹§CΓcˆê•FC–…”öd°C¼‰iŒú¶C–쑺”üŽ÷ŽqC“àŠCŒ‰C—é–ØŒhC•½àV‘åC–ì“c—TC“¡“c’¼FCàVˆä‚ŽuC‰FŒŽ”ü˜aCœA“c½ˆê: ˆÝ•ÇŠO«‚É—LŒs«”ˆç‚µ‚½ˆÝGIST‚Ì1—áD“úÁ•a‰ïŽ98: 822-826, 2001
57.
ŽO‰YNGC•£Œ°CŽÄ“c—S“ñCàVˆä‚ŽuC²“¡—F—ºCˆäã—m¼: œ‘ˆÙŒ`¬ÇŒóŒQ‚ÌŒo‰ß’†‚É–«Epstein-BarrƒEƒCƒ‹ƒXŠ´õ‚É‚æ‚é‚Æl‚¦‚ç‚ê‚錌‹…æÃHÇŒóŒQ‚ÆŽíX‚ÌŽ©ŒÈR‘Ì‚Ìã¸‚ðŽ¦‚µ‚½1Ç—áD—Õ°ƒŠƒEƒ}ƒ`13: 137-143, 2001
58.
ŽO‰YNGC•£Œ°CŽÄ“c—S“ñC‰ª“cMˆê˜YCàVˆä‚Žu: ‰E”x’†—t‚É”¶‚µ‚½d‰»«ŒŒŠÇŽî‚Ì1—á.f’f•a—18: 263-265, 2001
59.
“c‘º‘¥’jC‰FŒŽ”ü˜aC¼–{•s“ñ•vC—ÍŠÛöC‘•ª³ˆêCàVˆä‚Žu: ‹}‘¬”j‰óŒ^ŒÒŠÖßÇiRDCj‚Ìœ”j‰ó•”ˆÊ‚É‚¨‚¯‚éUrokinase-Type
Plasminogen ActivatoriuPAj‚¨‚æ‚ÑuPA ReceptoriuPARj‚Ì”Œ»‚Æœ”j‰ó‚ÌŠÖ˜ADƒŠƒEƒ}ƒ`41: 851-857, 2001
60.
—é–Ø—zŽqCŒIŒ´‰pŽqC–Ø”¦ŒjC”©ŽR–¾CòŽR•üC‰FŒŽ”ü˜aCàVˆä‚Žu: Ä”«‘½”“Š‚Ì2Ç—áD“ú“à‰ïŽ90: 2088-2092, 2001
61.
‰““¡‰p•FC•Ê•{‚–¾CrˆäŒ[ŽjC¬Š}Œ´–MºC—é–Ø‹C—é–Ø—Ï•ÛC¬ì²CÄ“¡—§‰ØCàVˆä‚Žu: ŠC–ÈÖ¬“´•”ƒAƒXƒyƒ‹ƒMƒ‹ƒX“÷‰èŽî‚Ì1—áD”]_ŒoŠO‰È29: 325-329, 2001
62.
‹g“c_ŽqC–Ñ—˜FC•“cWC—é–؇CŽR“àL•½Cˆäã—m¼CÄ“¡—§‰ØCàVˆä‚Žu: SjögrenÇŒóŒQ‚ÉBOOP•a•Ï‚ð‡•¹‚µ‚½1—áD“ú“à‰ïŽ90: 329-331, 2001
63.
ŒF’JƒC²“¡Ž–¤Cì–”•ü–›C²–씎‚CΈäG’‰CàVˆä‚Žu: äF”‘a•”‘¹‚Ì•a‘Ô \ 30‘ãˆÈ~‚ÌÇ—á‚ɂ‚¢‚Ä \DŒ¨ŠÖß25: 213-216, 2001
64.
ˆî“c·–çC‰““¡dŒú: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”Mi3jDMed Post 39: 33-46, 2001
65.
‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”Mi5jDMed Post 39: 269-278, 2001
66.
‰““¡dŒúCŽR“c—T•FC’†‰iŽmŽt–¾Cˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”Mi6jDMed Post 39: 29-38, 2001
67.
Š‹¼Œ’C‰““¡dŒúCˆî“c·–çC²“¡¬‘å: ƒCƒ€ƒmƒNƒƒ}ƒgƒOƒ‰ƒtƒB[–@‚É‚æ‚éƒvƒƒJƒ‹ƒ`ƒgƒjƒ“’l‘ª’è‚Ì—L—p«‚ÌŒŸ“¢DMed Post 39: 77-79,
2001
68.
‰““¡dŒúCˆî“c·–ç: ”sŒŒÇ‚Ì•a‘ÔŒ`¬‚ÉŠÖ‚·‚éƒTƒCƒgƒJƒCƒ“‚Ì–ðŠ„D‰ŠÇ‚ƖƉu9: 96-103, 2001
69.
‰““¡dŒúCŽR“c—T•FC’†‰iŽmŽt–¾CŠFìK—mC”óŒû_•¶Cˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”Mi7jDMed Post 39: 31-42, 2001
70.
’†‰iŽmŽt–¾C‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”Mi8jDMed Post 40: 23-36, 2001
71.
’†‰iŽmŽt–¾C‰““¡dŒúCˆäã‹`”ŽC“¡–ì–õ‹vCŽR“c—T•FC²“¡Œõ‘¾˜YCÔârŽ÷C‹g‘º•¶FCˆî“c·–çC²“¡¬‘å: PMX‚ðŽ{s‚µ‚½”sŒŒÇ«‘½‘ŸŠí•s‘S‚ÌŒŒ’†ƒGƒ“ƒhƒgƒLƒVƒ“CƒTƒCƒgƒJƒCƒ“CNOx’l‚ÌŒŸ“¢DƒGƒ“ƒhƒgƒLƒVƒ“ŒŒÇ‹~–½Ž¡—ÃŒ¤‰ïŽ5: 30-35, 2001
72.
ˆî“c·–çC‹v•Û‹^“Þ”üC‰““¡dŒúC²“¡¬‘å: ŋ߂̃Gƒ“ƒhƒgƒLƒVƒ“‘ª’è–@‚Ì–â‘è“_DƒGƒ“ƒhƒgƒLƒVƒ“ŒŒÇ‹~–½Ž¡—ÃŒ¤‰ïŽ5: 9-12, 2001
73.
àVˆä‚ŽuC‰FŒŽ”ü˜aCŽÄ“c—S“ñCŠâè^‹|CŽO‹{²mC“¡ì”ŽNC’†“‡—m: ¶ŒŸ‘œ‚Æ—Õ°ŠŒ©‚©‚çHypereosinophilic
SyndromeiHESj‚ª‹^‚í‚ꂽǗáD –¬ŠÇŠw42: 193-196, 2002
74.
àVˆä‚Žu: u“ú–{ƒeƒŒƒpƒ\ƒƒW[Œ¤‹†‰ïv‚Ì”‘«‚ɂ‚¢‚ÄD•a—‚Æ—Õ°20: 220-221, 2002
75.
ˆÉ“¡’C‰FŒŽ”ü˜aC“ˆ‘º³CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`ŒŒ´CŠÖ߉t’†‚ÌMatrix MetalloproteinaseiMMPj-13‚Ì“®‘ÔDƒŠƒEƒ}ƒ`42: 60-69, 2002
76.
‰FŒŽ”ü˜aC•½“c–œç‘ãCàVˆä‚Žu: ŠÖߎ¾Š³‚É‚¨‚¯‚é–Ɖu‘gD‰»Šw‚Æin situ hybridization. J Hard Tissue Biol 10: 141-148, 2002
77.
‹g“c“nC‰FŒŽ”ü˜aC“ˆ‘º³CàVˆä‚Žu: In situ zymography‚ð—p‚¢‚½–«ŠÖ߃ŠƒEƒ}ƒ`ŠŠ–Œ‘gD‚É‚¨‚¯‚éƒ[ƒ‰ƒ`ƒ“•ª‰ð”\‚ÌŒŸ“¢DŠâŽèˆãŽ54: 95-105, 2002
78.
²X–ØMlC¬—Ñ“NlC•£Œ°CàVˆä‚Žu: äPŒ´•a‚Ì•a—D‘Ž‡—Õ°51: 2213-2219, 2002
79.
Š‹‘×FC•Ê•{‚–¾CŽÄ“àˆê•vC¬Š}Œ´–M–¾C¬ì²C•£@Œ°: èò•”–À‘–_ŒoŒ´”malignant peripheral
nerve sheath tumoriMPNSTj‚Ì1—áD”]_ŒoŠO‰È30: 523-526, 2002
80.
’†‰iŽmŽt–¾C‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”MÇi9jDMed Post 40: 29-42, 2002
81.
’†‰iŽmŽt–¾C‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: ¶‘Ì”½‰ž‚©‚ç‚Ý‚½”MÇi10jDMed Post 40: 25-36, 2002
82.
‘å“à’¼‹vC¬—Ñ“NlCàVˆä‚Žu: RA‚É‚¨‚¯‚éœE“j‰ó‚Ì•a—D THE BONE 16: 2002-2009, 2002
83.
àN—§‰ØC•Ê•{‚–¾C•£Œ°CŽR“àL•½C›Œ´~C¬ì²CàVˆä‚Žu: Neoplastic
cells and proliferating endothelial cells express connective tissue growth
factoriCTGFj in glioblastom. ŠâŽèˆãŽ54: 322-323, 2002
84.
¬—Ñ“NlC•£Œ°CàVˆä‚Žu: ƒOƒŠƒI[ƒ}‚É‚¨‚¯‚éconnective tissue growth
factor‚Ì”Œ»‚Æ‚»‚ÌŒŒŠÇV¶‚Æ‚ÌŠÖ˜ADŠâŽèˆãŽ54: 323, 2002
85.
‰FŒŽ”ü˜aCù–ìŒöLC‘º¼N¬C‚‹´˜aLCŒËP˜alC‰«—²CàVˆä‚Žu: CRFƒtƒ@ƒ~ƒŠ[_Œoƒyƒvƒ`ƒh‚Æ‚»‚ÌŽó—e‘̂̉ŠÇ«Ž¾Š³‚É‚¨‚¯‚锌»DŠâŽèˆãŽ54: 323, 2002
86.
›Œ´~C—é–Ø—Ï•ÛCàVˆä‚ŽuC¬ì²: Rƒgƒƒ“ƒrƒ“ÜiƒAƒ‹ƒKƒgƒƒoƒ“j‚̃‰ƒbƒg‚Ì‘¹”]‚É—^‚¦‚é‰e‹¿@ŒŒŠÇ‚É‚¨‚¯‚éÚ’…•ªŽqintercellular
ahesion moleculeiICAM-1j‚Ì”Œ»‚ÆMac-1—z«×–E‚ÌZDŠâŽèˆãŽ54: 323-324, 2002
87.
²X–ØMlC•£Œ°Cˆäã—m¼CàVˆä‚Žu: ¬‡«Œ‹‡‘gD•a‚ɇ•¹‚·‚é”x‚ŒŒˆ³Ç‚ɑ΂·‚éR“à”ç×–ER‘Ì‚ÌŠÖ—^‚ɂ‚¢‚ÄD ƒŠƒEƒ}ƒ`42: 885-894, 2002
88.
àVˆä‚ŽuC‰FŒŽ”ü˜aCˆÉ“¡‹gŒ«CŠâè^‹|C‹yìáÁˆê: ”x“®–¬‚ɉÁ—îŠw“I•Ï‰»‚Í‘¶Ý‚·‚éH –¬ŠÇŠw‰ïŽiin pressj
89.
àVˆä‚ŽuC‰FŒŽ”ü˜aCˆÉ“¡‹gŒ«C“c’†^ŠóC‘å“àC“ñ: “gD‚Ì“Á«‚Æ‚»‚Ì”j‰ó‹@\D•a—‚Æ—Õ°iin pressj
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
90.
²X–Ø^—: MRI‚É‚æ‚éƒAƒ‹ƒcƒnƒCƒ}[•a‚̉摜‰ðÍD˜V”NŠú’s•ðŒ¤‰ïŽ11: 59-61, 1999
91.
ˆäãŒhC¬ì²C´…G–¾C‹g–{‚Žu: ˆÙŠ«ŠD”’Ž¿‚É‚¨‚¯‚é‹ÇŠ_ŒoüˆÛ‚ÌŠgŽU‹’² MRI i3DACj‚É‚æ‚錟“¢DCI Œ¤‹†22: 259-262, 2000
92.
¼ì‘׳C“y”ìŽçC“n•Ó”üŠì—YC—é–Ø—Ï•ÛC¬ì²: ƒXƒtƒBƒ“ƒSƒŠƒ“Ž‰Ž¿
Sphyngosylphosphorylcholine ‚É‚æ‚é”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚Ì”¶‹@˜D”]ŒŒŠÇ¹k12: 226-229, 2000
93.
“n•Ó”üŠì—YC“y”ìŽçC¼ì‘׳C—é–Ø—Ï•ÛC¬ì²Cìè@•qC²X–ؘa•F: ”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚ɑ΂·‚é Rho kinase inhibitor
Y-27632 ‚Ì—}§Œø‰ÊD”]ŒŒŠÇ¹k15: 247-250, 2000
94.
‹g“c—YŽ÷C¬ì²C•“c´ŽiC˜a“cŽiCŽçŒû®C—é–Ø—Ï•Û: ”íŠkoŒŒ‚ɑ΂·‚é“àŽ‹‹¾‰ºŒŒŽî‹zˆøpD”]‘²’†22: 605-609, 2000
95.
‘åŠÔX^ˆêC‹g“c—YŽ÷C—é–Ø—Ï•ÛC¬ì²C”óŒûh: ŠâŽèŒ§‚É‚¨‚¯‚é‚‚à–Œ‰ºoŒŒ‚Ì”Çó‹µ@•½¬3”N‚©‚çD”]‘²’†22: 623-627, 2000
96.
ŽÄ“àˆê•vC•Ê•{‚–¾CrˆäŒ[ŽjC¬Š}Œ´–MºC“y”ìŽçC¬ì²: ‘o“à”dŽí‚𗈂µ‚½craniopharyngioma‚Ì1Ç—áDVŠƒˆã‰ïŽ114: 500, 2000
97.
‰““¡‰p•FCŠÖ”Ž•¶C›Œ´FsC–p‰ir: ‰º‚‘Ì”^ᇂÌ1—áDVŠƒˆã‰ïŽ114: 500, 2000
98.
éF–›C¬•Û“àŽåÅF’†•_ŒoŒnŒ´”«ˆ««ƒŠƒ“ƒpŽî‚ɑ΂µHigh Dose
Methotrexate iHDMTXj—Ö@‚ðs‚Á‚½1Ç—áDVŠƒˆã‰ïŽ114: 497-498, 2000
99.
ˆäãŒhC’†—¢M˜aCŒG•”rGC‹g–{‚ŽuC´…G–¾CŽÐ–{”Ž: fMRI‚ð—p‚¢‚½Œ¾Œê—DˆÊ”¼‹…‚Ì“¯’èDVŠƒˆã‰ïŽ114: 496, 2000
100.
Ø‘Ö“TGCç—tCC“ú‚“O—YFƒ‚ƒ„ƒ‚ƒ„•a‚ɇ•¹‚µ‚½”j—ô”]“®–¬áŽ‚ÉŠJ“ªªŽ¡p‚ðs‚Á‚½1—áD VŠƒˆã‰ïŽ114: 490, 2000
101.
•Ê•{‚–¾C¬—ѳ˜aCrˆäŒ[ŽjC®–ìLC¬Š}Œ´–MºC“y”ìŽçC¬ì²C¬—ѽˆê˜Y: High-fiow
bypass ‚ð—p‚¢‚Ä“Eop‚ðs‚Á‚½ŠC–ÈÖ¬“´ZÒõŽî‚Ì1—áD“Œ–k”]Žîᇌ¤‰ïŽ4: 58, 2001
102.
¼ì‘׳CKŽ¡F—TC“y”ìŽç: ƒZƒƒgƒjƒ“‚É‚æ‚Á‚Ĉø‚«‹N‚±‚³‚ꂽƒEƒV”]ŒŒŠÇ•½ŠŠ‹ØŽûk‚É‚¨‚¯‚é Rho-kinase ‚É‚æ‚é‘‹‹@\DŠâŽèˆãŽ53: 117-127, 2001
103.
‘¾“cŒ´N¬C¬Š}Œ´–MºC“y”ìŽçC¬ì²: Permanent
symptomatic vasospasm‚ÌŒŸ“¢D ”]ŒŒŠÇ¹k16: 222-225, 2001
104.
¼ì‘׳C“y”ìŽçCKŽ¡F—TC“n•Ó”üŠì—YCìè•qC–Ø‘ºáÁŒáC¬ì²C²X–ؘa•F: ƒXƒtƒBƒ“ƒSƒŠƒ“Ž‰Ž¿
Sphingosylphosphorylcholine ‚É‚æ‚é”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚É‚¨‚¯‚é Rho Kinase‚ÌŠÖ—^D”]ŒŒŠÇ¹k16: 283-286, 2001
105.
“y”ìŽçC¼ì‘׳C“n•Ó”üŠì—YCKŽ¡F—TC¬ì²Cìè•qC–Ø‘º^ŒáC²X–ؘa•F: Myosin
light chain phosphataseŠˆ«‚Ì’²ß‚É‚æ‚é”]ŒŒŠÇ‚ÌŽûk§Œä‹@\D ”]ŒŒŠÇ¹k 16: 290-293, 2001
106. ‹g“c—YŽ÷: ”]ŒŒŠÇáŠQDŽ¡—Ã83:
113-119, 2001
107.
‰““¡‰p•FC•Ê•{‚–¾CrˆäŒ[ŽjC¬Š}Œ´–MºC—é–Ø‹C—é–Ø—Ï•ÛC¬ì²CÄ“¡—§‰ØCàVˆä‚Žu: ŠC–ÈÖ¬“´•”ƒAƒXƒyƒ‹ƒMƒX“÷‰èŽî‚Ì1—áDNeurol Surg 29: 325-329,
2001
108.
‹g“cŒ¤“ñC—é–Ø—Ï•ÛCH“¡–¾C¬ì²: ƒNƒ‚–Œ‰ºoŒŒŒã‚Ì”]ŒŒŠÇ¹k‚ɑ΂·‚éRƒgƒƒ“ƒrƒ“Ü‚ÌŽ¡—ÃŒø‰Ê‚ÉŠÖ‚·‚錤‹† \ Z“§ˆ³ƒ|ƒ“ƒv‚É‚æ‚鎑±‘‰to“à“Š—^–@‚ð—p‚¢‚Ä \D”]_ŠOƒWƒƒ[ƒiƒ‹10: 104-109, 2001
109.
ˆ¢•”[áC^£’q•FC‰““¡‰p—YC¬ì²: Ž‹‘©ŠÇŠJ•úp‚ª—L—p‚Å‚ ‚Á‚½2—áD“ú‹~‹}ˆã‰ïŽ12: 67-70, 2001
110.
¬Š}Œ´–Mº: ”]zŠÂ‘ãŽÓ‚ÌŠî‘bDƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO17: 10-16, 2001
111.
²X–Ø^—: MRI‚É‚æ‚éƒAƒ‹ƒcƒnƒCƒ}[•a‚̉摜f’fD˜V”NŠú’s•ðŒ¤‰ïŽ12: 24-26, 2001
112.
“n•Ó”üŠì—YC‹v•Û’¼•FC” 轎iCŒK“c’m”VC–åŠÔM”ŽC¬ì²: “ªŠW“à capillary hemangioma ‚Ì1—áDNeurol Surg 29: 1049-1054, 2001
113.
ˆÀ“cd: ¸_•ª—ô•a‚É‚¨‚¯‚鉹ŠyŒ¶’®‚ÌÓ”C•”ˆÊDŠâŽèˆãŽ54: 189-193, 2002
114.
²X–Ø^—C¼‰iŒåC•yàVLsC‰“ŽRe“ñ˜YC‹Êì–FtC¬ì”Ž”V: 3 Tesla‘•’u‚ð—p‚¢‚½ƒCƒkCƒlƒR”]‚ÌMRŠŒ©D“úŽ¥ˆãŽ22: 30-31, 2002
115.
‹Tˆä~C²X–Ø^—CÔâ^“Þ”üCç“cŸˆê: Ž¥‹C‹¤–‰摜‚ňÙí‚ð”F‚ß‚½EBƒEƒCƒ‹ƒX”]Ç‚É‚æ‚é•sŽv‹c‚Ì‘‚̃AƒŠƒXÇŒóŒQ‚Ì1—áD”]‚Æ”’B34: 348-35, 2002
116.
Š‹‘×FC•Ê•{‚–¾CŽÄ“àˆê•vC¬Š}Œ´–MºC¬ì²C•£Œ°: èò•”–À‘–_ŒoŒ´”malignant peripheral
nerve sheath tumor iMPNSTj‚Ì1—áDNeurol Surg 5: 523-526, 2002
117.
ã–ìˆçŽqC“¡Œ´r˜YC¼“c_ˆêC‹T“c¹ŽuC“yˆäÍ’jCˆäãŒhC¬ì²: ‚RŽŸŒ³—̈æŠg’£–@‚ð—p‚¢‚½”]MRI‰æ‘œ‚©‚ç‚ÌŽîᇗ̈撊oDMŠw‹Z•ñ11: 23-28, 2002
118.
²X–Ø‹P•vCrˆäŒ[ŽjCˆ¢•”[áC㙌›KC›ˆä•ÛC¬Š}Œ´–MºC’†‘ºáÁˆêC¬ì²: •@‘¤”¼–Ó‚ð’悵‚½ˆÆã•”ˆÙŠ«‰º‚‘Ì‘BŽî‚Ì1—áD”]_ŠOƒWƒƒ[ƒiƒ‹12: 124-128, 2003
119.
¼–{‰p–¾C˜a“cŽiC•“c´ŽiC‹g“c—YŽ÷C‰œŒû‘ìC¬Š}Œ´–MºC¬ì²C•½‰êŒbC‚‹´–¾: “ªŠWŠOŒã‚ÉŠg‘å‚ð‚Ý‚½ƒxƒ‹ƒKo‚Ì1—áDNeurol Surg 31: 297-301, 2003
120.
‹g“c—YŽ÷C•“c´ŽiC˜a“cŽiC‰œŒû‘ìC‰““¡dŒúC¬ì²: ‹~‹}ŠO—ˆ‚É‚¨‚¯‚é‹Ù‹}ú“ªp \ dÇ‹}«d–Œ‰ºŒŒŽî‚ÌŽ¡—Ã¬Ñ \D“ú‹~‹}ˆã‰ïŽ14: 179-186, 2003
˜a•¶‘à
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
²“¡—mˆê: ‹¤Å“_Œ°”÷‹¾‚ð—p‚¢‚½¶‘gD‚̃Cƒ[ƒWƒ“ƒO \ “Á‚É×–E“àƒJƒ‹ƒVƒEƒ€ƒCƒIƒ““®‘Ԃ̉Ž‹‰»‚ɂ‚¢‚ÄD “dŒ°ŽGŽ34: 217-219, 1999
2.
²X–ؘa•F: ‚f’`”’‚̉îÝ‚·‚é×–E“àî•ñ“`’B‹@\‚ƃVƒOƒiƒ‹’`”’ƒŠƒ“Ž_‰»‚É‚æ‚é’²ßDŠâŽèˆãŽ51: 327-344,
1999
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
3.
ˆî“c·–çC‰““¡dŒú: ƒGƒ“ƒhƒgƒLƒVƒ“‚ÌŽ¾Š³‚É‚¨‚¯‚é–ðŠ„D“úW’†ˆãŽ6: 337-345, 1999
4.
àVˆä‚ŽuC‰FŒŽ”ü˜a: ƒŠƒEƒ}ƒ`‚Ì•a— \
“®•¨ƒ‚ƒfƒ‹‚Ì•a‘ԉ𖾂Ǝ¡—Âւ̉ž—p \D•a—‚Æ—Õ°17i—ÕŽž‘Š§j: 321, 1999
5.
àVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`iRAjŒ¤‹†‚ÌV‚µ‚¢“®Œü \ “ÁW‚ÉŠñ‚¹‚Ä
\D×–E31: 2-3, 1999
6.
àN—§‰ØCŽR“àL•½: üˆÛ‰è×–E‚Æ”xƒŠƒ‚ƒfƒŠƒ“ƒODˆã‚Ì‚ ‚ä‚Ý3i•ÊûEŒÄ‹zŠíŽ¾Š³j: 91-94, 1999
7.
‰““¡dŒúCŽR“c—T•FCˆäã‹`”ŽCˆî“c·–çC²“¡M”ŽC쑺—²Ž}: ƒTƒCƒgƒJƒCƒ“‚ƃXƒeƒƒCƒh—Ö@D ICU‚ÆCCU 23: 845-851 1999
8.
‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: ”sŒŒÇD‹~‹}ˆãŠw23: 1481-1485,
1999
9.
‰““¡dŒúC’JŒû”ÉCˆî“c·–çC쑺—²Ž}C²“¡M”Ž: ‘½‘ŸŠí•s‘S‚Ì•a‘Ô¶—‚Æf’fD—Õ°“§Í15: 1379-1386,
1999
10.
‰““¡dŒúCŽR“c—T•FCˆäã‹[”ŽCˆî“c·–ç: ‹~‹}ƒZƒ“ƒ^[‚É‚¨‚¯‚銴õÇ‚Ìf’f‚ÆŽ¡—ÃDŠ´õ–hŽ~9: 9-14, 1999
11.
‰““¡dŒúCˆî“c·–ç: SIRS‚ƃGƒ“ƒhƒgƒLƒVƒ“ŒŒÇD Lis 6: 854-858, 1999
12.
ˆî“c·–çC‰““¡dŒú: ƒGƒ“ƒhƒgƒLƒVƒ“‚Ì’è—Ê–@DLis 6: 838-844, 1999
13.
‰““¡dŒúCŽR“c—T•FC’JŒû”ÉCˆî“c·–ç: RƒƒfƒBƒG[ƒ^—Ö@D ICU‚ÆCCU 23: 351-356, 1999
14.
‰““¡dŒúCŠ‹¼Œ’CŽR“c—T•FC’JŒû”ÉC²“¡M”ŽC”ì“cŒ\‰îC’r“cŒ’ˆê˜YCˆî“c·–ç: systemic
inflammatory response syndrome‚É‚¨‚¯‚銴õÇf’f‚¨‚æ‚ÑdÇ“x‚ÌŽw•W‚Æ‚µ‚ẴvƒƒJƒ‹ƒ`ƒgƒjƒ“’l‘ª’è‚̈Ӌ`DNP‚ƖƉu 8: 1-6, 1999
15.
‰““¡dŒúCŽR“c—T•FCˆî“c·–ç: dÇ•a‘Ԃł̃Gƒ“ƒhƒgƒLƒVƒ“ŒŒÇ‚ɑ΂·‚é‘ÎôDW’†Ž¡—Ã11: 169-174,
1999
16.
àVˆä‚Žu: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚ÌŒ»‹µ‚Æ–â‘è“_D“úˆã‰ï‘‰ï25‰ñ‰ïŽ3: 448, 1999
17.
àVˆä‚ŽuC‰FŒŽ”ü˜a: ƒŠƒEƒ}ƒ`‚Ì•a— \
“®•¨ƒ‚ƒfƒ‹‚Ì•a‘ԉ𖾂Ǝ¡—Âւ̉ž—p \D•a—‚Æ—Õ 17: 321, 1999
18.
ˆî“c·–ç: ƒGƒ“ƒhƒgƒLƒVƒ“‚Ì‘ª’è–@‚ð‚ß‚®‚Á‚ÄDƒGƒ“ƒhƒgƒLƒVƒ“ŒŒÇŽ¡—ÃŒ¤‰ïŽ 43: 177-196A2000
19.
‰““¡dŒúCˆî“c·–ç: SIRS‚ƃGƒ“ƒhƒgƒLƒVƒ“ŒŒÇDŒ»‘ãˆã—à 32i‘Š§IIIj: 79-84, 2000
20.
ˆî“c·–çC‰““¡dŒú: ”sŒŒÇ‚Ì—Õ°f’fƒKƒCƒhƒ‰ƒCƒ“‚Æ‚µ‚ẴvƒƒJƒ‹ƒVƒgƒjƒ“D —ÕŒŸ 44: 679-680, 2000
21.
‰““¡dŒúCŽR“c—T•FCˆî“c·–çC쑺—²Ž}C²“¡M”Ž: ‰ŠÇ«ƒƒfƒBƒG[ƒ^[iƒTƒCƒgƒJƒCƒ“‘¼jD W’†Ž¡—Ã12: 247-252, 2000
22.
àVˆä‚Žu: ƒeƒŒƒpƒ\ƒƒW[‚Ì—L—p«‚Æ–â‘è“_DVˆã—Ã308: 80-83, 2000
23.
‰FŒŽ”ü˜aCàVˆä‚Žu: ƒeƒŒƒpƒ\ƒƒW[‚ÌŒ¤‹†–ʂւ̉ž—pDˆã‚Ì‚ ‚ä‚Ý195: 503-510,
2000
24.
‰“ŽRe“ñ˜Y: ƒ~ƒNƒƒOƒŠƒA \
Œ`‘Ô“I“Á«‚Æ‹@”\D×–E32: 4-8, 2000
25.
àVˆä‚ŽuCˆä“¡‹v—YC“y‹´N¬CŠJŒ´¬ˆò: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚ÌŒ»ó‚Æ¡Œã‚Ì–â‘è“_ ƒeƒŒƒpƒ\ƒƒW[‘S‘’²¸‚©‚çDVˆã—Ã326: 95-99, 2002
26.
àVˆä‚Žu: ‰“Šuˆã—Â͂ǂ±‚Ü‚Åi‚Þ‚©DŒŽŠ§–òŽ– 44: 226i816j-232i822j, 2002
27.
ˆÉ“¡‹gŒ«CàVˆä‚Žu: ŠÖ߉Š‚Ì•a—Šw“IŠî‘bD—Õ°‰æ‘œ18: 30-243, 2002
28.
‰FŒŽ”ü˜aC¼–{•s“ñ•vCàVˆä‚Žu: ƒŠƒEƒ}ƒ`«Ž¾Š³‚Ì•a—ŠwDƒŠƒEƒ}ƒ`‰È27: 93-100, 2002
29.
àVˆä‚Žu: ‘•]uƒJƒ‰[ƒAƒgƒ‰ƒX@•a—‘gD‚ÌŒ©•û‚ÆŠÓ•Êf’fi‘æ4”ÅjDˆã‚Ì‚ ‚ä‚Ý 202: 142, 2002
30.
‰“ŽRe“ñ˜Y: ––½_ŒoˆÚA‚ÌŽÀŒ±Žè‹ZD Organ
Biol 10: 59-66, 2003
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
31.
²X–Ø^—C‹y씎•¶C‹Êì–Ft: MRI‚É‚æ‚éŠD”’Ž¿“à\‘¢‚Ì•`oD—Õ°•úü44: 1229-1234,
1999
32.
²X–Ø^—: _ŒoŒn‚ÌMRŽB‘œ–@D“úŽ¥‹C‹¤–ˆã‰ïŽ19: 503-519, 1999
33.
²X–Ø^—C‹y씎•¶C‹g‰ª–M_C‹Êì–Ft: _ŒoŠ´õǂ̉摜f’fD_Œ¤‚Ìi•à 43: 26-34, 1999
34.
²X–Ø^—C‹Tˆä~: JoubertÇŒóŒQDBrain Med 12: 429-431, 2000
35.
—é–Ø‹: Ò’ÅEÒ‘Ž¾Š³DƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO17: 35-42, 2001
36.
¬Š}Œ´–MºC¬ì²: èò“®–¬•a•ÏD“úˆã‰ïŽi“Á•Ê†; ”]ŒŒŠÇáŠQ‚Ì—Õ°j125: 253-258, 2001
37.
²X–Ø^—: ŠC–ÈÖ¬“´AspergillusÇDBrain Med 13: 93-95, 2001
38.
²X–Ø^—: 3 Tesla MR‰æ‘œ‚É‚¨‚¯‚鎋°‰ºŠjC• ‘¤Ž‹°‚̳í‰ð–UDˆã‚Ì‚ ‚ä‚Ý196: 747-748,
2001
39.
²X–Ø^—C‹y씎•¶C‹Êì–Ft: ‚Ä‚ñ‚©‚ñ‚ÉŠÖ—^‚·‚é”]\‘¢‚̳í‰ð–UD‰æ‘œf’f 21: 126-132,
2001
40.
²X–Ø^—: ¡‚·‚®¸_‰È—Õ°‚ÉŽg‚¦‚é”]ƒCƒ[ƒWƒ“ƒO \
ƒAƒ‹ƒcƒnƒCƒ}[•aD¸_‰ÈŽ¡—à 16: 1011-1015,
2001
41.
²X–Ø^—C•Ê•{‚–¾: ãó‰èˆÙŒ`¬«_Œoã”çŽîá‡DBrain Med 13: 193-195,
2001
42.
•“c´Ži: ¬lC‚—îŽÒ‚Ì“ª’ÉDŽ¡—à 83: 12-18, 2001
43. •“c´Ži: ˆÓŽ¯áŠQDŽ¡—à 83: 225-230, 2001
44.
‹g“c—YŽ÷: ”]‘²’†‚Ì•a—E•a‘ÔD ƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 214: 10-24,
2001
45.
ˆäãŒhC¬ì²C´…G–¾ CŒG•”rGC‹g–{‚Žu: Func Tool‚ðŽg—p‚µ‚½”]‹@”\‰ð͉摜DGE today
46.
¬ì²: “ªŠWŠO \
“àƒoƒCƒpƒXp‚Í—LŒø‚ÈŽ¡—Ö@‚½‚肤‚é‚©D“ú–{‚Ì’§íFJET study. EBMƒWƒƒ[ƒiƒ‹2: 50-54, 2001
47.
ˆäãŒhC¬ì²: V‚µ‚¢f’f–@ fMRI, 3DACDƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 17: 55-59, 2001
48.
²X–Ø^—C‹g‰ª–M_: Š´õ«”]“®–¬áŽDBrain Med 13: 299-301, 2001
49.
²X–Ø^—: 3 Tesla MRI‚ÌŒ»ó‚Æ¡ŒãD‰f‘œî•ñƒƒfƒBƒJƒ‹33: 958-962,
2001
50.
¬Š}Œ´–MºC¬ì²: ”]“®–¬áŽ‚ÌŽèpDClin Neurosci 19: 27-29, 2001
51.
¬ì²: JET study
Group, ”]‘²’†‚ÌŠO‰È‚É‚¨‚¯‚éEBM-JET study‚ð’†S‚ÉD”]_ŠOƒWƒƒ[ƒiƒ‹10: 596-603, 2001
52.
¬Š}Œ´–MºC¼ì‘׳: ŒÝ‚¢‚ɉe‹¿‚·‚éS‘Ÿ‚Æ”]DƒuƒŒƒCƒ“ƒi[ƒVƒ“ƒO 18: 17-21,
2001
53.
¬Š}Œ´–MºC¬ì²: •W€Ž¡—ÂÆÅVŽ¡—à \ ƒƒŠƒbƒgEƒfƒƒŠƒbƒg@Œz•”“àèò“®–¬‹·óÇDClin Neurosc 20: 110-111, 2001
54.
²X–Ø^—: ŠC”n‘ÌC‘Ñó‰ñC”]—ÀDMedicin 38: 32-37, 2001
55.
¬Š}Œ´–MºC¬ì²: 1. Ä”‚ð–h‚®@“ÁWQ4@Ä”—\–h‚Ì‚½‚ß‚Ì”]ŒŒŠÇ‚̃oƒCƒpƒXŽèp‚ÆC‚»‚ÌŒø‰Ê‚ÍH –ˆ“úƒ‰ƒCƒt1: 27-28, 2002
56.
“y”ìŽçC¬ì²: ”]‘²’†‹}«Šú‚̃}ƒ“ƒjƒg[ƒ‹—Ö@DClin Neurosci
20: 168, 2002
57.
®–ìLC¬ì²: ŒŒsÄŒšp‚͂ǂ̂悤‚ÈꇂÉl—¶‚·‚ׂ«‚©D“à‰È 89: 667-673,
2002
58.
²X–Ø^—: 3 Tesla MRI‚É‚æ‚鎋°‰ºŠj‚Ì“¯’èD”]‚̉Ȋw 24: 451-456,
2002
59.
²X–Ø^—: ƒAƒ‹ƒcƒnƒCƒ}[•a‚̉摜f’fD¸_Ž 104: 455-457,
2002
60.
²X–Ø^—: 3T‘•’u‚Ì—Õ°‰ž—p‚̉”\«DInnervision 17: 58-60, 2002
61.
²X–Ø^—: ”]_ŒoŒn‚Ì‚¨‚¯‚éƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚Ì—L—p«‚Æ–â‘è“_D’f‘w‰f‘œŒ¤‰ïŽ 29: 88-94,
2002
62.
²X–Ø^—: ”]_Œo—̈æ‚É‚¨‚¯‚éMDCT‚ÌŒ»óD Vˆã—Ã334: 82-84, 2002
63.
•Ê•{‚–¾CˆäãŒhC•£Œ°C‰FŒŽ”ü˜aCrˆäŒ[ŽjC¬Š}Œ´–MºC’†‘ºáÁˆêC¬ì²: Diffusion
tensor MRI‚É‚æ‚é¯×–EŒnŽîᇂÌfractional
anistoropy (FA) ’lD‰æ‘œf’f 9: 291-295, 2002
64.
ˆäãŒhC¬ì²: Functional
MRI. Clin Neurosc 20: 1047-1050, 2002
65.
¬Š}Œ´–MºC¬ì²F“ªŠWŠO’Åœ“®–¬‹·óE•ÂÇ«Ž¾Š³‚ɑ΂·‚錌sÄŒšpD”]_ŠO‚Š‚|‚Ž‚‚’‚•11: 783-788,
2002
66.
ˆäãŒhC¬ì²: V‚µ‚¢Ž¡—ÃKƒCƒhƒ‰ƒCƒ“‚ɑ΂µ‚Ä: ”]_ŒoŠO‰È‚Ì—§ê‚©‚çD˜V”NˆãŠw 40: 1767-1769, 2002
67.
¬Š}Œ´–Mº: Œã“ªŠWâ|‹•ŒŒ«•a•Ï‚ɑ΂·‚éSTA-SCA•«‡D”]ŠO‘¬•ñ 12: 222-223, 2002
68.
‹y씎•¶C²X–Ø^—C]Œ´–Î: Mesial
temporal sclerosisD—Õ°ˆã 29isupplj: 832-833, 2003
69.
²X–Ø^—C]Œ´–Î: ‹•ŒŒ«”]Ž¾Š³‚Ì•a‘Ô‚ÆŽ¡—à \ CT, MRI \DŒ»‘ãˆã—à 24: 466-472, 2003
70.
²X–Ø^—C‰“ŽRe“ñ˜YC]Œ´–Î: 3 Tesla MRI‚É‚æ‚é”÷×”]\‘¢‚Ì•`oD”]ŠO‘¬•ñ 13: 973-977,
2003
71.
²X–Ø^—C]Œ´–Î: _ŒoŒn‚É‚¨‚¯‚éƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚ÌV‹Zp‚Æ—Õ°‰ž—pD“úàÕˆã•ñ 48: 128-138, 2003
72.
•Ð“c˜aœAC²X–Ø^—C‚Œ´‘¾˜YC¬—ёהVCˆÀ–ì‘׎jC¼–Ø[: ƒ}ƒ‹ƒ`ƒXƒ‰ƒCƒXCT‚ÌŒ»ó‚Æ«—ˆD‰f‘œî•ñƒƒfƒBƒJƒ‹35: 24-47, 2003
73.
²X–Ø^—C]Œ´–Î: 16—ñMSCT‚Ì—L—p« \
”]_ŒoŒn‚ւ̉ž—p \D Innerviaion 18: 11-13, 2003
74.
²X–Ø^—: ƒ}ƒ‹ƒ`ƒfƒBƒeƒNƒ^CT‚Ì—Õ°•]‰¿ \
“ª•”?“ªèò•” \D
CLINICIAN 340: 113-116,
2003
75.
ˆäãŒhC¬ì²: 3ƒeƒXƒ‰MRI‚Ì—Õ°‰ž—pDVˆã—Ã6: 70-72, 2003
76.
²X–Ø^—C]Œ´–Î: V‚µ‚¢”]‚Ìf’f–@‚͂ǂ̂悤‚É–ð‚É—§‚‚̂© \ MRI \D ‰æ‘œf’f
23, 2003iin pressj
77.
²X–Ø^—CˆäãŒhC]Œ´–Î: ‚±‚ê‚©‚ç‚Ì”]Žîᇂ̉摜f’f: ’´‚Ž¥êMRID—Õ°‰æ‘œ, 2003iin pressj
’˜‘i•ÒW‘ÐE’P’˜j
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
²“¡—mˆêCÒŽR—m‰E: ‘B‘gD‚ÌŽOŽŸŒ³ŒuŒõƒCƒ[ƒWƒ“ƒOCƒoƒCƒIƒCƒ[ƒWƒ“ƒO‚ÌÅæ’[Cpp 176-181, Îìt—¥ ed, æ’[ˆã—Ã, “Œ‹žC1999
2.
²“¡—mˆêC‹{“cß–çCâV–ì’©K: ‚‘¬‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚É‚æ‚éCa2+‚̃}ƒbƒsƒ“ƒO, pp 152-157, ‘gD×–E‰»Šw2000C“ú–{‘gD×–E‰»Šw‰ï edCŠwÛŠé‰æ, “Œ‹ž, 2000
3.
—§ì‰pˆêC‚‹´‰hŽi: –ò—pläóƒTƒ|ƒjƒ“‚Ì–ò•¨Žó—e‘Ì‚Ö‚Ìì—p‚Æ–òŒø \ “`’B•¨Ž¿Žó—e‘Ì‚Ö‚Ìì—p \, pp 58-63, –ò—pläó 2000, ŒF’J˜N ed, ‹¤—§o”Å, “Œ‹ž, 2000
4.
‰“ŽRe“ñ˜YC²X–Ø^—: V”]‰ð–UƒAƒgƒ‰ƒX, ‹´–{ˆóü, ·‰ª, 2001
5.
²X–ؘa•FCìè•qC–Ø‘ºáÁŒáC‚“‡_ˆê˜Y: ƒAƒƒtƒ‰ƒV_Œoß×–E‚ÌD1Žó—e‘ÌŽhŒƒ‚ňø‚«‹N‚±‚³‚ê‚é“àŒü‚«“d—¬‰ž“š‚ÍGTPƒÁS‘¶Ý‰º‚ÅŠOŒü‚«“d—¬‰ž“š‚É‹t“]‚·‚éCpp 41-48, ”]‹@”\‚̉𖾠\¶–½‰ÈŠw‚ÌŽå’ª—¬ \, Ô’r‹I•} ed, ƒKƒCƒAo”ʼnïC‹ãB‘åŠw, 2002
6.
“¡“c—æŽqC–Ø‘ºáÁŒáCìè•qC‚“‡_ˆê˜YC¼–{Œõ”äŒÃC•½–ì_ŽqC²X–ؘa•F: ƒAƒfƒmƒVƒ“Žó—e‘Ì‹y‚ÑFSHŽó—e‘̉ž“š‚ɑ΂·‚éATPŽó—e‘ÌŽhŒƒ‚É‚æ‚é—}§ì—pC pp 83-89, ”]‹@”\‚̉𖾠\
¶–½‰ÈŠw‚ÌŽå’ª—¬ \CÔ’r‹I•} edCƒKƒCƒAo”ʼnï, ‹ãB‘åŠw, 2002
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
7.
—é–Ø–ž, ˆäŒ´—T: ‚ŽŸ”]‹@”\‹Çݘ_‚Ì“WŠJ‚Æ‹@”\C•œ“IŽ¡—ÃŒ¤‹†‚Ì—ðŽjC pp 297-309, —Õ°¸_ˆãŠwuÀspecial issue, ¼‰º³–¾C’‹“cŒ¹Žl˜Y edC’†ŽR‘“X, “Œ‹žC1999
8.
Ø‘ÖÆ—YCƒAƒ“ƒiƒXƒxƒ‹ƒcƒRC•½“c—¤³C•½ˆä‹`ˆêCŒE“c’B–çC’†–ì¹N: ƒvƒƒeƒEƒXLPS‚̶•¨Šˆ«, p 97, ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†II V‚µ‚¢“WŠJC‰¶“c¹•F‘¼ edCتo”Å, “Œ‹ž, 1999
9.
ˆî“c·–çF ƒqƒgƒŠƒ“ƒp‹…‚̃Gƒ“ƒhƒgƒLƒVƒ“‚ɑ΂·‚锽‰ž«C pp 129-135CƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†2 V‚µ‚¢“WŠJ, “ú–{ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†‰ï‘¼•ÒedCتo”Å, “Œ‹žC1999
10.
àVˆä‚ŽuC“n•Ó‚Ý‚©C¯Žiˆê•v: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[jŒ»ó‚Æ¡Œã‚̉ۑèCpp 1691-198, ŠO‰È•a—Šw‘æ3”Å, Îì‰h¢C‰“鎛@’medC•¶Œõ“°C“Œ‹žC1999
11.
Ž—’¹“OC“àŽRˆÀ’j: S‘Ÿ‚ƃAƒ|ƒg[ƒVƒX, pp 86-89C‘ŸŠí•ÊƒAƒ|ƒg[ƒVƒXØ–¾–@C ‘å’Ο‹IC¬˜H••FC“n•ÓŒcˆê edC“ì]“°C“Œ‹žC2000
12.
Sawai T, Uzuki M: In situ hybridization for RNA:
Radioactive DNA probe, pp 100-114, Molecular
Histochemical Techniques, Koji T ed, Springer-Verlag Tokyo,
13.
•½“c—¤³C“c‘ºOŽuC“c’†d‘¥C¬ŒFŒb“ñC’·‰ªŒ÷: CAP18ƒyƒvƒ`ƒh‚É‚æ‚éƒGƒ“ƒhƒgƒLƒVƒ“ƒVƒ‡ƒbƒN‚Ì–hŒäCp 141, ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†III V‚µ‚¢‹Ç–Ê, ŽR–{r•ã‘¼edCتo”ÅC“Œ‹žC2000
14.
ˆî“c·–ç: ƒGƒ“ƒhƒgƒLƒVƒ“‘ª’è–@‚ÌŒ»ó‚Æ–â‘è“_, pp 37-49, ƒGƒ“ƒhƒgƒLƒVƒ“‹z’…—Ö@‚ÌŠî‘b‚Æ—Õ°C ¬‹Ê³’qedCŽ©‘R‰ÈŠwŽÐC“Œ‹žC2000
15.
ˆî“c·–çC‹v•Û‹^“Þ”üC‰““¡dŒú: ƒŠƒ€ƒ‹ƒXƒeƒXƒg‚É‚æ‚錌’†ƒGƒ“ƒhƒgƒLƒVƒ“‘ª’è–@‚Ì–â‘è“_C“Á‚ɃJƒCƒlƒeƒBƒbƒN–@‚É‚¨‚¯‚é”ñ“ÁˆÙ“I”½‰ž‚Ì”¶‚Æ‚»‚Ì—vˆöC pp 203-209, ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†3 V‚µ‚¢‹Ç–ÊC“ú–{ƒGƒ“ƒhƒgƒLƒVƒ“Œ¤‹†‰ï‘¼ edCتo”ÅC“Œ‹žC2000
16.
‹g“c“nCàVˆä‚Žu: ŠÖ߉Š‚̉ð–UŠwCpp 3-6, ŠÖ߉Šƒ‚ƒfƒ‹, ˆÀ”{ç”VCàVˆä‚Žu edC“ú–{ˆãŠwŠÙC“Œ‹žC2000
17.
‹g“c“nCàVˆä‚Žu: ŠÖ߉Š‚̶‰»Šw, pp 7-16, ŠÖ߉Šƒ‚ƒfƒ‹CˆÀ”{ç”VCàVˆä‚Žu edC“ú–{ˆãŠwŠÙC“Œ‹žC2000
18.
‰FŒŽ”ü˜aCàVˆä‚Žu: ŠÖ߉Š‚Ì•a—ŠwCpp 17-24,
ŠÖ߉Šƒ‚ƒfƒ‹CˆÀ”{ç”VCàVˆä‚Žu ed, “ú–{ˆãŠwŠÙC“Œ‹žC2000
19.
àVˆä‚Žu: ‰ä‚ª‘‚É‚¨‚¯‚éƒeƒŒƒpƒ\ƒƒW[‚ÌŒ»óCpp 29-32, —Õ°ŒŸ¸•Ö——CŒŽŠ§Vˆã—à ed, ƒGƒ€EƒC[U‹»‹¦‰ïC“Œ‹ž, 2000
20.
•£Œ°CàVˆä‚Žu: ŒŒŠÇ‰Š‚É‚¨‚¯‚é‘gDŠQ‹@˜Cpp 49-54, ŒŒŠÇ‰ŠC‹´–{”ŽŽj ed, ’©‘q‘“X, “Œ‹ž, 2001
21.
•½“c—¤³: šM“û—Þ‚ª‚‚‚éR‹Û’`”’Ž¿iCAP18j‚̃Šƒ|‘½“œ’†˜aŠˆ«‚ƶ‘Ì–hŒäCp 575, ’`EŠjEyi—ÕŽž‘Š§†jC“àŽR’|•FC’†“ˆôçZC–¼Žær“ñC³–Ø°•F•Ò ed, ‹¤—§o”Å, “Œ‹ž, 2001
22.
àVˆä‚Žu: ‰“Šuˆã—Ẩۑè‚Æ‚±‚ê‚©‚ç‚Ì“WŠJCpp 116-124C’nˆæˆã—Âð•Ï‚¦‚éƒeƒŒƒƒfƒBƒVƒ“C—ìƒeƒŒƒƒfƒBƒVƒ“Œ¤‹†‰ï ed, “Œ—mŒoÏV•ñŽÐ, “Œ‹ž, 2001
23.
àVˆä‚Žu: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚ÌŒ»ó‚Æ–â‘è“_Cpp 3-9, ƒeƒŒƒpƒ\ƒƒW[2002-ŽÀ—p‰»‚Æ”“W‚ð‚ß‚´‚µ‚Ä-CàVˆä‚ŽuCˆä“¡‹v—Y edCˆãŽ•–òo”Å, “Œ‹ž, 2001
24.
‰FŒŽ”ü˜aCàVˆä‚Žu: ƒeƒŒƒpƒ\ƒƒW[‚ÌŒ¤‹†–ʂւ̉ž—pCpp 71-78, •ÊûEˆãŠw‚Ì‚ ‚ä‚Ý@ƒeƒŒƒpƒ\ƒƒW[2002 \
ŽÀ—p‰»‚Æ”“W‚ð‚ß‚´‚µ‚Ä \CàVˆä‚ŽuCˆä“¡‹v—Yed, ˆãŽ•–òo”ÅC“Œ‹žC2002
25.
àVˆä‚ŽuC‰FŒŽ”ü˜aCˆÉ“¡‹gŒ«: ŠÖ߃ŠƒEƒ}ƒ`‚Ì•a—Šw-ŠŠ–Œ‚̉ŠÇ‚©‚眔j‰ó‚Ü‚ÅC pp 22-33, ÅVˆãŠw•Êû@V‚µ‚¢f’f‚ÆŽ¡—ÂÌABC8/–Ɖu1ŠÖ߃ŠƒEƒ}ƒ`, ‹{âM”V ed, ÅVˆãŠwŽÐ, “Œ‹ž, 2002
26.
àVˆä‚ŽuCŠâè^‹|: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[jCpp 43-46CÅ‹ß‚Ì“®Œü‚Æ¡Œã‚̉ۑèC—Õ°ŒŸ¸•Ö——02, ŒŽŠ§Vˆã—à ed, iŠ”jƒGƒ€EƒC[U‹»‹¦‰ï, “Œ‹ž, 2002
27.
àVˆä‚Žu: ŠÖ߃ŠƒEƒ}ƒ`‚Ì•a—E•a‘ÔC pp 112-122, ƒŠƒEƒ}ƒ`Šî–{ƒeƒLƒXƒgià’c–@l“ú–{ƒŠƒEƒ}ƒ`@à’c‹³ˆçŒ¤CˆÏˆõ‰ï•ÒjC“ú–{ƒŠƒEƒ}ƒ`à’c‹³ˆçŒ¤CˆÏˆõ‰ï ed, “ú–{ƒŠƒEƒ}ƒ`à’c, “Œ‹ž, 2002
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
28.
²X–Ø^—: Fast spin
echo–@‚É‚¨‚¯‚éŽB‘œðŒ‚ÌÝ’èCpp 116-117C—Õ°•úŽËü‰È‚̃Rƒc‚Æ—Ž‚Æ‚µŒŠ‚QC¬’Ë—²O edC’†ŽR‘“XC“Œ‹žC1999
29.
²X–Ø^—: Mesial
temporal sclerosis‚ÌMRIf’f‚Æ—Ž‚Æ‚µŒŠCpp 46-47, —Õ°•úŽËü‰È‚̃Rƒc‚Æ—Ž‚Æ‚µŒŠ‚PC¬’Ë—²O edC’†ŽR‘“XC“Œ‹žC1999
30.
²X–Ø^—: _Œo”畆njóŒQCpp 385-396C”]Ò‘‚ÌMRI, ŽRŒûVˆêC‹{â˜a’j edCˆãŠw‘‰@, “Œ‹ž, 1999
31.
²X–Ø^—C‹Tˆä~: ‚Ä‚ñ‚©‚ñCpp 375-384, ”]Ò‘‚ÌMRICŽRŒûVˆêC‹{â˜a’j ed, ˆãŠw‘‰@, “Œ‹ž, 1999
32.
²X–Ø^—: ‰ºƒIƒŠ[ƒuŠj‹U”ì‘å, pp 397-400, ”]Ò‘‚ÌMRICŽRŒûVˆêC‹{â˜a’j ed, ˆãŠw‘‰@, “Œ‹ž, 1999
33.
²X–Ø^—: ‘å”]”玿‘wó‰óŽ€Cpp 404-407C”]Ò‘‚ÌMRICŽRŒûVˆêC‹{â˜a’j ed, ˆãŠw‘‰@, “Œ‹ž, 1999
34.
²X–Ø^—: AlzheimerŒ^’s•ðCpp 201-208, MRIC
—Õ°¸_ˆãŠwuÀS10: ¸_‰È—Õ°‚É‚¨‚¯‚é‰æ‘œf’fC¼‰º³–¾ ed, ’†ŽR‘“X, “Œ‹ž, 2000
35.
²X–Ø^—: 3 Tesla
MRI: ŽB‘œã‚Ì“Á’¥‚Æ’ˆÓ“_C pp 80-83, MRI‰ž—pŽ©Ý, ‚Œ´‘¾˜Y ed, ƒƒWƒJƒ‹ƒrƒ…[C“Œ‹žC 2001
36.
²X–Ø^—: ŠC”nC‘Ñó‰ñC”]—ÀCpp 27-32, CTCMRIƒAƒgƒ‰ƒX \ ³í‰ð–U‚Ɠlje‚̃|ƒCƒ“ƒg C”ª‘ã’¼•¶C‘å—F–MC–ؖΎ÷ ed, ˆãŠw‘‰@C“Œ‹žC2001
37.
‘¾“cŒ´N¬C¬ì²: Ž¸ŒêÇCpp 127-133Cƒi[ƒX‚Ì‚½‚ß‚Ì”]_ŒoŠO‰È@‰ü’ù‘æ2”ÅC 2001
38.
‰œŽ›—˜’jC²X–Ø^—C—é–ØGŒ›C”¨àV‡CˆÉ“¡Žõ‰îCYun Peng
Huang: “à‘å”]Ö¬‚¨‚æ‚уKƒŒƒ“Ö¬‚̉ð–U \ •úŽËüŠw“IƒAƒvƒ[ƒ`C pp 69-80,
Œ°”÷‹¾‰ºŽèp‚Ì‚½‚ß‚Ì”]_ŒoŠO‰È‰ð–UXIV-”]ŽºŒn‚Ì—§‘̉ð–U \C”÷¬”]_ŒoŠO‰È‰ð–UƒZƒ~ƒi[C“Œ‹žC2001
39.
ˆäãŒh: 3.0 Tesla
MRI ‚É‚æ‚é”]ŒŒŠÇ«áŠQ‚Ìf’f‚¨‚æ‚Ñp‘O•]‰¿, pp 86-89, •Êû@ˆãŠw‚Ì‚ ‚ä‚Ý, “Œ‹V‰p•v ed, ˆãŽ•–òo”ÅŠ”Ž®‰ïŽÐC“Œ‹ž, 2001
40.
¬Š}Œ´–MºC¬ì²: ”]ŽåŠ²“®–¬•ÂÇ«•a•Ï–«Šú‚ɑ΂·‚éƒoƒCƒpƒXp‚ÌŒ»óC pp 175-176, •Êû@ˆãŠw‚Ì‚ ‚ä‚Ý, “Œ‹V‰p•v edCˆãŽ•–òo”ÅŠ”Ž®‰ïŽÐ, “Œ‹ž, 2001
41.
²X–Ø^—C‹y씎•¶: ¬Ž™‚Ì”]ŒŒŠÇáŠQ,”]ŒŒŠÇáŠQ‚̉摜f’fCpp 297-307, ‚‹´ºŠì ed, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2002
42.
²X–Ø^—: MDCT‘ÎMRICpp 26-27, MDCT“O’êU—ªƒ}ƒjƒ…ƒAƒ‹C²X–Ø^— edCƒƒWƒJƒ‹ƒrƒ…[, “Œ‹ž, 2002
43.
²X–Ø^—C‰º–쑾˜Y: ”]_Œo: ŠïŒ`C•Ï«C‘ãŽÓˆÙíC’E‘C‰ŠÇCŠOCpp 27-33, •úŽËü‰ÈŠw
\ f’f \C“ú–{•úŽËü‰Èê–åˆã‰ï ed, ƒƒfƒBƒJƒ‹‹³ˆçŒ¤‹†ŽÐC“Œ¼ŽRŽsC2003
44.
²X–Ø^—C‹y씎•¶: ¬Ž™‚Ì”]ŒŒŠÇáŠQCpp 297-307C”]ŒŒŠÇáŠQ‚̉摜f’fC‚‹´ºŠì ed, ’†ŠOˆãŠwŽÐ, “Œ‹ž, 2003
45.
²X–Ø^—: ‰æ‘œf’f?ŒŸ¸: MDCT, pp 333-336C”]ŽîᇂÌÅVˆã—Ã, ‰ÃŽRF³ ed, æ’[ˆã—ËZpŒ¤‹†ŠC“Œ‹žC2003
46.
–؉º—dzC‰œŽ›—˜’jC‰¡“cW: ‘ÙŽ™”]‚Ì”’B, ”]MRI 1. ³í‰ð–U, ‚‹´ºŠìed, GŽÐ, “Œ‹ž
iin pressj
47.
²X–Ø^—C]Œ´–Î: MRI‚ÌV‚µ‚¢ŽB‘œ–@CAnnual Review_Œo2003C–öàVM•vC‘¼ ed, ’†ŠOˆãŠwŽÐC“Œ‹žiin pressj
‘“àƒVƒ“ƒ|ƒWƒEƒ€
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
²“¡—mˆê: ‘gD•W–{‚É‚¨‚¯‚é×–E“àî•ñ“`’BŒn‚̉Ž‹‰»FƒŠƒAƒ‹ƒ^ƒCƒ€‹¤Å“_Œ°”÷‹¾‚É‚æ‚éƒJƒ‹ƒVƒEƒ€ƒCƒ[ƒWƒ“ƒOC‘æ7‰ñƒRƒ“ƒtƒH[ƒJƒ‹488ƒTƒ}[ƒVƒ“ƒ|ƒWƒEƒ€, 1999, 7, ‘O‹´
2.
²“¡—mˆê: ‘gD•W–{‚É‚¨‚¯‚é×–E“àî•ñ“`’BŒn‚̉Ž‹‰»FƒŠƒAƒ‹ƒ^ƒCƒ€‹¤Å“_Œ°”÷‹¾‚É‚æ‚éƒJƒ‹ƒVƒEƒ€ƒCƒ[ƒWƒ“ƒOC ‘æ7‰ñƒRƒ“ƒtƒH[ƒJƒ‹488ƒTƒ}[ƒVƒ“ƒ|ƒWƒEƒ€, 1999, 7, ‘O‹´
3.
‹{“cß–çCÖ–ì’©KC²“¡—mˆê: DAF-2 DA‚É‚æ‚éˆêŽ_‰»’‚‘f‚̃Cƒ[ƒWƒ“ƒO \ V¶Ž™ƒ‰ƒbƒg”|—{S‹Ø×–E‚É‚¨‚¯‚錟“¢ \C‘æ8‰ñ“ú–{ƒoƒCƒIƒCƒ[ƒWƒ“ƒOŠw‰ï, 1999, 10, ‚‚‚Î
4.
’†ìGKC²“¡•¶•FCAmbreena
SiddiqC—ÑOŽOC—§ì‰pˆêC•xŒ´–õ”ŽCVéˆÀ“N: ƒEƒj“ŃŒƒNƒ`ƒ“‚Ì×–E”½‰ž‚ɂ‚¢‚ÄC‘æ47‰ñ“Å‘fƒVƒ“ƒ|, 2000, 7, ‘q•~
5.
²“¡—mˆê: •ª”å×–E‚ÌŠJŒû•úoC‘æ56‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ïƒVƒ“ƒ|ƒWƒEƒ€, 2000, 5, “Œ‹ž
6.
²“¡—mˆêC‹{“cß–ç: ‚m‚n‚̉Ž‹‰»C‘æ56‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ïƒVƒ“ƒ|ƒWƒEƒ€, 2000, 5, “Œ‹ž
7.
²“¡—mˆêC‹{“cß–çCâV–ì’©K: ‚‘¬‹¤Å“_ƒŒ[ƒU[Œ°”÷‹¾‚É‚æ‚éCa2+‚̃}ƒbƒsƒ“ƒOC‘æ25‰ñ‘gD×–E‰»Šw‰ï, 2000, 8, ’¬“c
8.
“¡“c—æŽqC–Ø‘ºáÁŒáCìè•qC‚“‡_ˆê˜YC¼–{Œõ”äŒÃC²X–ؘa•F: ƒAƒtƒŠƒJƒcƒƒKƒGƒ‹‚Ì—‘–E×–E–Œã‚ÌATPŽó—e‘ÌŽhŒƒ‚É‚æ‚éFSHŽó—e‘̉ž“š‚ƃAƒfƒmƒVƒ“Žó—e‘̉ž“š‚Ì—}§,•½¬12”N“x¶—ŠwŒ¤‹†ŠŒ¤‹†‰ï, 2000, 8, ‰ªè
9.
¼ì‘׳C“y”ìŽçC“n•Ó”üŠì—YC—é–Ø—Ï•ÛC¬ì²C–Ø‘ºáÁŒáC²X–ؘa•F: ƒXƒtƒBƒ“ƒSƒŠƒ“Ž‰Ž¿Sphingosylphosphorylcholin‚É‚æ‚é”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚Ì”¶‹@˜C‘æ15‰ñƒXƒpƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€, 2000, 7, ‹ž“s
10.
“n•Ó”üŠì—YC“y”ìŽçC¼ì‘׳C—é–Ø—Ï•ÛC¬ì²Cìè•qC²X–ؘa•F: ”]ŒŒŠÇ‚ÌŽ‘±“IŽûk‚ɑ΂·‚éRho kinase inhibitor Y-27632‚Ì—}§Œø‰ÊC‘æ15‰ñƒXƒpƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€, 2000, 7, ‹ž“s
11.
“y”ìŽçC¼ì‘׳C“n•Ó”üŠì—YC—é–Ø—Ï•ÛC¬ì²C–Ø‘ºáÁŒáC²X–ؘa•F: Rho kinase
activator‚É‚æ‚éŽûk‚ɑ΂·‚éŠeŽí”]ŒŒŠÇŠg’£–ò‚Ì—}§Œø‰ÊC‘æ15‰ñƒXƒpƒYƒ€ƒVƒ“ƒ|ƒWƒEƒ€, 2000, 7, ‹ž“s
12.
‹{“cß–çC²“¡—mˆê: V¶Ž™ƒ‰ƒbƒg”|—{S‹Ø×–E‚É‚¨‚¯‚éˆêŽ_‰»’‚‘f‚̃Cƒ[ƒWƒ“ƒOC‘æ56‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpu‰‰‰ïƒVƒ“ƒ|ƒWƒEƒ€, 2000, 5, “Œ‹ž
13.
²“¡—mˆê: ×–E“àî•ñ“`’BŒn‚Ö‚¨‚æ‚Ú‚·ƒŒ[ƒU[Œõ‚̉e‹¿C‘æ57‰ñ“ú–{“dŽqŒ°”÷‹¾Šw‰ïŠwpW‰ï, 2001, 5, •Ÿ‰ª
14.
Satoh Y, Saino T: Calcium signaling in cytoplasm
and nucleusC‘æ107‰ñ“ú–{‰ð–UŠw‰ï‘‰ï, 2002, 3, •l¼
15.
—§ì‰pˆêCH“¡Œ«ŽOCŠ~–{ˆÐŽu: ƒXƒeƒƒCƒhŒ^–ò—pläóƒTƒ|ƒjƒ“‘ãŽÓ•¨‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‘jŠQì—pC‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, 2002, 2, ·‰ª
16.
H“¡Œ«ŽOC—§ì‰pˆêCŠ~–{ˆÐŽu: ƒjƒ…[ƒƒXƒeƒƒCƒh‚É‚æ‚éƒJƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‘jŠQC‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€, 2002, 2, ·‰ª
17.
Ö–ì’©KC¼‰Y½C²“¡—mˆêFŒŒŠÇ•Ç‚ÌŒoŽž“IƒJƒ‹ƒVƒEƒ€“®‘ÔD‚»‚̃Cƒ[ƒWƒ“ƒO‚ƈӋ`C‘æ108‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2003, 4, •Ÿ‰ª
18.
—§ì‰pˆêCH“¡Œ«ŽOC…ŠÔŒªŽOC‹ß“¡‚ä‚«ŽqCŠ~–{ˆÐŽu: –ò—pläó‚Ì•›t‹@”\—}§F”|—{×–E‚Å‚ÌŒŸ“¢C‘æ76‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2003, 3, •Ÿ‰ª
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
19.
›Œ´~C—é–Ø—Ï•ÛC‹v•ÛŒc‚C‹g“cŒ¤“ñC¬ì²CàVˆä‚Žu: ƒ‰ƒbƒg‘¹”]‚É‚¨‚¯‚éE-selectin‚Ì”Œ» \
Thrombin‚ÌŠÖ—^‚ɂ‚¢‚Ä \C‘æ11‰ñ_Œo‘¹‚ÌŠî‘bƒVƒ“ƒ|ƒWƒEƒ€, 1999, 12, “Œ‹ž
20.
ˆ¢•”—²ŽuCˆé•”ç–¾CÎèŒb—C‘º“c—²•FC“Œ‹V‰p•v: ’s•ð‚ƃ‚ƒmƒAƒ~ƒ“ì“®ŒnáŠQC‘æ52‰ñ“ú–{Ž©—¥_ŒoŠw‰ï, 1999, 11, L“‡
21.
àVˆä‚ŽuC“n•Ó‚Ý‚©C‰FŒŽ”ü˜aC’†‘ºáÁˆê: –{–M‚É‚¨‚¯‚éf’f•a—ˆã‚Ì•Î݂ƃeƒŒƒpƒ\ƒƒW[‚Ì’nˆæˆã—Âɂ¨‚¯‚é—L—p«C‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
22.
“n•Ó‚Ý‚©CàVˆä‚Žu: ‰“Šu•a—f’fiƒeƒŒƒpƒ\ƒƒW[j‚Ìp’†v‘¬f’f‚É‚¨‚¯‚é—¿‹à‘ÌŒn‚ÉŠÖ‚·‚é’ñˆÄC‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
23.
›Œ´~C—é–Ø—Ï•ÛC‹v•ÛŒc‚C‹g“cŒ¤“ñC¬ì²CàVˆä‚Žu: Rƒgƒƒ“ƒrƒ“ÜiƒAƒ‹ƒKƒgƒƒoƒ“j‚̃‰ƒbƒg‚Ì‘¹”]‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä \ ŒŒŠÇ‚É‚¨‚¯‚éÚ’…•ªŽqiintercellular adhesion molecule (ICAM)-1j‚Ì”Œ»‚ÆMac-1—z«×–E‚ÌZ \C‘æ12‰ñ_Œo‘¹‚ÌŠî‘bƒVƒ“ƒ|ƒWƒEƒ€, 2000, 12, “Œ‹ž
24.
•£Œ°CàVˆä‚Žu: ‘ŸŠí•Êu‹`‚ւ̉摜‰ž—pC‘æ89‰ñ“ú–{•a—Šw‰ï‘‰ï, 2000, 4, ‘åã
25.
‰FŒŽ”ü˜aCàVˆä‚Žu: _ŒoE“à•ª”åŒn‚Æ–«ŠÖ߃ŠƒEƒ}ƒ`C‘æ44‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïEŠwpW‰ï, 2000, 5, ‰¡•l
26.
‰FŒŽ”ü˜aCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`‰Šú‚ÌŠŠ–Œ•a•ÏC‘æ44‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïEŠwpW‰ï, 2000, 5, ‰¡•l
27.
“c’†^ŠóCàVˆä‚ŽuC’Ò”ü’qŽqC“¡ˆäŽ”V: –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚鉊ú“a•Ï \ MRL/lƒ}ƒEƒX‚ðŽ¾Š³ƒ‚ƒfƒ‹‚Æ‚µ‚½•a—‘gDŠw“IŒŸ“¢C‘æ44‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïEŠwpW‰ï, 2000, 5, ‰¡•l
28.
‰FŒŽ”ü˜aCù–ìŒöLCŒËP˜alC‘º¼N¬C‚‹´˜aLC‰«—²C”Ñ–ì˜a”üCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`iRAjŠŠ–Œ‘gD‚ÆŠÖ߉t‚É‚¨‚¯‚éurocortinCCRF‚ÆCRF receptor‚Ì”Œ»C‘æ10‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 2000, 10, ·‰ª
29.
“c‘º‘¥’jC‰FŒŽ”ü˜aC¼–{•s“ñ•vC—ÍŠÛöC‘•ª³ˆêCàVˆä‚Žu: ‹}‘¬”j‰óŒ^ŒÒŠÖßÇ‚Ì‘å‘Úœ“ª‚É‚¨‚¯‚éurokinase‚¨‚æ‚Ñurokinase-receptor‚Ì”Œ»‚Æœ”j‰ó‚ÌŠÖ˜AC ‘æ10‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 2000, 10, ·‰ª
30.
›Œ´~C—é–Ø—Ï•ÛC‹v•ÛŒc‚C‹g“cŒ¤“ñC¬ì²CàVˆä‚Žu: Rƒgƒƒ“ƒrƒ“܂̃‰ƒbƒg‚Ì‘¹”]‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä \ Ú’…•ªŽq‚Ì”Œ»‚ƉŠÇ«×–EZ‚Ì‘gDŠw“I•]‰¿ \C
‘æ‚P‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€C2001, 2, ·‰ª
31.
ˆ¢•”—²Žu: ƒp[ƒLƒ“ƒ\ƒ“•a‚ÌŽ¡—ÃAƒ‹ƒSƒŠƒYƒ€C‘æ42‰ñ“ú–{_ŒoŠw‰ï‘‰ï, 2001, 5, “Œ‹ž
32.
•½“c—¤³: “à“Å‘f‚Ìì—p‹@\‚ÆCAP18‚É‚æ‚é‚»‚ÌŽ¡—Ö@‚ÌŠJ”CƒVƒ“ƒ|ƒWƒEƒ€: ׋ۓőfŒ¤‹†‚ÌŠî‘b‚Æ‚»‚̉ž—pC‘æ74‰ñ“ú–{׋ۊw‰ï‘‰ï, 2001, 4, ‰ªŽR
33.
Pan LH, Beppu T, Kurose, Yamauchi K, Sugawara,
Ogawa A, Sawai T: Neoplastic cells and proliferating endothelial cells express
connective tissue growth factoriCTGFj in glioblastoma, ‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ From Cell
Biology to Neuropathology, 2002, 2, ·‰ª
34.
Kobayashi T, Kurose A, Sawai T: Expression of
connective tissue growth factor and its relationship to angiogenesis in glioma, ‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€@From Cell
Biology to Neuropathology, 2002, 2, ·‰ª
35.
Uzuki M, Sasano H, Muramatsu Y, Takahashi K,
Totsune K, Oki Y and Sawai T: Corticotropin releasing factoriCRFj family neuropeptides
and CRF receptors in inflammatory disease, ‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ From Cell
Biology to Neuropathology, 2002, 2, ·‰ª
36.
Sugawara A, Suzuki M, Sawai T, Ogawa A:
Therapeutic effects of an antithrombin agent 'argatroban' on the expression of
intercellular adhesion moleculeiICAMj-1 positive vessels and
Mac-1 positive cells in the experimental brain injury of rat, ‘æ2‰ñŠâŽèˆã‰È‘åŠwæ’[ˆã—ÃŒ¤‹†ƒZƒ“ƒ^[ŒöŠJƒVƒ“ƒ|ƒWƒEƒ€ From Cell
Biology to Neuropathology, 2002, 2, ·‰ª
37.
‰FŒŽ”ü˜aCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`‚ƃqƒAƒ‹ƒƒ“Ž_C‘æ46‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ïŠwpW‰ï, 2002, 4, _ŒË
38.
àVˆä‚Žu: ŠâŽèŒ§‚̉“Šuˆã—Âɂ¨‚¯‚éŠâŽèˆã‰È‘åŠw‚̉ʂ½‚·–ðŠ„C‘æ56‰ñ“Œ–kˆãŽt‰ï˜A‡‰ï‘‰ï, 2002, 9, H“c
39.
Γc‹Ó“ñC‰Ôâ’qlC—ÑGˆê˜YC‰“ŽRe“ñ˜Y: “€Œ‹’´”–؂̬‚³‚Èi•àC“ú–{“dŽqŒ°”÷‹¾Šw‰ï‘æ‚S7‰ñƒVƒ“ƒ|ƒWƒEƒ€, 2002, 11, å‘ä
40.
‰“ŽRe“ñ˜YC—ÑGˆê˜YCÔ–ØIC‹´–{’B–ç: ‰t‘̃wƒŠƒEƒ€‚É‚æ‚é‹}‘¬“€Œ‹’uŠ·C“ú–{“dŽqŒ°”÷‹¾Šw‰ï‘æ‚S7‰ñƒVƒ“ƒ|ƒWƒEƒ€, 2002, 11, å‘ä
_ŒoĶE•Ï«Œ¤‹†•”–åi‰æ‘œ‰ðÍ•”–åj
41.
ˆäãŒhC¬ì²C¬Š}Œ´–MºC•Ê•{‚–¾C®–ìL: 3 ƒeƒXƒ‰ MRI ‚É‚æ‚é”÷×”]\‘¢‚¨‚æ‚Ñ”’Ž¿_ŒoüˆÛ•]‰¿F‚‰ð‘œ“x‰æ‘œEŠgŽUƒeƒ“ƒ\ƒ‹‰æ‘œ‚ð—p‚¢‚½ŒŸ“¢C“ú–{”]_ŒoCIŠw‰ï, 2001, 3, •Ÿˆä
42.
²X–Ø^—: ƒAƒ‹ƒcƒnƒCƒ}[•a‚̉摜f’fC‘æ97‰ñ“ú–{¸__ŒoŠw‰ï‘‰ï, 2001, 5, ‘åã
43.
²X–Ø^—: ’´‚Ž¥êMRI‚ð—p‚¢‚½”]‚Ì”÷׉ð–UC‘æ30‰ñ“ú–{Ž¥‹C‹¤–ˆãŠw‰ï‘å‰ï, 2002, 9, “Œ‹ž
44.
²X–Ø^—: ‚‰ð‘œ“xMRI‚ð—p‚¢‚½‚Ä‚ñ‚©‚ñ‚̉摜f’fC‘æ19‰ñƒuƒŒƒCƒ“ƒtƒ@ƒ“ƒNƒVƒ‡ƒ“ƒCƒ[ƒWƒ“ƒOƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX, 2003, 9, _ŒË
‘“àŠw‰ï
•a‘ԉ𖾕”–åi¶—•”–åj@
1.
Miyata S, Saino T, Satoh Y: The imaging of
nitric oxide on neonatal rat cardiomyocytes, ‘æ105‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2000, 3, ‰¡•l
2.
Saino T, Matsuura M, Satoh Y: Digital imaging
analysis on intracellular calcium ion dynamics of rat arterioles, ‘æ105‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2000, 3, ‰¡•l
3.
“nç³´ŽqC‹{“cß–çCÖ–ì’©KC²“¡—mˆê: Intracellular
calcium ion dynamics in the rabbit corneal epithelium, ‘æ105‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2000, 3, ‰¡•l
4.
Koji T, Nishikawa Y, Doi M, Kimura S, Kawasaki
S, Sasaki K, Ogawa A: Involvement of Rho-kinase activation in the thromboxane A2-induced
contraction in the middle cerebral artery of bovine, ‘æ78‰ñ“ú–{¶—Šw‰ï‘å‰ï, 2001, 3, ‹ž“s
5.
Kawasaki S, Kimura S, Fujita R, Takashima K,
Sasaki K: Role of small G-protein Rho in 5-HT-induced facilitation of
voltage-dependent Ca2+ channel, ‘æ78‰ñ“ú–{¶—Šw‰ï‘å‰ï, 2001, 3, ‹ž“s
6.
Kimura S, Kawasaki S, Fujita R, Takashima K,
Sasaki K: CaM-kinase II and protein phosphatase 2A regulate quisqualic
acid-induced K+-current response in the ganglion cells of Aplysia, ‘æ78‰ñ“ú–{¶—Šw‰ï‘å‰ï, 2001, 3, ‹ž“s
7.
—§ì‰pˆêCH“¡Œ«ŽOCŠ~–{ˆÐŽuC…ŠÔŒªŽOCŠ~–{ˆÐŽu C‹{Žè‹`˜aCŠaè~C‚‹´Ÿ—YC’·’JìG•v: –ò—pläóƒXƒeƒƒCƒhƒTƒ|ƒjƒ“‘ãŽÓ•¨‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ɑ΂·‚éŒø‰ÊC‘æ52‰ñ“ú–{–ò—Šw‰ï–k•”‰ï, 2001, 10, ŽD–y
8.
H“¡Œ«ŽOC—§ì‰pˆêC‹ß“¡‚ä‚«ŽqCŠ~–{ˆÐŽu: ƒjƒRƒ`ƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘ÌŽhŒƒ‚É‚æ‚éƒJƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ɑ΂·‚éƒvƒŒƒOƒlƒmƒƒ“—°Ž_‚Ì—}§‹@\C‘æ52‰ñ“ú–{–ò—Šw‰ï–k•”‰ï, 2001, 10, ŽD–y
9.
Kawasaki S, Kimura S, Fujita R, Takashima K,
Sasaki K: Rho-kinase regulates 5-HT-induced facilitation of voltage dependent
Ca2+ channel, ‘æ24‰ñ“ú–{_Œo‰ÈŠw‘å‰ï, 2001, 9, ‹ž“s
10.
¼ì‘׳CKŽ¡F—TC“n•Ó”üŠì•vC“y”ìŽçC²X–ؘa•FC¬ì²: Serotonin‚É‚æ‚é”]ŒŒŠÇ•½ŠŠ‹Ø‚ÌŽûk‚É‚¨‚¯‚é’ᕪŽq—Ê’`”’‚f’`”’Rho‚ÌŠÖ—^C‘æ17‰ñƒXƒpƒYƒ€EƒVƒ“ƒ|ƒWƒEƒ€, 2001, 3, ‘åã
11.
KŽ¡F—TC¼ì‘׳Cìè•qC–Ø‘ºáÁŒáC“y”ìŽçC¬ì²C²X–ؘa•F: ƒgƒƒ“ƒ{ƒLƒTƒ“‚`‚QŽó—e‘ÌŽhŒƒ‚Å”¶‚·‚é”]ŒŒŠÇŽûk‚É‚¨‚¯‚éRho-kinase‚É‚æ‚éŽûk‘‹‹@\C‘æ17‰ñƒXƒpƒYƒ€EƒVƒ“ƒ|ƒWƒEƒ€, 2001, 3, ‘åã
12.
H“¡Œ«ŽOC—§ì‰pˆêC‹ß“¡‚ä‚«ŽqCŠ~–{ˆÐŽuFƒjƒRƒ`ƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘ÌŽhŒƒ‚É‚æ‚éƒJƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ɑ΂·‚éƒvƒŒƒOƒlƒmƒƒ“—°Ž_‚Ì—}§‹@\C‘æ52‰ñ“ú–{–ò—Šw‰ï–k•”‰ï, 2001, 10, ŽD–y
13.
—§ì‰pˆêCH“¡Œ«ŽOC…ŠÔŒªŽOCŠ~–{ˆÐŽuC‹{Žè‹`˜aCŠaè~C‚‹´Ÿ—YC’·’JìG•v: –ò—pläóƒXƒeƒƒCƒhƒTƒ|ƒjƒ“‘ãŽÓ•¨‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ɑ΂·‚éŒø‰ÊC‘æ52‰ñ“ú–{–ò—Šw‰ï–k•”‰ï, 2001, 10, ŽD–y
14.
²“¡—mˆêCÖ–ì’©K: Bio-imaging
techniques showing morphological and functional changes in living tissue
specimens: application of confocal microscopy, ‘æ106‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2001, 3, ‚’m
15.
²“¡—mˆêCÖ–ì’©K: Imaging of
intracellular calcium dynamics of intestine: with special reference to crypt
cells, ‘æ106‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2001, 3, ‚’m
16.
Watanabe S, Miyata S, Saino T, Satoh Y: ATP-stimulated
[Ca2+]i dynamics in the cultured human corneal epithelial
cells, ‘æ106‰ñ“ú–{‰ð–UŠw‰ï‘‰ïE‘S‘ŠwpW‰ï, 2001, 4, ‚’m
17.
…ŠÔŒªŽOC—§ì‰pˆêCH“¡Œ«ŽOC‹ß“¡‚ä‚«ŽqC‹g“cà†CŠ~–{ˆÐŽu: ‹ÇŠ–ƒŒ–ò‚ªƒEƒV•›t‘Ž¿×–E‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚É—^‚¦‚é‰e‹¿C‘æ75‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2002, 3, ŒF–{
18.
—§ì‰pˆêC‹{Žè‹`˜aCåyè~C’·’JìG•vCH“¡Œ«ŽOC‚‹´Ÿ—YCŠ~–{ˆÐŽu: –ò—pläóƒTƒ|ƒjƒ“‚Æ‚»‚ê‚ç‘ãŽÓ•¨‚Ì•›t”玿ƒRƒ‹ƒ`ƒ]ƒ‹ŽY¶‚ɑ΂·‚éŒø‰ÊC‘æ122‰ñ“ú–{–òŠw‰ï, 2002, 3, ç—t
19.
H“¡Œ«ŽOC—§ì‰pˆêCŠ~–{ˆÐŽu: ƒEƒV•›t‘Ž¿×–E‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ÉŠÖ‚·‚éƒjƒRƒ`ƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘̃Tƒuƒ^ƒCƒv‚̃ŠƒKƒ“ƒh‚É‚æ‚铯’èC‘æ122‰ñ“ú–{–òŠw‰ï, 2002, 3, ç—t
20.
—§ì‰pˆêC’·’JìG•vCH“¡Œ«ŽOC…ŠÔŒªŽOC‹ß“¡‚ä‚«ŽqCŠ~–{ˆÐŽu: –ò—pläóƒXƒeƒƒCƒhŒ^ƒTƒ|ƒjƒ“‘ãŽÓ•¨‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‘jŠQC75‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2002, 3, ŒF–{
21.
…ŠÔŒªŽOC—§ì‰pˆêCH“¡Œ«ŽOC‹ß“¡‚ä‚«ŽqC‹g“cà†CŠ~–{ˆÐŽu: ‹ÇŠ–ƒŒ–ò‚ª‹•›t‘Ž¿×–E‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚É—^‚¦‚é‰e‹¿C75‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2002, 3, ŒF–{
22.
—§ì‰pˆêC‹{Žè‹`˜aCŠaè~C’·’JìG•vCH“¡Œ«ŽOC‚‹´Ÿ—YCŠ~–{ˆÐŽu: –ò—pläóƒTƒ|ƒjƒ“‚Æ‚»‚ê‚ç‘ãŽÓ•¨‚Ì•›t”玿ƒRƒ‹ƒ`ƒ]ƒ‹ŽY¶‚ɑ΂·‚éŒø‰ÊC‘æ122‰ñ”N‰ï–òŠw‰ï, 2002, 3, ç—t
23.
H“¡Œ«ŽOC—§ì‰pˆêCŠ~–{ˆÐŽu: ƒEƒV•›t‘Ž¿×–E‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ÉŠÖ—^‚·‚éƒjƒRƒ`ƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘̃Tƒuƒ^ƒCƒv‚̃ŠƒKƒ“ƒh‚É‚æ‚铯’èC‘æ122‰ñ”N‰ï–òŠw‰ï, 2002, 3, ç—t
24.
Koji T, Nishikawa Y, Doi M, Ogawa A, Sasaki K: Augmenting
mechanism of slowly developing contractile response to the stimulation of thromboxane
A2-receptor in the middle cerebral artery of bovine, ‘æ79‰ñ“ú–{¶—Šw‰ï, 2002, 3, L“‡
25.
Fujita R, Kimura S, Kawasaki S, Takashima K,
Hirano H, Matsumoto M, Sasaki K: Mechanism of P2Y-receptor induced inhibition
of K+-current responses to FSH and adenosine in the follicular cells
of Xenopus oocyte, ‘æ79‰ñ“ú–{¶—Šw‰ï, 2002, 3, L“‡
26.
Takashima K, Kawasaki S, Kimura S, Fujita R,
Sasaki K: Accute modulation of ionotropic receptor responses by progesterone
and estradiol in the ganglion cells of Aplysia, ‘æ79‰ñ“ú–{¶—Šw‰ï, 2002, 3, L“‡
27.
Kimura S, Kawasaki S, Fujita R, Sasaki K: Regulatory
mechanism of K+-current response produced by AMPA-like receptor in
the ganglion cells of Aplysia, ‘æ25‰ñ“ú–{_Œo‰ÈŠw‘å‰ï, 2002,7, “Œ‹ž
28.
Kawasaki S, Kimura S, Fujita R, Sasaki K: Reversal
of an inward current response induced by dopamine to an outward current
response after the intracellular application og GTPgammaS in the ganglion cells
of Aplysia, ‘æ25‰ñ“ú–{_Œo‰ÈŠw‘å‰ï, 2002,7, “Œ‹ž
29.
Koji T, Nishikawa Y, Kawasaki S, Kimura S, Ogawa,
Sasaki K: Regulatory role of PI3-kinase and Rho-kinase in the slowly developing
contraction induced by stimulation of TXA2-receptor in the cerebral artery of
bovine, ‘æ25‰ñ“ú–{_Œo‰ÈŠw‘å‰ï, 2002,7, “Œ‹ž
30.
Kawasaki S, Kimura S, Fujita R, Sasaki K: D1-receptor-induced
response reverses from inward current to outward current after the injection of
guanosinethiophosphate in the ganglion cells of Aplysia, ‘æ80‰ñ“ú–{¶—Šw‰ï‘å‰ï, 2003, 3, •Ÿ‰ª
31.
Fujita R, Kimura S, Kawasaki S, Hirano H,
Matsumoto M, Sasaki K: P2Y-receptor induced inhibition of K+-current
resposes to FSH and adenosine in the follicular cells of Xenopus oocyte, ‘æ80‰ñ“ú–{¶—Šw‰ï‘å‰ï, 2003, 3, •Ÿ‰ª
32.
H“¡Œ«ŽOC—§ì‰pˆêC‹ß“¡‚ä‚«ŽqC…ŠÔŒªŽOCŠ~–{ˆÐŽu: ƒfƒqƒhƒƒGƒsƒAƒ“ƒhƒƒXƒeƒƒ“‚Æ‚»‚Ì—°Ž_‘Ì‚Ì•›t‘Ž¿×–E‚©‚ç‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚ɑ΂·‚é—}§Œø‰ÊC ‘æ76‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2003, 3, •Ÿ‰ª
33.
…ŠÔŒªŽOC—§ì‰pˆêCH“¡Œ«ŽOC‹ß“¡‚ä‚«ŽqCŠ~–{ˆÐŽu: ‹ÇŠ–ƒŒ–ò‚ª‹•›t‘Ž¿×–E‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“•ª”å‚É‹y‚Ú‚·Œø‰ÊC‘æ76‰ñ“ú–{–ò—Šw‰ï”N‰ï, 2003, 3, •Ÿ‰ª
34.
—§ì‰pˆêCH“¡Œ«ŽOC’·’JìG•vCŠ~–{ˆÐŽuC‹{è‰ë—YC•½G°: –ò—pläóƒTƒ|ƒjƒ“‚ª’°“à׋ۂɂæ‚Á‚Ä‚½‚½‚©‚ꂽ‘ãŽÓ•¨‚̓jƒRƒ`ƒ“«ƒAƒZƒ`ƒ‹ƒRƒŠƒ“Žó—e‘Ì‚ðƒuƒƒbƒN‚·‚éC“ú–{–òŠw‰ï123”N‰ï, 2003, 3, ’·è
35.
H“¡Œ«ŽOC—§ì‰pˆêCŠ~–{ˆÐŽuCTu AT: ƒwƒriAgkistrodon contortrix
contortrixj‚̓ʼnt‚©‚番—£‚µ‚½ƒqƒAƒ‹ƒƒjƒ_[ƒ[C“ú–{–òŠw‰ï123”N‰ï, 2003, 3, ’·è
Ž¡—Ö@ŒŸ“¢•”–åi•a—•”–åj
1.
ŒF’JƒC²“¡Ž–¤CàVˆä‚ŽuCì–”•ü–›C²–씎‚C‘•ª³ˆê: äF”‘a•”‘¹‚Ì•a—‘gDŠŒ© \ ŠŠ–Œ‚¨‚æ‚ÑŠÖß•ï‚Ì‘B«‚ƉŠÇ«×–E‚Ì‹ÇÝ \C‘æ14‰ñ“ú–{®Œ`ŠO‰ÈŠî‘bŠwpW‰ï, 1999, 10, “Þ—Ç
2.
ŒF’JƒCì–”•ü–›C²–씎‚C²“¡Ž–¤CàVˆä‚Žu: Š®‘S’f—ô‚É‚¨‚¯‚éäF”Â’f’[‚Ì‘gD•ª—ÞC ‘æ26‰ñ“ú–{Œ¨ŠÖߊw‰ï, 1999, 11, ‘å‹{
3.
²–씎‚CŒF’JƒCàVˆä‚Žu: Ž©‰Æ‘å‘Ú‹Ø–Œpatch–@‚É‚¨‚¯‚éäF‘gD‚¨‚æ‚ÑäFœ•t’…•”‚ÌÄŒ`¬‰ß’ö \ ŽÀŒ±“IŒ¤‹†C‘æ26‰ñ“ú–{Œ¨ŠÖߊw‰ï, 1999, 11, ‘å‹{
4.
ˆî“c·–çC‹v•Û‹^“Þ”üC²“¡¬‘åC‰““¡dŒú: ƒxƒ“Å‘fVTI‚̃qƒgD’†‹…‚Ö‚ÌŒ‹‡‚ÆŠˆ«‰»C ‘æ4‰ñ’°ŠÇoŒŒ«‘å’°‹ÛƒVƒ“ƒ|ƒWƒEƒ€, 1999, 6, ‘åã
5.
ˆî“c·–çC²“¡¬‘åC‰““¡dŒú: ƒxƒ“Å‘f‚É‚æ‚éƒqƒgD’†‹…‚ÌŠˆ«‰»FÚ’…•ªŽq”Œ»‚¨‚æ‚уTƒCƒgƒJƒCƒ“ŽY¶‚Ì‘£iC‘æ72‰ñ“ú–{׋ۊw‰ï, 1999, 3, “Œ‹ž
6.
—é–Ø–ž, –k”©Œ°_, 쑺—@: ‘–¸Œ^“dŽqŒ°”÷‹¾‚É‚æ‚éƒOƒŠƒAŽ²õŠÔ‘ŠŒÝŠÖŒW‚ÌŠÏŽ@C‘æ4‰ñƒOƒŠƒAŒ¤‹†‰ï, 1999, 11, å‘ä
7.
ŽO‰YNGC•£Œ°CàVˆä‚Žu: ‰E‘¤“ª—t‚É”¶‚µ‚½¬Ž™”]ŽîᇂÌ1—áC‘æ1‰ñ“ú–{•a—Šw‰ï“Œ–kŽx•”ŠwpW‰ïE‘æ35‰ñ“ú–{•a—ˆã‹¦‰ï“Œ–kVŠƒŽx•”ŒðŒ©‰ï, 1999, 2, å‘ä
8.
•£Œ°CàVˆä‚Žu: ”ñ’èŒ^“I‚ÈS‹ØÇ‚Ì2—áC‘æ1‰ñ“ú–{•a—Šw‰ï“Œ–kŽx•”ŠwpW‰ïE‘æ35‰ñ“ú–{•a—ˆã‹¦‰ï“Œ–kVŠƒŽx•”ŒðŒ©‰ï, 1999, 2, å‘ä
9.
‹g“c_ŽqCˆÉ“¡°•ûC‹àŽqŽqCŽR“àL•½CΓc—z“ñC~Mˆê˜YCˆäã—m¼CÄ“¡—§‰ØCàVˆä‚Žu: œ‘ˆÙŒ`¬ÇŒóŒQ‚ɇ•¹‚µCNSIP‚ª‹^‚í‚ꂽŠÔŽ¿«”x‰Š‚Ì1—áC‘æ68‰ñ“ú–{ŒÄ‹zŠíŠw‰ï“Œ–k’n•û‰ïE‘æ98‰ñ“ú–{Œ‹Šj•aŠw‰ï“Œ–k’n•û‰ï, 1999, 2, H“c
10.
‰FŒŽ”ü˜a: –«ŠÖ߃ŠƒEƒ}ƒ`‚É‚¨‚¯‚éƒqƒAƒ‹ƒƒ“Ž_iHAj‚Ì“®‘Ô-ƒqƒAƒ‹ƒƒ“Ž_Œ‹‡’`”’(HABP)‚ð—p‚¢‚½ŒŸ“¢C‘æ1‰ñŠâŽè“¤‹†‰ï, 1999, 3, ·‰ª
11.
‰FŒŽ”ü˜aCù–ìŒöLC‘º¼N¬CŒËŠ_˜alC‰«—²C‚‹´˜aLC”Ñ–ì˜a”üCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`ŠŠ–Œ‘gD‚ÆŠÖ߉t‚É‚¨‚¯‚é urocortin ‚¨‚æ‚Ñ CRF receptor‚Ì”Œ»C‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
12.
àN—§‰ØCŽR“àL•½C‹g“c_ŽqC’†¼“OC‘êì³tC‰FŒŽ”ü˜aCˆäã—m¼CàVˆä‚Žu: ”xüˆÛÇ‚É‚¨‚¯‚é connective tissue
growth factoriCTGFj‚Ì”Œ»C‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
13.
àVˆä‚ŽuC‰FŒŽ”ü˜aC“n•Ó‚Ý‚©CŠâè^‹|C{ŽR‹ŽO: ’e«Œ^ƒGƒ‰ƒXƒ`ƒ“‚̉ˋ´ƒAƒ~ƒmŽ_‚̉ðÍ \
”x“®–¬‚Æ‘å“®–¬‚Ì”äŠr \C ‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
14.
¼–씎–¾C‰FŒŽ”ü˜aC—V“¹˜a—YC’†‘ò•s“ñ—YC“n•Ó‘×—TC•ÄŒ´LCàVˆä‚ŽuC–Ø‘º—FŒú: RA‚ÌŠÖߓj‰ó‚É‚¨‚¯‚éapoptosisC‘æ43‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï, 1999, 5, ŽD–y
15.
‹g“c¹–¾CˆêŒË’啶C¼“c~C‹g“c—FŽjC“ˆ‘º³CàVˆä‚ŽuC•£Œ°C‰FŒŽ”ü˜aCˆÀ“¡‹MMC‰““¡N“ñ˜YC¬ŽR“cŠìŒh: A‚Ì•GŠÖß‹ß–T‚É‚Ý‚ç‚ê‚鋑圔XŽî‚Ì”¶‹@˜‚ɂ‚¢‚Ä \ ‰æ‘œ‚¨‚æ‚Ñ•a—‘gDŠw“I‰ðÍ \C‘æ43‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï, 1999, 5, ŽD–y
16.
‰FŒŽ”ü˜aCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`iRAjŠŠ–Œ‘gD‚ÆŠÖ߉t‚É‚¨‚¯‚éurocortin‚Ì”Œ»C ‘æ43‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï, 1999, 5, ŽD–y
17.
òŽR•üC”©ŽR–¾CÖ“¡‹PMCàVˆä‚Žu: ‹ÃŒÅ˜´ió‘ԂƔ畆’×ᇂð’悵‚½ˆ««ŠÖ߃ŠƒEƒ}ƒ`‚Ì1Ç—áC‘æ43‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï‘‰ïEŠwpW‰ï, 1999, 5, ŽD–y
18.
àVˆä‚ŽuC“n•Ó‚Ý‚©C‰FŒŽ”ü˜aCŠâè^‹|C”~“c‰pKC{ŽR‹ŽO: HPLC‚É‚æ‚éƒqƒg‘匌ŠÇƒGƒ‰ƒXƒ`ƒ“‚̉ˋ´ƒAƒ~ƒmŽ_‚̉ðÍC‘æ31‰ñ“ú–{Œ‹‡‘gDŠw‰ï, 1999, 6, –¼ŒÃ‰®
19.
àN—§‰ØCŽR“àL•½C‰FŒŽ”ü˜aC‹g“c_ŽqC ’†¼“OC‘êì³tCˆäã—m¼CàVˆä‚Žu: ”xüˆÛÇ‚É‚¨‚¯‚éconnective tissue growth
factor iCTGFj‚Ì”Œ»C‘æ31‰ñ“ú–{Œ‹‡‘gDŠw‰ï, 1999, 6, –¼ŒÃ‰®
20.
›Œ´–õ‘¥C“c“‡ˆç˜NCŒã“¡—S³C’¹‰H—LC‘ºãGŽ÷C“ˆ‘º³CàVˆä‚ŽuC…àV“TŽqC–x“àŽO˜Y: ƒEƒTƒMŠÖߓ|—{Œn‚É‚¨‚¯‚éƒqƒAƒ‹ƒƒ“Ž_ƒŒƒZƒvƒ^[ˆâ“`Žq”Œ»‚É‹y‚Ú‚·IL-1ƒÀ‚̉e‹¿C ‘æ31‰ñ“ú–{Œ‹‡‘gDŠw‰ï, 1999, 6, –¼ŒÃ‰®
21.
‰FŒŽ”ü˜aCù–ìŒöLC‘º¼N¬CŒËP˜alC‚‹´˜aLC‰«—²C”Ñ–ì˜a”üCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`ŠŠ–Œ‘gD‚ÆŠÖ߉t‚É‚¨‚¯‚éurocortin‚¨‚æ‚Ñ CRF receptor‚Ì”Œ»C‘æ31‰ñ“ú–{Œ‹‡‘gDŠw‰ï, 1999, 6, –¼ŒÃ‰®
22.
•£Œ°CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`‚Ì×–EŒv—ÊŠw“I‰ðÍC ‘æ9‰ñ“ú–{ƒTƒCƒgƒƒgƒŠ[Šw‰ï, 1999, 6, ŽD–y
23.
àVˆä‚ŽuC‰FŒŽ”ü˜aC¼–씎–¾: –«ŠÖ߃ŠƒEƒ}ƒ`iRAj‚Ì•a‘Ô‰ðÍ‚©‚玡—Â̌ø‰Ê”»’è‚ÉŽŠ‚é•a—‘gDŠw‚̉ž—p, ‘æ20‰ñ“ú–{‰ŠÇŠw‰ï, 1999, 7, å‘ä
24.
àN—§‰ØCŽR“àL•½C‰FŒŽ”ü˜aC’†¼“OC‘êì³tCˆäã—m¼CàVˆä‚ŽuF”xüˆÛÇ‚É‚¨‚¯‚éconnective
tissue growth factoriCTGFj‚Ì”Œ», ‘æ20‰ñ“ú–{‰ŠÇŠw‰ï, 1999, 7, å‘ä
25.
‹g“c¹–¾CˆêŒË’啶C@‘œF‰ÀC“ˆ‘º³C‰FŒŽ”ü˜aC•£Œ°C‹g“c“nCàVˆä‚Žu: RA‚Ì‹‘圔XŽî‚É‚¨‚¯‚éMMP‚Æ‚»‚Ì‘jŠQy‘f‚Ì”Œ»‚ɂ‚¢‚ÄC‘æ504‰ñŠâŽèˆãŠw‰ï—á‰ï, 1999, 8, ·‰ª
26.
•£Œ°CàVˆä‚Žu: AIDS‚Ì•a—FƒƒVƒAAIDSƒZƒ“ƒ^[‚̃GƒCƒY–UŒŸ—á‚ɂ‚¢‚ÄC‘æ505‰ñŠâŽèˆãŠw‰ï—á‰ï, 1999, 9, ·‰ª
27.
àN—§‰ØCŽR“àL•½C‰FŒŽ”ü˜aC ’†¼“OC‘êì³tCˆäã—m¼CàVˆä‚Žu: üˆÛ‰»”x‚É‚¨‚¯‚éconnective tissue growth
factoriCTGFj‚Ì”Œ»‚Æ‚»‚Ì‹ÇÝC ‘æ7‰ñ”xƒŠƒ‚ƒfƒŠƒ“ƒOŒ¤‹†‰ï, 1999, 10, “Œ‹ž
28.
•£Œ°C‹g“c¹–¾CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ”|—{×–E‚Ì‘B“®‘ԂƃAƒ|ƒg[ƒVƒX‚Ì—U“±C‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
29.
‰FŒŽ”ü˜aC¼–씎–¾C—V“¹˜a—YC’†‘ò•s“ñ—YC•ÐŽR—ŒbC–Ø‘º—FŒúCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`“gD‚É‚¨‚¯‚éƒAƒ|ƒg[ƒVƒXC‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
30.
@‘œF‰ÀC‰FŒŽ”ü˜aC‹g“c¹–¾C‹g“c“nC“ˆ‘º³CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É‚¨‚¯‚éinterleukiniILj-18‚Ì“®‘Ô, ‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
31.
‹g“c¹–¾CˆêŒË’啶C@‘œF‰ÀC“ˆ‘º³C‰FŒŽ”ü˜aC•£Œ°C‹g“c“nCàVˆä‚ŽuCˆÀ“¡‹MMC‰““¡N“ñ˜Y: RA‚Ì‹‘圔XŽî‚É‚¨‚¯‚éMMP‚ÆTIMP mRNA‚Ì”Œ»‚ɂ‚¢‚ÄC‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
32.
“c‘º‘¥’jC‰FŒŽ”ü˜aC¼–{•s“ñ•vC—ÍŠÛöC‘•ª³ˆêCàVˆä‚Žu: ‹}‘¬”j‰óŒ^ŒÒŠÖßÇ‚ÌŠŠ–Œ‚É‚¨‚¯‚éplasminogen
activatoriPAj‚Æ‚»‚Ìreceptor‚Ì”Œ»‚Æœ”j‰ó‚ÌŠÖ˜AC ‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
33.
‹g“c“nC‰FŒŽ”ü˜aC•£Œ°C²“¡FC‹g“c¹–¾C¼“c~C“ˆ‘º³CàVˆä‚Žu: F‘f«ãO–ÑŒ‹ß«ŠŠ–Œ‰ŠiPVSj‚Ì×–EŠw“I“Á’¥C‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
34.
àN—§‰ØCŽR“àL•½C‰FŒŽ”ü˜aC’†¼“OC‘êì³tCˆäã—m¼CàVˆä‚Žu: üˆÛ‰»”x‚É‚¨‚¯‚éconnective tissue growth
factoriCTGFj ‚Ì”Œ»‚Æ‚»‚Ì‹ÇÝC‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
35.
—é–Ø—zŽqC”©ŽR–¾CòŽR•üC‰FŒŽ”ü˜aCàVˆä‚Žu: ‘½”«’P_Œo‰Š‚ðŽåÇó‚Æ‚µ‚½ANCAŠÖ˜AŒŒŠÇ‰Š‚Ì1—áC‘æ9‰ñ“ú–{ƒŠƒEƒ}ƒ`Šw‰ï–kŠC“¹E“Œ–kŽx•”ŠwpW‰ï, 1999, 10, ŒSŽR
36.
•£Œ°C‹g“c¹–¾C‹g“c“nCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ”|—{×–E‚Ì‘B“®‘ԂƃAƒ|ƒg[ƒVƒX‚Ì—U“±CŠâŽè–Ɖu§˜b‰ï, 1999, 11, ·‰ª
37.
¼–씎–¾C—V“¹˜a—YC‰FŒŽ”ü˜aC•ÄŒ´LC‘å’ι•FC¼‰ª‹vŽõŽ÷CàVˆä‚Žu: V‹Kƒqƒg‰»RFasR‘Ì R-125224ih-HFE7Aj‚Ì–«ŠÖ߃ŠƒEƒ}ƒ`Ž¡—Öò‚Æ‚µ‚Ẳ”\«C‘æ29‰ñ“ú–{–ƉuŠw‰ï‘‰ïEŠwpW‰ï, 1999, 12, ‹ž“s
38.
@‘œF‰ÀC‰FŒŽ”ü˜aC‹g“c¹–¾C‹g“c“nC“ˆ‘º³CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒ‚É‚¨‚¯‚é InterleukiniILj-18‚Ì“®‘ÔC‘æ14‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï, 1999, 12, ‹ž“s
39.
‰FŒŽ”ü˜aCù–ìŒöLCŒËP˜alC‘º¼N¬C‚‹´˜aLC‰«—²C”Ñ–ì˜a”üCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`iRAjŠŠ–Œ‘gD‚ÆŠÖ߉t‚É‚¨‚¯‚éurocortin‚Æ CRF receptor‚Ì”Œ»C ‘æ14‰ñ“ú–{—Õ°ƒŠƒEƒ}ƒ`Šw‰ï‘‰ï, 1999, 12, ‹ž“s
40.
àVˆä‚Žu: ƒqƒg”x“®–¬CƒGƒ‰ƒXƒ`ƒ“‰Ë‹´ƒAƒ~ƒmŽ_—ʂ̉Á—‚æ‚Ñ•a“Ió‘Ô‚É”º‚¤•Ï‰»CThe Meeting
for Elastin Research 1999, 1999, 12,
“Œ‹ž
41.
‹v•ÛŒc‚C—é–Ø—Ï•ÛCH“¡–¾C‹g“cŒ¤“ñC›Œ´~C¬ì²: ƒ‰ƒbƒg”]‘¹‚É‚¨‚¯‚鉊ǫזE‚ɑ΂·‚éRthrombinÜ‚ÌŒø‰ÊC‘æ58‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï, 1999, 10, “Œ‹ž
42.
ˆî“c·–çC‰““¡dŒú: ƒqƒg‚ÌŽ¾Š³‚ƃGƒ“ƒhƒgƒLƒVƒ“ \ Å‹ß12”NŠÔ‚̬т©‚ç \C ‘æ46‰ñ“Å‘fƒVƒ“ƒ|ƒWƒEƒ€, 1999,7, ·‰ª
43.
’†‘ºáÁˆêCàVˆä‚Žu: ‰“Šu•a—f’f‚É]Ž–‚·‚é•a—ˆã‚̃Aƒ“ƒP[ƒg’²¸ \ ˜J“‰ßd‚ɂ‚¢‚ÄC‘æ88‰ñ“ú–{•a—Šw‰ï, 1999, 4, “Œ‹ž
44.
›Œ´~C—é–Ø—Ï•ÛC‹v•ÛŒc‚C‹g“cŒ¤“ñCH“¡–¾C¬ì²CàVˆä‚Žu: Rƒgƒƒ“ƒrƒ“ÜiƒAƒ‹ƒKƒgƒƒoƒ“j‚̃‰ƒbƒg‚Ì‘¹”]‚É—^‚¦‚é‰e‹¿‚ɂ‚¢‚Ä \ Ú’…•ªŽqiIntercellular Adhesion Molecule iICAMj-1j‚Ì”Œ»‚ƉŠÇ«×–E”‚Ì‘gDŠw“I•]‰¿ \C‘æ21‰ñ“ú–{‰ŠÇŠw‰ï, 2000,7, “Œ‹ž
45.
ŽO‰YNGC•£Œ°CàVˆä‚ŽuC•Ê•{‚–¾: Dysembryoplastic
neuroeptitherial tumoriDNTj‚Ì1—áC‘æ3‰ñ“ú–{•a—Šw‰ï“Œ–kŽx•”ŠwpW‰ïE‘æ37‰ñ“ú–{•a—ˆã‹¦‰ï“Œ–kVŠƒŽx•”ŒðŒ©‰ï, 2000, 2, å‘ä
46.
•£Œ°C›Œ´~CàVˆä‚Žu: “ªŒz•”ŽîᇂÌ1—áC‘æ4‰ñ“ú–{•a—Šw‰ï“Œ–kŽx•”ŠwpW‰ï, 2000,7, O‘O
47.
›Œ´~C—é–Ø—Ï•ÛC‹v•ÛŒc‚C‹g“cŒ¤“ñC¬ì²CàVˆä‚Žu: Š£‘‡”ZklRƒgƒƒ“ƒrƒ“III»ÜŽ‘±“I• o“à“Š—^‚É‚æ‚é”]‘¹‚ɑ΂·‚鎡—ÃŒø‰Ê \ ”]‘¹ƒ‚ƒfƒ‹‚É‚æ‚é‘gDŠw“I‰ðÍ \C
‘æ59‰ñ“ú–{”]_ŒoŠO‰ÈŠw‰ï‘‰ï, 2000, 10, “Œ‹ž
48.
àN—§‰ØCàVˆä‚ŽuCˆÉ“¡°•û: ”x‚É‘½”«‹CŽî‚Ì‚Ý‚ç‚ꂽ1—áC ‘æ3‰ñ“ú–{•a—Šw‰ï“Œ–kŽx•”ŠwpW‰ïE‘æ37‰ñ“ú–{•a—ˆã‹¦‰ï“Œ–kVŠƒŽx•”ŒðŒ©‰ï, 2000, 2, å‘ä
49.
•£Œ°CàVˆä‚Žu: ƒŒƒU[ƒXƒLƒƒƒjƒ“ƒOƒTƒCƒgƒƒgƒŠ[ \ Œ`‘ÔŠÏŽ@‚ð‰Â”\‚É‚µ‚½ƒTƒCƒgƒƒgƒŠ[C‘æ510‰ñŠâŽèˆãŠw‰ï—á‰ï, 2000, 3, ·‰ª
50.
‰FŒŽ”ü˜aC“n•Ó’mKCŒj‘דTCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`ŠŠ–Œ‘gD‚É‚¨‚¯‚éƒqƒAƒ‹ƒƒ“Ž_‡¬y‘f \ ‰æ‘œ‰ðÍ‘•’u‚ð—p‚¢‚½y‘fŠˆ«‚Ì’è—ʉ» \C‘æ510‰ñŠâŽèˆãŠw‰ï—á‰ï, 2000, 3, ·‰ª
51.
“c‘º‘¥’jC‰FŒŽ”ü˜aC¼–{•s“ñ•vC—ÍŠÛöC‘•ª³ˆêCàVˆä‚Žu: ‹}‘¬”j‰óŒ^ŒÒŠÖßÇiRDCj‚ÌŠŠ–Œ‘gD‚É‚¨‚¯‚éurokinaseiURasej‚¨‚æ‚Ñurokinase-receptoriUR/Rcj‚Ì”Œ»‚Æœ”j‰ó‚ÌŠÖ˜AC‘æ2‰ñŠâŽè“¤‹†‰ï, 2000, 3, ·‰ª
52.
àVˆä‚ŽuC‰FŒŽ”ü˜aC“n•Ó‚Ý‚©CŠâè^‹|C{ŽR‹ŽO: ”x“®–¬ƒGƒ‰ƒXƒ`ƒ“‚̉ˋ´ƒAƒ~ƒmŽ_‚̉ðÍi2j \
”x“®–¬‚̉Á—‚æ‚Ñ”x‚ŒŒˆ³Ç‚É‚¨‚¯‚é•Ï‰» \C‘æ89‰ñ“ú–{•a—Šw‰ï‘‰ï, 2000, 4, ‘åã
53.
•£Œ°C‹g“c“nC‹g“c¹–¾CàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`Š³ŽÒŠŠ–Œ”|—{×–E‚Ìpaclitaxel‚É‚æ‚é×–E“®‘ԂƃAƒ|ƒg[ƒVƒX‚Ì—U“±C ‘æ89‰ñ“ú–{•a—Šw‰ï‘‰ï, 2000, 4, ‘åã
54. ‰FŒŽ”ü˜aC¼–씎–¾C—V“¹˜a—YC’†‘ò•s“ñ—YC•ÐŽR—ŒbC–Ø‘º—FŒúCàVˆä‚Žu: –«ŠÖ߃ŠƒEƒ}ƒ`“îœ×–E‚É‚¨‚¯‚éƒAƒ|ƒg[ƒVƒX‚Æ’`”’•ª‰ðy‘fC‘æ89‰ñ“ú–{•a—Šw‰ï‘‰ï, 2000, 4, ‘